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Given any rule, however “fundamental” or “necessary” for 
science, there are always circumstances when it is 
advisable not only to ignore the rule, but to adopt its 
opposite. For example, there are circumstances when it is 
advisable to introduce, elaborate and defend ad hoc 
hypotheses, or hypotheses which contradict well-established 
and generally accepted experimental results, or hypotheses 
whose content is smaller than the content of the existing 
and empirically adequate alternative, or self-inconsistent 
hypotheses, and so on.  
 
— Paul K. Feyerabend (1975)  
Against Method: Outline of an Anarchistic Theory of Knowledge. 
  
 
 
 
 
  
Summary. 
 
 
During the last 4 years I have gained important new insights regarding how GABAergic 
neurotransmission influences neuronal synchronization as measured with magnetoencephalographic 
(MEG) recordings in healthy humans. Lorazepam (LZP), a GABAergic enhancer, produced strong 
modulations in occipital oscillatory activity under rest and working memory (WM) conditions. My novel 
insight is that gamma oscillations associated to the stimulus period seem to share common 
neurophysiological mechanisms as the ones described in rat hippocampus models. Specifically, the 
increase of GABA efficacy by LZP increase stimulus-induced gamma oscillations increased in power 
while decreased in frequency. Conversely, alpha oscillations were implicated in functional inhibition 
during top-down periods, being also modulated by lorazepam (LZP). Importantly, I found that 
pharmacologically induced alpha-power reductions predicted WM performance decrease. However, I 
could not find relationship between the drug-related oscillatory activity changes with the endogenous 
GABA concentrations in occipital nor motor cortices as assessed with magnetic resonance 
spectroscopy (MRS). It remains unclear whether this absence of correlation is physiological in nature 
or explained by limitations in the recording techniques. During resting state and during WM information 
maintenance periods, I found that the amplitude envelope of the beta-low gamma band (20 – 45Hz) is 
locked to the ongoing phase of the alpha oscillations (8 – 12Hz). Only the highest LZP dosage during 
resting state affected the alpha to beta-low gamma cross-frequency coupling (CFC). However, the CFC 
metrics employed here did not allow me to distinguish a true neuronal cross-frequency interaction from 
spurious CFC due to the non-sinusoidal properties in the alpha band.  
 
In sum, computational and experimental rat hippocampal models have convincingly demonstrated the 
critical role of GABAergic neurotransmission, especially in fast neuronal oscillations. My work 
contributed to generalize to human visual cortex these physiological mechanisms, showing its 
behavioural relevance during WM operations. 
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CHAPTER 1. 
 
 
General introduction. 
 
A large body of evidence have shown that oscillatory brain activity in multiple frequency bands is 
implicated in cognitive processing. Animal physiology and computational models have demonstrated 
that inhibition through GABAergic neurotransmission controls oscillatory activity. On the other hand, 
recent frameworks suggest that neuronal oscillations in different frequency bands do not work in 
isolation but they interact forming the so-called cross-frequency coupling (CFC). In this thesis I asked 
how neuronal communication through oscillatory activity and CFC are gated by the inhibition of task-
irrelevant regions, thus routing information to the task-relevant regions to get the optimal behavioural 
performance. More specifically, the goal was to study how GABAergic neuronal networks influenced 
oscillatory activity in participants during rest and working memory tasks and how they impacted on 
behavioural performance. To tackle this question, we designed an experiment employing various 
techniques in combination with a pharmacological challenge using Lozarepam (LZP; a GABAergic 
enhancer, see BOX 1). Therefore, I performed a multisession cross-over design to measure the 
GABAergic-induced brain oscillatory activity associated to resting state and working memory operations 
using whole-head human magnetoencephalography (MEG; see BOX 2). In addition, I used in-vivo  
 
 
 
 
 
 
 
 
 
 
 
  
 
magnetic resonance spectroscopy (MRS; see BOX 3) to estimate endogenous GABA concentration   
BOX 1. Lorazepam (LZP). 
The neuron’s most basic response is the action potential, an electrical response produced by voltage 
sensitive membrane receptors. Electrical pulses from pre-synaptic cells produce an influx of calcium in the 
pre-synapse that releases neurotransmitters (NT) in the synaptic cleft. Depending on the type of synapse the 
NTs can depolarize (i.e. glutamate) of hyperpolarize (i.e. GABA) the membrane potential in postsynaptic 
cells. This potential change may open voltage-gated ion channels that resulting in a further depolarization (or 
hyperpolarization in case of inhibitory effect) of the postsynaptic cell. If a threshold is reached, an action 
potential is generated. After the action potential, there is a period (after-hyperpolarization) where the neuron 
is less likely to fire again because the potential inside of the cell relative to the outside is too negative (< -70 
mV). LZP is a common benzodiazepine that binds allosterically to GABAA receptors and enhances chloride 
conductance by increasing its channel opening frequency (Riss et al., 2008). The net effect of the drug results 
in increased GABAergic inhibition. For example, investigations using the diazepam (a benzodiazepine with 
similar mechanisms of action as LZP) in neural tissue find that GABAergic enhancement decreases the 
number of action potentials per burst, leaving the burst rate unaffected (Antkowiak, 1999). 
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magnetic resonance spectroscopy (MRS; see BOX 3) to estimate endogenous GABA concentration 
levels in primary visual and motor cortices. Finally, I pursued to establish a link between LZP-induced 
oscillatory activity and the resting GABA levels, thereby covering the gap between endogenous and 
pharmacologically-induced GABAergic modulations. 
 
In this first introductory chapter, I explain the functional role and physiological mechanisms underlying 
the gamma (>30Hz) and the alpha (8-12Hz) oscillations and how they can interact via CFC. Finally I 
describe the techniques used and the thesis outline. 
 
Functional role of gamma oscillations: information-processing. 
Neuronal synchronization in the gamma band has been associated with the encoding of visual stimuli 
and attention (Fries, 2009). Specifically, gamma power and coherence increase with spatial allocation 
of attention (Fries, Reynolds, Rorie, & Desimone, 2001; Koelewijn, Rich, Muthukumaraswamy, & Singh, 
2013; Womelsdorf, Fries, Mitra, & Desimone, 2006), (but see (Chalk et al., 2010)) and is predictive of 
response times to visual stimuli (Gonzalez Andino, Michel, Thut, Landis, & Grave de Peralta, 2005; 
Womelsdorf et al., 2006). Mechanistically, a gamma cycle could be generated when the firing rate of 
pyramidal neurons trigger inhibitory interneurons which then decrease the pyramidal neurons response. 
When the inhibition dies out, the principal neurons fire again forming the Pyramidal-Interneuronal 
Network Gamma (PING) model (Börgers, Epstein, & Kopell, 2005). In another minimalistic mechanism, 
the Interneuronal Network Gamma (ING) model, only inhibitory interneurons are necessary and 
sufficient for generating gamma oscillations (Whittington, Traub, & Jefferys, 1995). They entrain the 
pyramidal excitatory neurons and as for the PING model, the GABAergic synaptic time constants will 
determine the amplitude and frequency of the gamma oscillations. In ING models, pyramidal neurons 
are the slaves of the inhibitory interneurons. It is still to be determined under which circumstances the 
PING and/or the ING mechanism underlie oscillations in the gamma band (Tiesinga & Sejnowski, 2009). 
Gamma oscillations are thought to establish functional connectivity in a bottom-up manner (Bosman et 
al., 2012; Grothe, Neitzel, Mandon, & Kreiter, 2012). Although stimulus-induced gamma response 
characteristics are dependent on the physical properties of stimuli (see (Brunet, Vinck, Bosman, Singer, 
& Fries, 2014; Hermes, Miller, Wandell, & Winawer, 2015) for a recent debate), it has been shown that 
the neuronal communication between remote populations (i.e. V1 and V2) can be efficiently achieved 
through a wide-range of frequencies (Roberts et al., 2013). Then matching the frequency between 
different neuronal populations facilitate the information transmission between relevant brain areas 
(Fries, 2005). Gamma band activity has also been associated with WM information maintenance. 
Importantly, several studies have demonstrated that oscillatory gamma activity is present during WM 
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delays in monkeys (Pesaran, Pezaris, Sahani, Mitra, & Andersen, 2002) and humans (Howard et al., 
2003; Jokisch & Jensen, 2007; Tallon-Baudry, Bertrand, & Fischer, 2001). All these speak to the role 
of the gamma band in information processing in the visual system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GABAergic inhibition and the gamma band. 
The physiological mechanisms underlying gamma oscillations have been studied intensively in animals. 
In particular recordings from hippocampal rat slices have demonstrated that GABAergic interneurons 
play a crucial role in determining the properties of neuronal gamma oscillations both in terms of 
synchronization and in terms of frequency. For instance it has been shown that inhibitory interneurons 
alone can produce oscillations in the gamma band even if the input from excitatory neurons is blocked 
(Traub, Whittington, & Jefferis, 1999; Whittington, Traub, & Jefferys, 1995). Interestingly, application of 
GABA receptor enhancers modulated the amplitude of the gamma oscillations while decreased its 
frequency due to the prolongation of the inhibitory synaptic time constant (Brunel and Wang, 2003; 
Bartos, Vida, & Jonas, 2007; Traub, Whittington, Colling, Buzsáki, & Jefferys, 1996; Whittington, 
Jefferys, & Traub, 1996). Computational modeling work has demonstrated that GABAergic inhibition 
can indeed promote neuronal synchronization and oscillatory activity in the gamma band (Börgers et 
al., 2005; Traub, Whittington, Stanford, & Jefferys, 1996b; Whittington, Traub, Kopell, Ermentrout, & 
Buhl, 2000). On the other hand, there is a recent report that showed an increase of visual gamma power 
BOX 2. Magnetoencephalography (MEG). 
MEG is a non-invasive technique that measures the magnetic fields arising from electrophysiological brain 
activity. The brain-induced magnetic fields can be reliable recorded when a sufficiently large assembly of 
pyramidal neurons with dendrites oriented in parallel to the cortical surface receive synaptic input in 
synchrony, producing primary currents (Hämäläinen et al., 1993). To measure these very weak fields resulted 
from the primary currents (approximately one millionth of the earth’s magnetic field), it is necessary to use 
superconducting quantum interference devices (SQUIDS) in combination with a magnetically shielded room. 
Thanks to SQUIDS, we can measure oscillatory brain responses outside the head with an excellent temporal 
resolution at the rate of at least 1 ms. 
BOX 3. In-vivo magnetic resonance spectroscopy (MRS). 
MRS is a non-invasive technique able to detect concentrations of endogenous metabolites in the human body 
in-vivo. 1H MRS detects chemical shift properties of the atoms (Puts and Edden, 2012). When participants’ 
brain are in the MR, the NT metabolites are exposed to an external magnetic field that will produce a change 
in the local magnetic field of the NT nuclei. This change leads to a change in the spin frequency of the atom 
and the phenomenon is called chemical shift. It produces radiofrequency signals whose amplitude represents 
a rough estimation of the metabolite concentration and it is expressed in particles per million (ppm) (Bertholdo 
et al., 2013). Different NT resonate at different frequencies because their chemical structure contains a 
different 1H configuration. 
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by benzodiazepines in humans during eye closed/open conditions (Hall, Barnes, Furlong, Seri, & 
Hillebrand, 2010). Furthermore, an influential MRS study found a significant correlation between resting 
GABA concentration and gamma peak frequency in visual cortex using square gratings 
(Muthukumaraswamy, Edden, Jones, Swettenham, & Singh, 2009). However, a more recent 
investigation challenged this relationship using a larger sample than in Muthukumaraswamy et al., (n = 
50 v.s. n = 12). Cousijn et al., found no significant relationship between neither the endogenous GABA 
concentrations in visual cortex as measured with MRS and stimulus-induced gamma peak frequency 
nor amplitude (Cousijn et al., 2014). I use here MRS to investigate whether endogenous GABA 
concentrations as measured with MRS relate to the stimulus-induced gamma frequency and amplitude. 
In addition, I study whether the drug-related gamma changes could be predicted from the GABA levels 
in visual cortex as measured in the MRS spectrum.  
 
In sum, animal research in combination with computational work have demonstrated that GABAergic 
inhibition plays a key role in producing oscillatory gamma activity. However, it remains unclear how 
these mechanisms generalize to human gamma oscillations under strong cognitive demands.  
 
The functional role of alpha oscillations: gating by inhibition. 
Successful WM maintenance depends not only on the preservation of task-relevant representations but 
also on the protection of those representations in the face of intervening distractors. WM benefits from 
inhibiting distracting sensory input during retention (Sauseng et al., 2009). Recent findings suggest that 
posterior alpha activity can serve this purpose. Posterior alpha activity has traditionally been interpreted 
as an idling rhythm (Pfurtscheller, Stancák Jr, & Neuper, 1996) or as the main player during cognitive 
processing (Palva & Palva, 2007). However, the idling hypothesis has been challenged by findings 
demonstrating an increase in alpha power during WM maintenance. In particular the alpha activity was 
shown to increase parametrically with WM load (Jensen, Gelfand, Kounios, & Lisman, 2002; Sauseng 
et al., 2009). On the basis of these findings it was proposed that information is routed by functionally 
blocking off the task-irrelevant pathways: gating by inhibition would be reflected by oscillatory activity in 
the alpha band (Jensen & Mazaheri, 2010; Klimesch, Sauseng, & Hanslmayr, 2007). Furthermore, it 
has been demonstrated that the disengagement of alpha in task-irrelevant regions is associated with 
optimal task performance (Bonnefond & Jensen, 2012; Sauseng et al., 2009; Thut, Nietzel, Brandt, & 
Pascual-Leone, 2006; van Ede, Köster, & Maris, 2012; Worden, Foxe, Wang, & Simpson, 2000). 
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GABAergic inhibition and the alpha band. 
GABA transmission has recently also been implicated in oscillatory activity in the alpha band. 
Computational models suggested the strong influence of GABAergic feedback from interneurons and 
the calcium T-currents (Jones, Pinto, Kaper, & Kopell, 2000). Thalamic inhibitory interneurons firing rate 
has been linked to the occipital alpha band in cats (Lörincz, Crunelli, & Hughes, 2008; Lőrincz, Kékesi, 
Juhász, Crunelli, & Hughes, 2009). Although the oscillatory alpha activity has been studied since the 
late 1920s, the neurophysiological mechanisms producing this rhythm are still unknown. While the alpha 
rhythm clearly is generated in neocortical networks (Lopes da Silva & Storm Van Leeuwen, 1977), the 
thalamus might also play an important role in the rhythm generation (da Silva, van Lierop, Schrijer, & 
van Leeuwen, 1973; Hughes & Crunelli, 2005; Lopes da Silva, Vos, Mooibroek, & Van Rotterdam, 1980; 
Saalmann, Pinsk, Wang, Li, & Kastner, 2012). On the other hand, there is compelling evidence that the 
alpha power is reduced when administrating medium-high dosages of GABA enhancers (Ahveninen et 
al., 2007; Berchou, Chayasirisobhon, Green, & Mason, 1986; Connemann et al., 2005; Fingelkurts et 
al., 2004; Golombok & Lader, 1984; Link, Leigh, & Fell, 1991; Muñoz-Torres, Del Rio-Portilla, & Corsi-
Cabrera, 2011; Romano-Torres, Borja-Lascurain, Chao-Rebolledo, Rio-Portilla, & Corsi-Cabrera, 2002; 
Schreckenberger et al., 2004) but reverse results (using small diazepam dosage (Hall et al., 2010)) or 
null results (Jensen et al., 2005; Urata et al., 1996) are also reported.  
 
These pharmacological results are in opposite direction to the alpha gating by inhibition hypothesis. It 
was postulated that GABAergic input from the interneuronal network is a key mechanism producing the 
pulsed inhibition. Task-irrelevant brain regions need strong alpha activity (i.e. the stronger the 
GABAergic inhibition), for an optimal task performance (Jensen & Mazaheri, 2010). In a classical visuo-
spatial attention task it is well known that the alpha power in ipsilateral hemi-sphere (relative to the 
attended visual hemi-field) is stronger in comparison to the contralateral hemisphere (Händel, 
Haarmeier, & Jensen, 2010; Thut et al., 2006; Worden et al., 2000). For instance, one would predict 
that benzodiazepines would increase even more the alpha power in ipsilateral hemisphere in 
comparison with placebo. Moreover, the rhythmic pulses of alpha inhibition are linked to its amplitude 
asymmetric properties (Mazaheri & Jensen, 2010). Then if the physiological substrates of alpha are 
based on GABAergic inhibition, one could predict stronger resistance for detection of salient unattended 
stimuli (Jensen, Bonnefond, & VanRullen, 2012) or decrease of gamma power in a given alpha duty-
cycle (Jensen, Gips, Bergmann, & Bonnefond, 2014). The present apparent discrepancy between 
previous pharmacological evidence and theory could be reconciled taking into account that most of the 
benzodiazepine-alpha power reductions I reviewed were performed under resting state conditions. In a 
typical covert visuospatial attention task, benzodiazepines could increase ipsilateral alpha power more 
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relative to the contralateral hemisphere. Another not mutually exclusive interpretation would be that the 
GABAergic enhancement produced by benzodiazepines could reduce the activity of prefrontal 
structures such as the frontal eye field (Capotosto, Babiloni, Romani, & Corbetta, 2009), leading that 
an impairment of the top-down drive to parieto-occipital regions that would results in the typical alpha 
power reduction. In this thesis I will address whether benzodiazepine dosage (low v.s. high) and task 
conditions (resting state v.s. WM task) increase or decrease alpha power and whether the alpha-drug 
related changes have consequences for WM performance. 
 
Cross-frequency coupling (CFC) between gamma and alpha oscillations. 
The optimal behavioural performance requires an efficient information transmission between the 
different brain regions. While the relevant nodes would be activated by the gamma band, the irrelevant 
brain-nodes may be efficiently shutted down by the alpha rhythm (Jensen & Mazaheri, 2010; Klimesch 
et al., 2007). An elegant mechanism to coordinate the different brain rhythm with intrinsic functional 
differences would be the CFC, specifically the phase-to-amplitude coupling. The general and elegant 
idea behind the phase-to-amplitude coupling assumes that different brain rhythms would interact 
hierarchically: while slower oscillations would synchronize large neuronal ensembles, local populations 
would be activated by the amplitude envelope of faster rhythms and, at the same time, being nested to 
the phase of the slower oscillations (Buzsaki, 2006). For example, theta oscillations in the rat 
hippocampus can modulate neocortical gamma rhythms (Sirota et al., 2008). A groundbreaking study 
carried out in epileptic patients demonstrated that the power of high frequencies was enhanced at 
specific phase bins of the theta oscillations during various cognitive tasks (Canolty et al., 2006). Another 
influential model suggests that the WM capacity limits could be constrained by the amount of gamma 
cycles in a given theta cycle (Lisman & Idiart, 1995; Lisman & Jensen, 2013). Early 2000’s, it was 
postulated that visual perception could be discrete (instead of continuous) and the span of the 
perceptual snapshots would be defined by the gamma/alpha ratio (VanRullen & Koch, 2003). From 
theoretical point of view, CFC represents a highly versatile and powerful framework that could 
implement serial and parallel information processing. It has been suggested that alpha-phase to gamma 
power coupling would serve to: 
 Discrete visual perception (VanRullen & Koch, 2003). 
 Network regulation of the working brain (Jensen & Mazaheri, 2010). 
 Would be the congruent (although not necessary) with the amplitude asymmetric 
rhythmic pulsing nature of alpha oscillations on where gamma bursts can only occur at 
specific alpha phases (Mazaheri & Jensen, 2010). 
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 Create sequences of neuronal representations (gamma bursts) embedded into an alpha 
duty cycle as a function of its saliency (Jensen et al., 2012; Jensen et al., 2014). 
 
There are few reports showing CFC modulated by task performance in humans. Moreover, most of the 
studies that find parametric phase-to-amplitude coupling correlating with performance are based on 
invasive recordings. Then, one of the questions is whether task modulated CFC can be observed using 
MEG? How does GABAergic inhibition modulate the gamma-alpha CFC? Are drug-related changes in 
CFC correlated with drug-related modulations in behavior? The present thesis will address these 
questions. 
 
Thesis outline. 
In chapter 2, I explore the GABAergic modulations of visual gamma and alpha oscillations during WM 
task. Importantly, I link the gamma and alpha power modulations produced by LZP with the drug-
associated changes in behavioral performance. Here, I use a pharmacological challenge in combination 
with MEG to test whether the stimulus-induced gamma frequency and power can be parametrically 
modulated by LZP dosage as it is shown in the rat hippocampus. Additionally, I also assess whether 
pharmacological GABAergic enhancement increases alpha power, as predicted by the gating by 
inhibition hypotheses (Jensen & Mazaheri, 2010). 
 
Chapter 3, is based on the study of (Muthukumaraswamy et al., 2009). Here I seek to relate endogenous 
GABA levels in visual cortex with the stimulus-induced gamma frequency. Moreover, in order to assess 
whether the endogenous GABA concentrations levels in visual cortex predicted the pharmacological 
response, I relate the local GABA concentrations in visual cortex as measured with MRS with the LZP-
induced gamma modulations described in chapter 2. 
 
In chapter 4, I characterize the oscillatory brain activity associated to resting state and WM delay periods 
by means of cross-frequency interactions. To achieve that, I used the cross-frequency coherence index 
(Osipova, Hermes, & Jensen, 2008) to establish whether the amplitude envelope of the gamma band 
is phase-locked to the ongoing alpha oscillations. Secondly, I assess whether GABAergic inhibition 
modulates the alpha-gamma coupling. I reason that, if both rhythms are inhibitory in nature (from 
physiological point of view), LZP could in principle enhance the coupling between alpha and gamma. 
Alternatively, LZP could decrease the gamma band center frequency slowing down its coupling with 
alpha. 
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Finally, in chapter 5 I discuss some methodological issues regarding CFC data analysis. I generated 
synthetic data to study how different signal wave morphologies can produce non-zero CFC. Specifically, 
I demonstrate the important role of signal wave morphology can yield significant spurious directionality 
between slower and faster rhythms. This chapter aims to help to explain the empirical CFC results 
obtained in chapter 4. 
 
Overview. 
This thesis has the following goals: first, to test whether the same GABAergic oscillatory mechanisms 
that support the hippocampal gamma oscillations can be generalized to human visual cortex. Second, 
given the gating by inhibition hypothesis, to assess whether the alpha activity is a consequence of 
GABAergic inhibitory bouts every 100ms provided by the interneuronal network. Third, to further study 
the cross-frequency interactions between alpha and gamma bands by showing how pharmacological 
inhibition modulates the phasic relationship between the two rhythms as a function of dosage and task 
demands.  
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CHAPTER 2. 
 
 
GABAergic modulation of visual gamma and alpha oscillations and its consequences 
for working memory performance. 
 
Diego Lozano-Soldevilla1, Niels ter Huurne1,2, Roshan Cools1,2, Ole Jensen1 
 
1Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, PO Box 9104, 
6500 HE Nijmegen, The Netherlands. 
2Department of Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University 
Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The work in this chapter was previously published asLozano-Soldevilla, D., ter Huurne, N., Cools, R., & Jensen, 
O. (2014). GABAergic Modulation of Visual Gamma and Alpha Oscillations and Its Consequences for Working 
Memory Performance. Current Biology. doi: 10.1016/j.cub.2014.10.017  
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Abstract:  
Background: Impressive in vitro research in rodents and computational modeling have uncovered the 
core mechanisms responsible for generating neuronal oscillations. In particular GABAergic 
interneurons play a crucial role for synchronizing neural populations. Do these mechanistic principles 
apply to human oscillations associated with function? To address this we recorded ongoing brain activity 
using magnetoencephalography (MEG) in healthy human subjects participating in a double blind 
pharmacological study receiving placebo, 0.5 mg and 1.5 mg of lorazepam (LZP; a benzodiazepine 
upregulating GABAergic conductance). Participants performed a demanding visuo-spatial working 
memory (WM) task.  
Results: We found that occipital gamma power associated with WM recognition increased with LZP 
dosage. Importantly, the frequency of the gamma activity decreased with dosage as predicted by 
models derived from the rat hippocampus. A regionally specific gamma increase correlated with the 
drug related performance decrease. Despite the system-wide pharmacological intervention, gamma 
power drug-modulations were specific to visual cortex: sensorimotor gamma power and frequency 
during button-presses remained unaffected. In contrast, occipital alpha power modulations during the 
delay interval decreased parametrically with drug dosage, predicting performance impairment. 
Consistent with alpha oscillations reflecting functional inhibition, LZP affected alpha power strongly in 
early visual regions not required for the task demonstrating a regional specific occipital impairment.  
Conclusion: GABAergic interneurons are strongly implicated in the generation of gamma and alpha 
oscillations in human occipital cortex where drug-induced power modulations predicted WM 
performance. Our findings bring us an important step closer to linking neuronal dynamics to behavior 
by embracing established animal models. 
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Introduction. 
The human ability to encode, maintain and manipulate visual representations requires a strict temporal 
coordination of neuronal activity. Numerous investigations point to oscillatory brain activity playing an 
important role in cognition (Wang, 2010), including one of the most important cognitive operations: 
working memory (WM). Impressive in vitro animal models have shown that GABAergic interneurons are 
intimately involved in the mechanisms producing neuronal synchronization, especially the gamma band 
(30 – 100Hz) (Bartos et al., 2007; Traub et al., 1999). This notion is supported by exhaustive 
experimental work in rat hippocampus slices demonstrating that pharmacological GABAergic 
enhancement increases the amplitude of spontaneous gamma oscillations while decreases the 
frequency (Faulkner, Traub, & Whittington, 1998; Traub, Whittington, Colling, Buzsáki, & Jefferys, 1996; 
Whittington et al., 1996; Whittington et al., 1995). These gamma modulations can be mechanistically 
explained by a prolongation of the time course of inhibitory postsynaptic currents (IPSC) caused by the 
GABAergic enhancement. As a consequence, the inhibitory period, which determines the gamma 
frequency, increases. Although these oscillatory mechanisms have been extensively investigated in 
animal models, such as brain-slice preparations of the rat hippocampus, the link to function is highly 
limited. It is not known whether the same physiological mechanisms apply to human brain oscillations 
and, most importantly, whether they support human WM operations. 
 
Visuo-spatial WM requires the encoding and retention of neuronal representations as well as 
recognition. Neuronal synchronization in the gamma band has been associated with the processing of 
visual stimuli and attention in monkeys and humans (Fries, Nikolić, & Singer, 2007). Specifically, 
gamma power and coherence increase with the spatial allocation of attention (Fries et al., 2001; 
Womelsdorf et al., 2006), (but see (Chalk et al., 2010)) and are predictive of response times to visual 
stimuli (Womelsdorf et al., 2006). On the other hand, during rest, GABAergic neurotransmission is 
implicated in the generation of oscillatory activity in the alpha band (8 – 14Hz) in animals (Lőrincz et al., 
2009) and humans (Ahveninen et al., 2007; Schreckenberger et al., 2004). Functionally, the alpha band 
has been linked to the allocation of computational resources by inhibiting regions not required for a 
given task (Jensen & Mazaheri, 2010; Klimesch, 2012).  
 
In short, recent evidence supports the notion that gamma band activity is involved in active processing 
whereas alpha oscillations reflect the allocation of neuronal resources by functional inhibition. In the 
present study we have used MEG to investigate whether the animal models for gamma and alpha 
oscillations generalize to humans. By pharmacologically manipulating the GABAergic efficacy with 
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lorazepam (LZP) we here ask whether inhibitory interneurons are involved in producing the WM related 
gamma and alpha band activity and its consequences for behavior. 
 
Results 
We performed a double-blind randomized cross-over design where healthy participants received either 
placebo or LZP at two different doses (0.5mg and 1.5mg). LZP is a common benzodiazepine that binds 
allosterically to GABAA receptors and enhances chloride conductance by increasing its channel opening 
frequency (Riss, Cloyd, Gates, & Collins, 2008). We used MEG to measure the ongoing brain activity 
while subjects performed a delayed match-to-sample visuo-spatial WM task (Vogel & Machizawa, 2004) 
(Figure 1AB). Each trial started by presenting a centrally presented visual cue for 1.5s. The task was to 
encode the sample array composed of colored squares presented in the cued hemifield while 
maintaining central fixation. After a 1.5s delay interval, a probe array was presented and participants 
had to indicate whether it matched the sample array or not. Prior to the MEG experiment, we had 
assessed the participants WM capacity. This allowed us to have the participants perform with accuracy 
close to 75%, matching task difficulty (see Supplemental Experimental Procedures for details).  
 
Importantly, head position showed no systematic differences over the three experimental sessions (F2, 
48 = 0.69, p = 0.45; Figure S1, see Supplemental Experimental Procedures and (Stolk, Todorovic, 
Schoffelen, & Oostenveld, 2013)). Although performance decreased with LZP, (see below), it did not 
influence performance in a control task (WM load 1, Figure S2) or drowsiness as measured by 
subjective questionnaire tests as a function of dosage (visual analog scales or the placebo-drug scale, 
Figure S3).  
 
LZP decreases performance and WM capacity 
We first set out to investigate the behavioral consequences of LZP. Performance was assessed by 
considering Kspan (a measure of the effective memory span when considering hits and false alarm rates) 
and accuracy (Figure 1C). Regarding the Kspan, we found a strong main effect of drug (F2, 48 = 9.77, p < 
5*10-4; Placebo = 0.5mg LZP: t24 = 1.73, p = 0.09; Placebo > 1.5mg LZP: t24 = 4.39, p < 0.001; 0.5mg 
LZP > 1.5mg LZP: t24 = 2.7, p < 0.02; Figure 1D) explained by a decrease in hit rate (F2, 48 = 9.78, p < 
5*10-4) without false alarm rate change with LZP (F2, 48 = 1.14, p = 0.33; Figure 1D). As expected, LZP 
resulted in an increase in reaction times (F1.5, 35.6 = 6.16, p < 0.01; Placebo = 0.5mg LZP: t24 = -0.02, p 
= 0.98; Placebo < 1.5mg LZP: t24 = -2.43, p < 0.05; 0.5mg LZP < 1.5mg LZP: t24 = -3.88, p < 0.005; 
Figure 1E). Similarly, LZP decreased d-prime without impact response bias (Figure S4). In conclusion, 
LZP produced a WM performance impairment accompanied by an increase in reaction times.  
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Figure 1. Experimental design and behavioral results. (A) The timing of the drug administration (see 
Supplemental Experimental Procedures for details) (B) The working memory (WM) task. Each trial started by 
presenting a cue (left or right arrow) in the center of the screen for 1.5s. Participants had to encode a sample 
array of colored squares in the cued hemifield while maintaining central fixation. After a 1.5s delay interval, a 
probe array was presented and participants had to indicate whether it matched the sample array. “Match” and 
“non-match responses” were assigned using respectively the right index and middle finger. The probe stimulus 
remained on the screen until the participant responded (maximum of 2s). (C) The accuracy (hits plus correct 
rejections divided by total responses) decreased as a function of drug dosage. (D) The Kspan (Pashler), an index 
that estimates the memory span when considering the errors, decreased with drug dosage. The hit and false 
alarm rates are also shown as blue and red lines respectively (right y-axes scale). (E) The reaction times 
increased as a function of drug dosage. Abbrebiations: Lorazepam (LZP), Visual Analog Scale (VAS), 
physiological measure (blood pressure and pulse rate; P), *p < 0.05, **p < 0.01, ***p < 0.005, Ϯp < 5*10-4. Error 
bars show the SEM. 
 
LZP increases stimulus-induced gamma power. 
We here asked whether GABAergic neurotransmission plays a role in the generation of human gamma 
activity by characterizing how stimulus-induced gamma activity as measured by MEG is affected by 
LZP. First, we calculated the time-frequency representations (TFR) of power in the gamma band (40 – 
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150Hz). We observed strong stimulus-induced gamma activity over occipital sensors in response to the 
sample (0.1 – 0.35s) and probe (1.75 – 2.15s) periods in all drug conditions (Figure 2ABC). Using a 
beamformer approach we localized the sources of the gamma activity to occipital cortex with maxima 
in primary visual cortex. 
 
Next, we asked whether the stimulus-induced gamma band activity was modulated by LZP by 
considering a set of posterior sensors (marked sensors in Figure 2 topography plots; see Supplemental 
Experimental Procedures for sensor selection). We constructed pair wise scatter plots comparing the 
different drug conditions over participants (Figure 2D). Clearly LZP increased the stimulus-induced 
gamma power during the probe period in most participants, as also confirmed by a Wilcoxon signed-
rank test. Also during the sample interval the LZP resulted in an increase in stimulus-induced gamma 
power (F2, 48 = 3.75, p < 0.05; Placebo < 0.5mg LZP: t24 = -2.29, p < 0.05; Placebo < 1.5mg LZP: t24 = -
2.56, p < 0.05; 0.5mg LZP = 1.5mg LZP: t24 = -0.89, p < 0.38; Figure 2E).The same pattern was 
observed in the probe interval (F2, 48 = 6.13, p < 0.005; Placebo < 0.5mg LZP: t24 = -2.4, p < 0.05; 
Placebo < 1.5mg LZP: t24 = -2.89, p < 0.05; 0.5mg LZP = 1.5mg LZP: t24 = -1.87, p = 0.07; Figure 2F). 
Finally, the gamma power in contralateral hemisphere was stronger in comparison with ipsilateral 
hemisphere regardless of LZP dose for both the sample arrays (Figure 2G) and the probe arrays (Figure 
2H). As control analysis, we tested whether there were systematic gamma power differences between 
the drug sessions in the baseline interval (-0.5 − -0.1s) but this was not the case (F1.1, 26.8 = 1.89, p = 
0.18). Despite the strong stimulus-induced gamma power increase, the LZP dosage did not modulate 
the degree of gamma band modulation as induced by the cue (F2, 48 = 0.25, p = 0.77, Figure S5). 
 
In sum, we found that gamma power during sample and probe increased with LZP dosage. However 
the cue-induced hemispheric lateralization in the gamma band did not systematically change with drug. 
 
The gamma power increases with LZP-predicted increased reaction times. 
Do the changes in gamma power with LZP explain the changes in behavior? To explore this, we 
correlated the drug-related changes in gamma power with the drug related changes in performance. 
When considering the gamma power in occipital sensors contralateral to the attended visual hemifield, 
we found a positive correlation with reaction times between 0.5mg LZP and placebo (rspearman = 0.42, p 
< 0.05, Figure 2I). No significant correlations were found between 1.5mg LZP and reaction time (rspearman 
= 0.3, p = 0.14, Figure 2J) or any other behavioral index. Further, we did not find an effect in sensors 
ipsilateral to the cued hemifield. Summarizing, the increase in reaction time with 0.5mg LZP dosage 
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(but not with 1.5mg) was predicted by a drug-related increase of contralateral gamma power in response 
to the probe. 
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Figure 2. High-frequency Lorazepam (LZP)-induced power modulations during the working memory (WM) task. 
(A) Placebo session. Left: topographic representation of the stimulus-induced relative gamma (60 – 90Hz) power 
during the probe interval (1.75 – 2.15s). Color code represents relative power changes with respect to the 
baseline (-0.5 – -0.1s). Middle: Averaged power time-frequency representations (TFR) over selected occipital 
sensors (marked in topographic representations). Time t = 0s indicates sample array onset. Dashed rectangles 
indicate the time and frequency selections for the statistical analysis. Right: Sources of the gamma band activity 
obtained using a beamformer approach morphed onto a MNI standard brain. The peak of the source was in 
occipital cortex (probe vs. baseline; cluster-based nonparametric permutation test, p < 0.001, controlled for 
multiple comparisons). The color code represents the relative power masked by significant grids points within 
the cluster. The sensors marked in the topographical representations are the sensors of interested used in the 
subsequent analysis. (B and C) show stimulus-induced gamma power increase for 0.5mg LZP and 1.5mg LZP 
respectively (same conventions as in (A)). (D) Scatter plots of the stimulus-induced gamma power; each dot 
corresponds to a participant. Wilcoxon signed rank test revealed that the stimulus-induced gamma power 
increased with LZP dosage. The top-right frequency histogram was constructed by summing the scatter plot 
values within diagonally oriented bins. (E and F) Repeated measures ANOVA confirmed that the LZP-induced 
gamma power increased both during the sample and probe intervals. Error bars show the SEM. (G and H) The 
stimulus-induced gamma power was stronger in sensors contralateral to the attended side for both sample and 
probe periods. Error bars show the SEM. (I) Correlation between drug-related modulations of stimulus-induced 
gamma power and reaction times. The y-axes is the reaction time difference between 0.5mg LZP session minus 
placebo session and the x-axis represents the difference between stimulus-induced contralateral gamma power 
for 0.5mg LZP minus placebo (each dot represents a participant). (J) Correlation for 1.5 mg LZP session (same 
conventions as in (I)). *p < 0.05, **p < 0.01, ***p < 10-5. 
 
Gamma frequency decreased with LZP. 
Experiments on hippocampal slices have shown that an increase in inhibitory conductance by 
pharmacological GABAergic enhancement decreases gamma frequency (Faulkner et al., 1998; Traub 
et al., 1996; Whittington et al., 1996; Whittington et al., 1995). We sought to test whether this finding 
generalizes to the human visual stimulus-induced gamma response. To quantify potential frequency 
changes in the power spectra, we first computed the TFR of the relative change in stimulus-induced 
gamma during probe presentation (Figure 3A). We observed that the power in the gamma band shifted 
towards lower frequencies (<75Hz) with LZP. This is also observed when averaging over the 1.8 − 1.95s 
probe array interval (Figure 3B). To quantify this frequency-shift, we calculated the “center-of-mass” 
index (see Supplemental Experimental Procedures) applied to the 50 − 100Hz range around the peak 
in the probe interval defined above. A Wilcoxon signed rank test revealed that 1.5mg LZP significantly 
reduced the gamma frequency in comparison with placebo (z = -2.68, p < 0.01) and 0.5mg LZP (z = -
2.6, p < 0.01). We did not observe a difference between 0.5mg LZP and placebo (z = -0.55, p = 0.58). 
We conclude that the dominant frequency in the gamma band frequency decreases with LZP dosage. 
26  
 
 
 
Figure 3. The gamma frequency (“center-of-mass” index) decreased with Lorazepam (LZP) dosage. (A) Induced 
power time-frequency representations (TFR) in selected occipital sensors (marked sensors topography Figure 
4, same conventions) during the probe interval. A relative baseline was applied (-0.5 − -0.1s). Time t = 1.6s 
indicates probe stimuli onset. (B) Gamma power spectra computed in the 1.8 – 1.95s interval (black rectangles 
in A) for each drug session. (C) Scatter plots of the gamma center-of-mass frequency (Hz); each dot represents 
a participant. Wilcoxon signed rank test showed a significant gamma frequency decrease with LZP. 
 
As gamma frequency decreases with LZP one might wonder whether individual gamma frequencies 
correlate with WM capacity or whether the reduction in WM capacity is predicted by the slowing of the 
gamma frequency. We addressed this by correlating the gamma frequency (center-of-mass) with the 
maximum WM capacity (Kspan) measured during the behavioral experiment in Session 1. There was no 
significant correlation between Kspan and gamma frequency in any of the sessions (Placebo rspearman = 
0.09, p = 0.64; 0.5mg LZP rspearman = 0.07, p = 0.73; 1.5mg LZP rspearman = 0.18, p = 0.37). Further when 
comparing the drug sessions, there were no significant relationship between the WM capacity reduction 
and the gamma frequency slowing with neither 0.5mg LZP (rspearman = 0.14, p = 0.50) nor 1.5mg LZP 
(rspearman = 0.08, p = 0.71). 
 
LZP leaves gamma activity in motor cortex unaffected. 
To further determine the brain region specificity of our pharmacological manipulation, we explored the 
oscillatory dynamics in sensorimotor cortex during the button-press response. Recent human studies 
have report on gamma activity in motor cortical areas (Hall et al., 2011; Muthukumaraswamy et al., 
2013b). To this end, we calculated the TFRs of power, which were time locked to participants’ button 
presses. This revealed gamma activity at the time of the motor response. Contrary to visual areas, the 
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motor related gamma power was not affected by LZP (F2, 48 = 0.78, p = 0.46; Figure 4). Likewise 
absolute gamma power during baseline period (-0.5 – -0.3s) was not statistically different (F1.1, 28.5 = 
0.85, p = 0.81), discarding the possibility that systematic changes during the pre-movement period could 
explain the null effect. These results demonstrate that the pharmacological manipulation specifically 
affected gamma band activity in the visual cortex.  
 
Modulation of occipital alpha power is reduced by LZP. 
We then set out to examine how brain activity in the lower frequency bands (<40Hz) was modulated by 
LZP. TFRs of power were calculated for individual trials and then averaged with respect to spatial 
attention condition (left or right) for each MEG session separately. We first considered the modulation 
with respect to spatial attention. A modulation index (MI) was calculated as the normalized power 
difference between the attention left v.s. right trials (Thut et al., 2006): MI = (powerattention left – powerattention 
right) / (powerattention left + powerattention right). Importantly the same denominator for all drugs session was 
used in the normalization (i.e. powerattention left + powerattention right from the placebo condition). As shown 
in Figure 5, alpha band activity was strongly modulated by spatial attention throughout the task. It was 
reduced contralateral to the direction of attention while it increased relatively over the ipsilateral 
hemisphere (Figure 5ABC, left and right columns). Source reconstruction using a beamforming 
approach revealed that the alpha power mainly was modulated in occipital regions (Figure 5ABC, center 
column). 
 
To identify sensors-of-interest that showed oscillatory power modulations as a function of allocation of 
attention, we pooled all MEG sessions and conducted a cluster-based nonparametric permutation test 
applied to the cue period (-1 – -0.1s) in the alpha band (9 – 13Hz) (see Supplemental Experimental 
Procedures). For these sensor groups (see Figure 5ABC topographical plots, bold circles), we averaged 
the MI with attention over the left and the right hemisphere (absolute value) and tested the influence of 
LZP during the delay period (0.5 – 1.4s). In addition, we constructed pair wise scatter plots comparing 
the different drug conditions over participants. These plots revealed that the alpha MI decreased with 
drug dosage in most participants as confirmed by the Wilcoxon signed rank test (Figure 5D). The 
parametric reduction in modulation with dosage was further confirmed by repeated measures ANOVA 
(F1.4, 34.3 = 11.95, p < 5*10-4; Placebo > 0.5mg LZP: t24 = 2.9, p < 0.01; Placebo > 1.5mg LZP: t24 = 3.84, 
p < 0.005; 0.5mg LZP > 1.5mg LZP: t24 = 3.01, p < 0.01; Figure 5E) with both hemispheres being 
affected by LZP in a nondifferent way. Similar statistical conclusions were found using within-session 
total power as a denominator (F2, 48 = 6.35, p < 0.005). Complementarily, for each participant, we fitted 
regression lines to the alpha MI for each session using categorical values (1, 2, and 3) to represent LZP 
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Figure 4. High-frequency Lorazepam (LZP)-induced power modulations during button-press. (A) Left: 
Topography of button-pressed relative gamma power (60 – 90Hz) around the button-press (-0.1 – 0.1s). Color 
code represents relative changes with respect to the baseline (-0.5 – -0.3s). Right: Averaged time-frequency 
representations (TFR) of power over selected left sensorimotor sensors (sensors marked topography). Time t=0 
s indicates participant’s button-press. Dashed lines indicate the baseline interval and button-press period. (B 
and C) shows induced gamma power for 0.5mg LZP and 1.5mg LZP respectively (same conventions as in panel 
A). (D) Cluster of significant gamma power modulations around the button-presses (cluster-based 
nonparametric permutation test p < 0.02 corrected for multiple comparisons). Color code based on t-values 
when comparing the button-press to baseline. (E) LZP did not modulate sensorimotor gamma power. Error bars 
show the SEM. 
 
dosages. This resulted in negative slopes significantly different from zero (-0.015 ± 0.004; t24 = -3.84, p 
< 0.001).supporting the notion that the decrease in alpha power with LZP was highly robust.  
 
In short, we found that posterior alpha band activity was modulated as a function of spatial allocation of 
attention during WM maintenance and this modulation was reduced with LZP dosage.  
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The decrease in alpha power modulations with LZP predicts WM impairment. 
Next, we investigated the modulations in alpha power by LZP in relation to WM performance. To do so, 
we correlated the drug-related alpha MI changes (combined over hemispheres) with the drug-related 
performance changes over participants (combined over hemifields). We found a positive correlation 
between the alpha MI reduction and the decrease in Kspan when comparing 0.5mg LZP to placebo 
(rspearman = 0.60, p < 0.005; Figure 5F). This was also the case when comparing placebo with 1.5mg LZP 
(rspearman = 0.45, p < 0.05; Figure 5G). To conclude, the participants with the strongest memory related 
impairment were the ones with the strongest alpha MI reductions.  
 
LZP interacts with alpha power in ipsilateral and contralateral hemisphere. 
Is the decrease in alpha MI by LZP mainly explained by alpha modulations in the hemisphere ipsilateral 
or contralateral to the cued hemifield? WM impairment could be a consequence of a failure to inhibit 
distracting visual information as reflected by ipsilateral alpha power. To investigate this issue, we 
computed the absolute alpha power in ipsi- and contra-lateral sensors during the delay interval for all 
dosages separately. This revealed that the absolute alpha power during the delay interval in ipsilateral 
hemisphere was stronger than in contralateral hemisphere (F1, 24 = 35.5, p < 5*10-6; Figure 6). Strikingly, 
as seen in Figure 6, the 3x2 repeated-measures ANOVA revealed a significant drug x hemisphere 
interaction (F1.6 38.4 = 6.07, p < 0.01; Figure 6DE) suggesting that LZP impacted alpha power in ipsilateral 
hemisphere differently compared to contralateral hemisphere. This was explained by LZP strongly 
reducing the alpha power in the ipsilateral hemisphere to the cued visual hemifield strongly (ipsi Placebo 
> ipsi 0.5mg LZP: t24 = 3.15, p < 0.01; ipsi Placebo > ipsi1.5mg LZP: t24 = 6.43, p < 5*10-6; ipsi 0.5mg 
LZP > ipsi 1.5mg LZP: t24 = 5.09, p < 10-4) in comparison to the contralateral power (contra Placebo > 
contra 0.5mg LZP: t24 = 2.26, p < 0.05; contra Placebo > contra 1.5mg LZP: t24 = 4.44, p < 5*10-4; contra 
0.5mg LZP > contra 1.5mg LZP: t24 = 5.28, p < 5*10-5; Figure 6DE). The present interaction was specific 
to the delay interval; it was not observed in the cue interval (F2, 48 = 0.82, p = 0.44). 
 
As for alpha MI, for each participant we fitted regression lines to ipsi- and contra-lateral hemispheric 
alpha power using categorical values to represent LZP concentrations. Both the ipsilateral (-0.07 ± 
0.01; t24 = -6.43, p < 5*10-6) and contralateral (-0.06 ± 0.01; t24 = -5.28, p < 5*10-5) slopes were 
significantly different from zero. Importantly, the regression slopes were significantly more negative in 
sensors in the ipsilateral hemisphere compared to the contralateral hemisphere (t24 = -2.82, p < 0.01). 
We also tested whether the absolute power correlated with the alpha MI over subjects; this was not 
the case. In addition, the individual drug related changes in alpha MI did not correlate with the drug 
related changes in absolute alpha power during the delay interval.  
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Figure 5. Low frequency lorazepam (LZP)-induced power modulations during WM task. (A) Placebo session. 
Averaged time-frequency representations (TFR) shown by the alpha modulation index (MI) over left and right 
occipital sensors (marked sensors in topography). Color code represents the modulation in power with attention 
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(normalized difference for left minus attention right). Time points t = 0s indicate sample array onset. Middle: MI 
topography for the time and frequency ranges indicated by the dashed rectangles (9 – 13Hz; 0.5 – 1.4s). Middle 
below, alpha sources producing the MI obtained with a beamforming approach morphed to a MNI standard 
brain. The peak of the source was located in occipital cortex (attention left v.s. right; cluster-based nonparametric 
permutation test; p < 0.02, controlled for multiple comparisons). The color code represents the alpha MI of 
significant grid points. The marked sensors were used in the subsequent analysis. (B and C) show the alpha MI 
for 0.5mg LZP and 1.5mg LZP respectively (same conventions as in (A)). (D) Scatter plots of the alpha MI during 
the delay period; each dot corresponding to a participant. Wilcoxon signed rank tests shows that the alpha MI 
significantly decreased with LZP dosage. (E) The main effect during and alpha MI show a highly robust 
decrease. Error bars show the SEM. (F) Participants with a strong drug related decrease in alpha MI were also 
participants with a strong decrease in working memory (WM) capacity). The y-axes represents the Kspan 
difference between 0.5mg LZP session minus placebo session and the x-axis represents the difference between 
alpha MI for 0.5mg LZP minus placebo (each dot represents a participant). (H) Correlation for 1.5mg LZP 
session (same conventions as in (G)).*p < 0.01, **p < 0.005. 
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Figure 6. Drug related alpha power changes in the hemispheres contra- and ipsi-lateral to the cued direction. 
(A) Placebo session. Left: absolute power in the hemisphere ipsilateral to the attended visual field. Both 
topographic plots (delay period; 0.5 – 1.4s; alpha power: 9 – 13Hz) and time-frequency representations (TFRs) 
represent power for occipital sensors shown (marked in topographical plot). Time points t = 0s indicate sample 
array onset. Right: The similar plots for effects contralateral to the attended visual hemifield. (B and C) show 
0.5mg and 1.5mg lorazepam (LZP) sessions respectively (same conventions as in (A)). (D) The absolute alpha 
power during the delay period decreased systematically with drug both in the hemisphere contra- and ipsi-lateral 
to the cue. Further the decrease ipsi-lateral to the cue was stronger than the decrease contralateral yielding a 
significant interaction as revealed by repeated-measures ANOVA. Error bars show the SEM. (E) The difference 
in absolute alpha power when comparing the different drug conditions for contra- and ipsi-lateral hemisphere to 
cue. A paired-wise post-hoc t-tests showed that alpha absolute power in the ipsilateral hemisphere was more 
suppressed with LZP in comparison to the contralateral hemisphere. Error bars show the SEM. 
 
In sum, LZP reduced alpha power in the ipsilateral hemisphere more so than in the contralateral 
hemisphere during the delay interval of the WM task. 
 
Gamma and alpha attentional power modulations correlate over participants. 
So far, we have demonstrated that gamma and alpha power are modulated as a function of spatial-
attention (Figure S4 and Figure 5ABC, respectively). Does the alpha modulation in the delay interval 
predict the gamma modulation during the probe delay? To test this, we correlated over participants the 
alpha MI during the delay interval with the gamma MI during the probe interval for each MEG session 
separately (using the MIs combined over hemispheres). We found a significant negative correlation 
during Placebo (rspearman = -0.42, p < 0.05) and 1.5mg LZP (rspearman = -0.42, p < 0.05), but not during 
0.5mg LZP (rspearman = -0.31, p = 0.13; Figure S6). This means that the participants with a stronger alpha 
power modulation during retention (positive MI) are also those with a stronger gamma power modulation 
in the reverse direction during probe processing (negative MI). These findings suggest that alpha band 
modulation reflects top-down control which is predictive of the gamma band activity reflecting 
feedforward processing. 
 
Discussion 
We used MEG to investigate how the GABAergic allosteric modulator LZP influences human oscillatory 
brain activity during WM operations. We show for the first time in humans that stimulus-induced gamma 
power increases while frequency decreases due to the enhancement of inhibitory conductance by the 
selective enhancement of GABAA receptors. The drug-related increase in occipital gamma power 
contralateral to the attended hemifield was predictive of increases in response times. Even though LZP 
modulates GABAA receptors brain-wide, sensorimotor gamma activity was not modulated by LZP i.e. 
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the effect in the gamma band was specific to the visual cortex. Oscillations in the alpha band were 
strongly lateralized according to direction of attention during the memory delay: they decreased in 
occipital regions contralateral to the side of the cued memory array, whereas they increased relatively 
in ipsilateral regions. The alpha band lateralization was reduced with LZP dosage and furthermore it 
predicted WM performance. Our findings strongly implicate GABAergic interneurons in the regulation 
and generation of gamma and alpha activity, respectively, during human WM operations.  
 
GABAergic modulations of gamma oscillations 
Our findings show that human visual gamma power and frequency are modulated by an increase in 
GABAA neurotransmission. While previous studies have implicated GABA in generating gamma band 
activity associated with visual stimulation, the findings are mixed. Recent MEG studies reported a 
gamma power increase with the GABAA receptor agonist propofol (Saxena et al., 2013) but not with the 
GABA re-uptaker inhibitor tiagabine (Muthukumaraswamy et al., 2013a). The decrease in gamma 
frequency with LZP has not been reported in other studies applying GABAergic allosteric modulators in 
humans (Muthukumaraswamy et al., 2013a; Saxena et al., 2013) but has been shown in rat and monkey 
visual cortex under anesthesia (Oke et al., 2010; Xing et al., 2012). In addition, the administration of 
alcohol (GABA and NMDA modulator) did produce a decrease in gamma frequency during visual 
stimulation (Campbell, Sumner, Singh, & Muthukumaraswamy, 2014). Finally, a recent study combining 
magnetic resonance spectroscopy (MRS) and MEG did find a relationship between gamma frequency 
and GABA concentration (Muthukumaraswamy et al., 2009) although the reliability of the findings have 
been challenged very recently (Cousijn et al., 2014). 
 
In our study, sensorimotor gamma power changes locked to the button-press were not modulated by 
the drug (Hall et al., 2011; Muthukumaraswamy et al., 2013b). In a recent study on humans in which 
acethylcholine was enhanced, an effect on gamma power in visual, but not sensorimotor regions was 
reported (Bauer et al., 2012). Further it should be emphasized that the concentration of GABA receptors 
is disproportionally high in the occipital cortex as measured by PET (Gründer et al., 2001). We 
concluded that the physiological mechanisms of sensorimotor gamma activity differ from the 
mechanisms visual gamma activity. As such, our findings are the first to report a robust increase in 
gamma band activity in a WM task associated with a frequency decrease due to GABAA enhancement. 
 
Which mechanisms might explain the increase in gamma power and the decrease in frequency with 
LZP? The physiological mechanisms behind gamma oscillations have been extensively studied by in 
vitro work in the rat hippocampus (Bartos et al., 2007; Traub et al., 1999). This work has demonstrated 
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that GABAergic interneurons play a critical role for the rhythmic synchronization on neuronal 
populations in the gamma band. It has been demonstrated that gamma power increases as a function 
of IPSP (Traub et al., 1996; Whittington et al., 1996; Whittington et al., 1995) but see (Faulkner et al., 
1998). Also the increases in IPSPs result in a prolongation of the gamma cycle thus reducing the gamma 
frequency (Faulkner et al., 1998; Traub et al., 1996; Whittington et al., 1996; Whittington et al., 1995). 
Two mechanisms have been proposed for generating gamma oscillations: the Interneuronal Network 
Gamma (ING) and the Pyramidal-Interneuronal Network Gamma (PING) mechanism. In ING models, 
inhibitory interneurons are necessary and sufficient for generating gamma oscillations (Whittington et 
al., 1995) while in PING the gamma oscillations are a consequence of the interplay between pyramidal 
and inhibitory interneurons (Tiesinga & Sejnowski, 2009). As MEG recordings cannot tell apart cell 
types (Hämäläinen, Hari, Ilmoniemi, Knuutila, & Lounasmaa, 1993), we cannot distinguish whether a 
PING or an ING mechanism dominate. However, in a recent non-human primate study Vinck et al., 
(Vinck, Womelsdorf, Buffalo, Desimone, & Fries, 2013) analyzed intracranially recorded single unit 
activity in association with gamma oscillations in V4. They applied a spike-waveform analysis to sort 
the cells in broad spiking (BS) and narrow spiking (NS) neurons, i.e. putative pyramidal neurons and 
inhibitory cells respectively. The firing BS neurons preceded the NS neurons by 3.3 ms while both were 
locked to the phase of the gamma as identified in the local field potential (LFP). This finding supports 
the PING model and might generalize to the human gamma band activity.  
 
The functional role of gamma oscillations. 
We observed that gamma band activity was strongest contralateral to the direction of attention during 
visual stimulation. Previously studies have implicated gamma oscillations in visual processing and 
neuronal communication (Fries, 2005). For instance, it has been proposed that gamma band 
synchronization results in a stronger feedforward drive to down-stream visual regions (Bosman et al., 
2012; Grothe et al., 2012; van Kerkoerle et al., 2014). We propose that the gamma band 
synchronization we observe during the sample and probe intervals reflects encoding and recall of the 
attended memory array involving early visual areas. Importantly the increase in gamma power with LZP 
does not predict better performance. We conclude that while the gamma band synchronization might 
reflect the encoding visual stimuli, it does not necessarily mean that more gamma power is predictive 
of better performance.  
 
GABAergic modulation of alpha oscillations. 
It is well established that alpha power recorded during rest is reduced with GABAergic agonists 
(Ahveninen et al., 2007; Schreckenberger et al., 2004) (but see (Hall et al., 2010; Jensen et al., 2005)). 
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We now extend these findings by demonstrating that the modulation of alpha power also is robustly 
reduced during WM maintenance. High alpha power has been proposed to reflect reduced vigilance. 
Since we find that LZP decreases alpha power while performance is reduced, it is clear that the 
magnitude of alpha power does not simply equate lack of vigilance.  
 
What are the mechanisms explaining the decrease in alpha power with LZP? One simple explanation 
is that LZP increases GABAergic inhibition and reduces the pyramidal firing without affecting oscillatory 
frequency per se. This interpretation is consistent with an in vitro study applying diazepam: while this 
GABAergic agonist decreases the number of spikes per burst, it leaves the burst rate unaffected 
(Antkowiak, 1999). Another not mutually exclusive possibility is the involvement of the thalamus in the 
generation of alpha oscillations. While the alpha activity measured with MEG is most likely produced by 
sources in the deeper layers of neocortex (Lopes da Silva & Storm Van Leeuwen, 1977; Spaak, 
Bonnefond, Maier, Leopold, & Jensen, 2012), the neocortical alpha sources have been found to be 
coupled to thalamic generators (Lopes da Silva et al., 1980; Lőrincz et al., 2009; Saalmann et al., 2012). 
These findings have been used to constrain physiologically realistic computational models of the alpha 
rhythm (Vijayan, Ching, Purdon, Brown, & Kopell, 2013). As such the modulation in alpha activity with 
LZP might have a thalamic origin as well.  
 
Given the proposed inhibitory role of the alpha band activity (Jensen & Mazaheri, 2010; Klimesch, 
2012), one might have expected the alpha power to increase as the GABAergic inhibition increases. 
Because we obtained the reverse finding, the dynamics are evidently more complicated than that. 
Future intracranial animal recordings would be required to gain full insight into this issue. 
 
In future research it would be interesting to uncover if it actually is the GABAergic modulation of frontal 
or subcortical sources causing the changes in posterior alpha band activity. Given that it is problematic 
to detect deeper sources with MEG, this could be done in a combined EEG/fMRI. Drug specific effects 
in relation to the alpha activity could then be investigated in regions potentially involved in the control 
of the alpha activity (dorsal attention network, pulvinar and striatum).  
 
The functional role of the alpha band oscillations. 
It has been proposed that alpha band activity reflects the allocation of computational resources (Jensen 
& Mazaheri, 2010; Klimesch, 2012). Basically a regional specific increase in alpha power reflects 
functional inhibition whereas a decrease reflects engagement. This inhibition might be crucial for 
distracter suppression, ensuring the integrity of the WM representations (Bonnefond & Jensen, 2012; 
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Sauseng et al., 2009). Our findings are fully consistent with this notion. Consistently, LZP produced a 
stronger reduction in alpha power suppression over ipsilateral hemisphere in comparison with the 
suppression in contralateral hemisphere during the delay period, not during the cue. We interpret this 
finding as a pharmacological task-specific effect on alpha oscillations that cannot be accounted for by 
a general decrease in vigilance (i.e. same power decrease would be expected in ipsi- and contra-lateral 
hemispheres). 
 
Conclusion. 
All together, the results presented here suggest that the same GABAergic physiological mechanism for 
neuronal gamma oscillations uncovered by hippocampal rat models applies to human visual brain 
oscillations during WM processing. Since the modulations in the alpha band were present during the 
cue and delay intervals, we propose that alpha oscillations reflect top-down processing (see also (van 
Kerkoerle et al., 2014)). The gamma band activity mainly occurred during the presentation of the 
memory array and probe and is therefore likely to be dominated by feedforward processing. Our data 
underscores an important role of GABAergic neurotransmission for neuronal synchronization on both 
gamma and alpha band oscillations. As such our findings bring us an important step closer to linking 
neuronal dynamics to human behavior by embracing established animal models.  
 
Experimental Procedures. 
Thirty two healthy participants gave informed consent approved by the local research ethics committee 
(“Commissie Mensgebonden Onderzoek”, Arnhem-Nijmegen, number: 2011/199, date: 5 August 2011) 
and were compensated for their participation. Data from seven participants were rejected (see 
Supplemental Experimental Procedures for rejection criteria) leaving a total of 25 participants. They 
were all right-handed and had normal or corrected-to-normal vision (mean age 22.4, range 18 - 28 
years, 12 males; see Supplemental Experimental Procedures and Figure 1A for a complete 
experimental design and general pharmacological procedure). 
 
We adapted a classical delayed match-to-sample visuo-spatial WM task (Vogel & Machizawa, 2004) 
while ongoing brain activity was recorded using a whole-head MEG system with 275 axial gradiometers 
(VSM/CTF systems, Port Coquitlam, Canada). Data were analyzed offline using FieldTrip (Oostenveld, 
Fries, Maris, & Schoffelen, 2011) (http://fieldtrip.fcdonders.nl/); an open-source toolbox developed at 
the Donders Institute for Brain, Cognition, and Behaviour (Nijmegen, The Netherlands) and custom 
Matlab code (MathWorks, Natick, MA, USA). 
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1. Supplemental Data:  
Figure S1. Head position deviation from template position. Related to Figure 1. 
Figure S2. Control task Working Memory load 1. Related to Figure 1. 
Figure S3. Lorazepam (LZP) influence over subjective questionnaires. Related to Figure 1. 
Figure S4. The relationship between Lorazepam (LZP) and performances as assessed by signal 
detection theory measures. 
Figure S5. Visual gamma power lateralization as a function of spatial allocation of attention. Related to 
Figure 2. 
Figure S6. Correlation between alpha modulation index (MI) and gamma MI. 
 
2. Supplemental Experimental Procedures 
Participants 
Experimental paradigm 
Pharmacological design and general procedure 
Data acquisition 
Data analysis  
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1. Supplemental Data. 
 
 
Figure S1. Head position deviation from template position. No systematic differences in head position were found 
between the three MEG experimental sessions as tested by repeated-measures ANOVA using drug as a main 
factor. The y-axes expresses the grand mean head position (mm) projected onto the vector explaining most 
variance by singular value decomposition (SVD). Error bars show the SEM. See Supplemental Experimental 
Procedures for details.  
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Figure S2. Control task Working Memory load 1. Lorazepam (LZP) did not modulate accuracy (correct 
responses/total responses) on the load 1 task ((A); F2, 44 = 1.85, p = 0.17), but it significantly delayed reaction times 
((B); F2, 44 = 15.48, p < 1 x 10-5). Post-hoc t-tests revealed that during 1.5mg LZP sessions participants were slower 
than 0.5mg LZP (t22 = -4.45, p < 5 x 10-4) and placebo session (t22 = -5.01, p < 5 x 10-4). We found that although 
reaction times were delayed with LZP dosage, accuracies were not significantly different. Error bars show the SEM. 
  
41 
 
Figure S3. Lorazepam (LZP) influence over subjective questionnaires. (A) LZP influence over Visual Analog Scale 
(VAS) Drowsiness factor. LZP produced a significant interaction between time and drug on Drowsiness factor (F6, 
144 = 3.07; p < 0.05) meaning that participants reported subjective higher drowsiness levels (mm) after the MEG 
experiment (VAS 11.45h) during the 1.5mg LZP in comparison with the rest of the time points. No other significant 
main effects nor interactions were found on Contentedness or Calmness factors. (B) LZP influence over Placebo-
Drug scale question 1: What type of treatment did you think that you received: placebo or drug? 1.5mg of LZP was 
correctly guessed from placebo and 0.5mg, but the last two were not significantly different (left). Participants and 
researcher guessed similarly (right). (C) LZP influence over Placebo-Drug scale question 2: If you think that you 
are under the effects of the drug, under what kind of dosage do you think you are: Low dose or High dose? LZP 
influenced subjective guessing as for question 1: 1.5mg session was correctly guessed and placebo was not 
significantly different from 0.5mg session (left). Participants and researcher guessed similarly (right). See 
Supplemental Experimental Procedures for Placebo-Drug scale details. *p < 0.05, **p < 0.005, ***p < 5 x 10-5, †p 
< 1 x 10-5. Error bars show the SEM. 
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Figure S4. The relationship between Lorazepam (LZP) over signal detection theory analysis measures. (A) D-prime 
decreased with LZP. (B) The drug did not significantly influence participants’ response bias. See Supplemental 
Experimental Procedures for measure definition. *p < 0.05. Error bars show the SEM. 
43 
 
Figure S5. Visual gamma power lateralization as a function of spatial allocation of attention. (A) Gamma (60 – 
90Hz) topography calculated over probe period (1.75 – 2.15s) and averaged over all MEG sessions shows 
statistically significant sensors that modulated its power when comparing attention left v.s. attention right. Color 
code is based on t-statistics from the contrast described above correcting for multiple comparisons along the sensor 
dimension by cluster-based nonparametric permutation test. (B) Time-frequency representation of induced gamma 
power of statistically significant sensors (left and right columns) marked as bold circles in (A) and a topographical 
representation (middle) during the probe period. The color code scale in based on gamma power modulation when 
comparing attention left minus attention right divided by the sum of both (gamma modulation index, MI). No main 
effect on drug was found of the gamma modulation in the probe period. 
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Figure S6. Correlation between alpha modulation index (MI) and gamma MI. Correlation between alpha (8 – 13Hz) 
MI during the delay interval (0.5 – 1.4s) and gamma (60 – 90Hz) MI during the probe interval (1.75 – 2.15s) for 
each pharmacological session separately. MI was computed for each hemisphere separately as the normalized 
power difference between attention left vs. right trials for alpha and gamma bands (Figure 5 and Figure S5). Then 
we combined the MI over the two hemispheres ((MIleft hemisphere – MIright hemisphere)/2) separately for alpha, gamma and 
for each pharmacological session. For Placebo and 1.5mg LZP we found significant negative correlations between 
alpha and gamma MI. This means that the stronger the hemispheric modulation in alpha power is prior probe onset, 
the stronger the gamma MI with reverse sign during probe processing.  
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2. Supplemental Experimental Procedures. 
 
Participants. 
Thirty-two healthy participants gave informed consent approved by the local research ethics committee 
(“Commissie Mensgebonden Onderzoek”, Arnhem-Nijmegen, number: 2011/199, date: 5 August 2011). 
The participants were compensated financially for participation. Seven participants were excluded from 
the analysis for the following reasons: one participant withdrew after the first MEG session; one 
participant showed excessive head movements and blinks during the first MEG session; one participant 
performed the working memory (WM) task at chance level during all MEG sessions; one MEG dataset 
was unusable due to SQUID artifacts on several occipital and temporal sensors; three participants could 
not finished all the sessions since they become too sedated. The remaining 25 participants were right-
handed, had normal or corrected-to-normal vision (mean age 22.4, range 18–28 years, 12 men) and no 
relevant medical/psychiatric history one year prior to testing. All participants completed the three MEG 
sessions but half of the data in one of the sessions got lost due to a malfunctioning of the MEG 
acquisition electronics (this occurred for two participants). 
 
Experimental Paradigm. 
Stimuli were presented using the MATLAB Psychophysics toolbox (Brainard, 1997) via an LCD 
projector with a vertical refresh rate of 60Hz. The screen was located outside the magnetically shielded 
room and back-projected onto a translucent screen via two front-silvered mirrors. We adapted a 
classical delayed match-to-sample visuo-spatial WM task (Vogel & Machizawa, 2004) (see Figure 1B). 
On non-match trials only one square changed its color. Unattended squares also could change color 
(50%), but this had to be ignored by participants. All stimuli arrays were presented within 4 x 7.3 
rectangular regions with a 3 eccentricity. They were displayed on a light grey background. Each sample 
array consisted of 2–6 colored squares (0.65 x 0.65). Each square was selected randomly from a 
predefined set of 10 discriminable colors (blue, red, green, yellow, white, black, purple, brown, 
turquoise, skin), and a given color could appear no more than twice within an array (including the two 
visual hemifields). Stimulus positions were randomized on each trial, with the constraint that the 
distance between squares within a hemifield was more than 2. Participants were told to avoid 
movements, blink or break fixation during the cue, sample array, delay and probe periods. The button-
press match/non-match assignments were counterbalanced across participants. During the three MEG 
sessions, the visuo-spatial WM load was individually adjusted to 75% accuracy during Session 1 (see 
below).  
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Pharmacological Design and General Procedure. 
Participants were tested on four occasions separated by at least four days. During the intake session 
(Session 1), all participants were screened using the Mental International Neuropsychiatric Interview 
(Sheehan et al., 1998) and a general physical examination (thorax, sensorimotor and vestibular 
coordination, skin, pulse rate and blood pressure) to exclude major psychiatric, neurological or medical 
illnesses. They also completed the trait scale of the State-Trait Anxiety Inventory questionnaire 
(Spielberger CD, Gorsuch RL, & Lushene RD, 1970). In addition, a behavioural session of ~45mins 
duration tested participants’ WM span using 320 trials (four blocks of 80 trials each with self-paced 
breaks) using variable loads presented randomly from trial to trial (two to six items per hemifield). The 
reason was two-fold: a) to train the volunteers on the task and b) to determine the WM span 
corresponding to ~75% accuracy (i.e. to ensure that task difficulty was similar among participants). To 
monitor participant’s fixation an EyeLink 1000 infrared camera (SR Research, Osgoode, ON, Canada) 
tracked right eye movements at 1000Hz. After discarding trials with saccades and blinks (visual 
inspection), individual WM load accuracy closer to ~75% accuracy was selected for the three MEG 
pharmacological sessions. In this way, participants differed in memory load while task difficulty was 
matched. 
 
The starting time of the three drug sessions (8.00 or 9.00AM) was kept constant across experiments 
within participants (Sessions 2, 3 and 4). Participants were asked to abstain from alcohol, nicotine, tea, 
coffee or any another caffeinate beverage 24h prior to the testing day. Upon arrival, participants were 
asked about their compliance with the above-mentioned restrictions and were given a light breakfast 
1h before ingestion of the drug. Participants were tested after placebo, low LZP dosage (Ativan®, 0.5mg) 
and high dosage (1.5mg). Timing was optimized to have maximal effects: the drugs were administered 
~1h before the beginning of the MEG recording. The study was double-blind and the order of 
administration was randomized. The dose selection was based on previous studies, which revealed 
significant behavioral effects for high dosages, mixed results for low dosage and good tolerance in 
general (Hall et al., 2010; Mintzer & Griffiths, 2007; Van Ruitenbeek, Vermeeren, & Riedel, 2010). The 
mean time for maximal plasma concentration of LZP is approximately between 1 and 1.5h, with a 
plasma half-life of approximately 12 – 15h (Greenblatt et al., 1979; Wyeth-Laboratories, 2012).  
 
Before the WM task, two minutes eyes-closed and two-minutes eyes-opened recordings were acquired 
(the order was counterbalanced across sessions).  
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Subjective mood ratings were measured with the visual analogue scales (VAS) (Bond & Lader, 1974). 
Mood measures, blood pressure, and heart rate were measured approximately 5min before and 60min, 
2.5h, and 5h after drug intake. Approximately 20min after the MEG task participants performed 80 trials 
of the WM task now with one item as load. 
 
After the MEG WM task (load 75%), both participant and researcher (first author of the present 
manuscript D.L.S.) filled independently a Likert scale questionnaire to quantify how they subjectively 
would rate if they had received LZP or placebo. The questions were:  
1. What type of treatment did you think that you received: placebo or drug? Rate from -3 to 3 how 
confident are you being zero "do not know", -3 certainly placebo and +3 certainly drug. 
2. If you think that you are under the effects of the drug, under what kind of dosage do you think 
you are: Low dose or High dose? Rate from -3 to 3 how confident are you being zero "no clue", -3 
certainly Low dose and +3 certainly High dose. 
 
Data Acquisition. 
MEG. 
Ongoing brain activity was recorded (sampled at 1200Hz) using a whole-head MEG system with 275 
axial gradiometers (VSM/CTF systems, Port Coquitlam, Canada). To monitor blinks and eye 
movements horizontal and vertical electro-oculograms (EOGs) were recorded using bipolar Ag/AgCl 
electrodes (<10kΩ impedance) placed below and above the left eye and at the bilateral outer canthi. 
An EyeLink 1000 eyetracker was used to monitor the movements of the participants’ right eye. The 
electrocardiogram (ECG) was also recorded with electrodes (impedance < 50kΩ) attached above the 
right clavicle and under the last false rib on the left side. All data were low-pass filtered by an anti-
aliasing filter (300Hz cutoff), and stored on disk for offline processing.  
 
To anticipate the known muscular fatigue produced by LZP, we used an orthopedic neck-collar (Push 
braces, height 10, size 2, model 1.60.2.02; http://www.push.eu) during the MEG recordings. 
Participants were instructed to rest their head while seated in the MEG chair in a comfortable position, 
releasing neck muscles from extra fatigue. Further the neck-collar helped us to stabilize participants 
head position. 
 
Online head repositioning. 
The CTF275 MEG system has three head localization coils that produce electrical sinusoidal current at 
unique frequencies, thereby generating magnetic fields with dipole-like distributions that are measured 
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by the MEG sensors. The position of each coil is then localized relative to the dewar using dipole fitting. 
Using a real-time head localizer tool (Stolk et al., 2013), head coil positions were plotted in real-time 
(see (Stolk et al., 2013) for more details). At the beginning of the first MEG session, head coil positions 
(placed at anatomical fiducials: nasion, left and right ear canals) were tracked and stored. In the 
subsequent session the real-localization tool was used to reposition the participants’ heads as close as 
possible to the position stored in the first session. Further the heigh and angle of the MEG seat was 
kept the same over sessions for each participant.  
 
The experiment was paused when head position deviated more than 5mm in one or more fiducials 
during several consecutive trials. When this happened, the experiment was stopped (stop only was 
allowed during the 2s blinking period) allowing the participant to reposition the head. These procedures 
allowed us to keep participant’s head position stable over session thus increasing the accuracy of the 
source modeling  
 
The circumcenter of the three head localization coils, i.e. the center of the circle that passes through all 
the positions of the fiducials, was used as an index for head position analysis (Stolk et al., 2013). 
Differences in head positions between drug treatments were obtained by computing the mean position 
of the head on each session and submit them to repeated-measures ANOVA. Before statistical analysis 
(see Figure S1), we first identify the initial head position during the first trial for each MEG session, we 
averaged them and we use it to demean each MEG fiducial time courses separately. Second, as MEG 
head position is expressed by three time courses (x-, y- and z- coordinates), we use singular value 
decomposition (SVD) to project time courses on the principal axes that explain the most variance (Stolk 
et al., 2013). 
 
Structural MRI 
T1-weighted images (TR/TE/TI=2300/3.03/1100ms, 8˚ flip angle, 1.0 x 1.0 x 1.0mm3 resolution, 192 
sagittal slices) were acquired on a 3T Siemens Magnetom TimTrio MRI system (Siemens Healthcare, 
Erlangen, Germany). MEG head coils were co-registered to individual MRIs manually according to the 
respective anatomical landmarks (nasion, left and right ear canals). 
 
Data Analysis. 
Behavioral analysis. 
Behavioral performance was computed in terms of accuracy (correct responses divided by total  
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responses) and reaction times (RTs). In addition, d’ and response bias (criterion) was quantified 
following Hautus approach (Hautus, 1995): 
𝑑′ = 𝜑−1(ℎ + 0.5) − 𝜑−1(𝑓 + 1) 
 
𝑐 =  
−(𝜑−1(ℎ + 0.5) − 𝜑−1(𝑓 + 1))
2
 
where h is the hit rate and f is the false alarm rate, 𝜑−1 is a function that converts probabilities into z 
scores.  
 
The memory span, Kspan, was estimated using Pashler formula (Pashler, 1988): 
𝐾𝑠𝑝𝑎𝑛 = N(
ℎ − 𝑓
1 − 𝑓
) 
where N is the memory load. 
 
Eye-tracking 
Before each behavioural and MEG session, a saccade calibration was performed. Nine dots (0.3 
radius) were presented sequentially during 3 s each in a 3x3 grid. Participants had to sequentially fixate 
on each dot. Three distances from the screen’s center (1, 3, 5) were assessed and the order of the 
dot position and calibration distance was randomized. Horizontal (x) and vertical (y) eyetracker positions 
were smoothed with a 21ms-wide boxcar kernel to reduce noise (Martinez-Conde, Macknik, & Hubel, 
2000). To estimate eye position during the task, we linearly regress x and y positions separately with 
the grid-calibration dot coordinates to find a set of coefficients that will be used to predict eye position. 
Eyetracker calibration was performed at the beginning of each block and the regression coefficients 
were updated.  
 
MEG 
Data were analyzed offline using FieldTrip (Oostenveld et al., 2011) (http://fieldtrip.fcdonders.nl/), an 
open-source Matlab toolbox developed at the Donders Institute for Brain, Cognition, and Behaviour 
(Nijmegen, The Netherlands). For each participant and session, continuous MEG data was down-
sampled to 600Hz after they were low-pass filtered at 200Hz. Trials of 6.1s (2 s before sample array 
stimulus to 4.1s post-stimuli) were extracted. We eliminated line noise by fitting sine and cosine 
functions at 50Hz, 100Hz, 150Hz and subsequently subtracting these estimated components. The 
offset of each trial was removed by subtracting the mean. Trials with muscle artifacts, trials with 
extremely high variance, head movements beyond 5mm from the beginning of the MEG session, 
saccades beyond 1.5, blinks ±500ms around sample stimuli and trials with no response were removed 
from the main analysis. This resulted in an average of 358 ± 49 trials per participant. Blinks and 
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electrocardiogram activity were isolated by independent component analysis (ICA) (Jung et al., 2000). 
The artefactual independent components (ICs) were semi-automatically identified by correlating the 
time-course of the ICs and respectively the vertical EOG and ECG. ICs with the strongest correlations 
were visually inspected and rejected (0.58 ± 0.25).  
 
Spectral analysis. For the sensor-level analysis, synthetic planar gradients (Bastiaansen & Knösche, 
2000) were generated by comparing the magnetic field distribution of each sensor and with its neighbors 
resulting in a vertical and horizontal components. Time-frequency decomposition was performed on 
both components and subsequently combined (vector summation). The planar gradient makes data 
interpretation easier since the strongest field is situated above the neural sources (Hämäläinen et al., 
1993). We calculated time-frequency representations (TFR) of oscillatory power by means of Fast 
Fourier Transform (FFT). For frequencies below 40Hz, we used an adaptive sliding time window six 
cycles long (Δt = 6/f) for the frequencies 2Hz to 40Hz in steps of 1Hz. Power was estimated in steps of 
5ms. Prior to the FFT, each time-window was multiplied by a Hanning taper. For frequencies above 
40Hz, we used a fixed window length of 0.5 s multiplied by a Hanning taper applied to the frequencies 
of 40Hz to 150Hz in 2Hz steps.  
 
To test the dependency between the gamma frequency and drug we computed ‘center of mass index’ 
(first spectral moment (Cohen, 1989)) defined as: 
𝑓𝑐 =
 ∑ 𝑓𝑖  · 𝑃(𝑓𝑖)
𝑁
𝑖=1
∑ 𝑃(𝑓𝑖)
𝑁
𝑖=1
 
where fi is frequency and P(fi) power after subtracting a prestimulus baseline (-0.5 – -0.1s). The center-
of-mass characterizes how the gamma power is weighted in a given a frequency interval. It differs from 
the peak frequency in the sense that it takes the full frequency interval into account and is useful when 
a frequency peak cannot be unambiguously identified. 
 
Source analysis. To localize the sources of the oscillatory activity we applied an adaptive spatial filtering 
technique (Gross et al., 2001). Alpha band source reconstruction was computed by applying a 
multitaper FFT approach to the data of the delay interval (0.5 – 1.4s) centered at 11Hz with 3 orthogonal 
Slepian tapers resulting in 2Hz smoothing. The source reconstruction of the gamma band activity during 
the probe interval (1.75 – 2.15s) was centered at 75Hz and 11 orthogonal Slepian tapers resulted in a 
15Hz smoothing. The brain volume of each individual was divided into a grid with a 1cm resolution and 
normalized toward the template MNI brain (International Consortium for Brain Mapping, Montreal 
Neurological Institute, Canada) using SPM2 (http://www.fil.ion.ucl.ac.uk/spm). Lead-field matrices were 
computed for each grid location using a realistically shaped single-shell description of the brain for each 
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participant, using the individual anatomical MR image (Guido, 2003). A common spatial filter was 
constructed for all conditions for each grid point, for each participant and session. The spatial filters 
were constructed for each grid location based on leadfield and cross spectral density (CSD) matrices. 
CSD matrices were computed between all MEG pairs for the time period and frequency of interest. 
Using this common spatial filter, the distribution of power was estimated for each experimental condition 
separately. We estimated the orientation in which the power of each dipole grid was maximal according 
to a SVD (Schoffelen, Poort, Oostenveld, & Fries, 2011). 
 
Statistical analysis. To statistically assess the difference between experimental conditions at the 
sensors and source data, a cluster-based nonparametric permutation test was applied (Maris & 
Oostenveld, 2007). This approach provides an effective method for controlling for multiple comparisons. 
The procedure was performed as follows: 
a) For every participant, a given contrast was compared using a test statistics. When considering 
the alpha power estimate for the left versus power right condition, the test statistics was constituted by 
means of a permutation t-test. For the stimulus induced gamma power the relative change in gamma 
power was applied to build the test statistics: 
 ∆𝑝𝑜𝑤𝑒𝑟 = (𝑝𝑜𝑤𝑒𝑟𝑠𝑡𝑖𝑚𝑢𝑙𝑢𝑠 − 𝑝𝑜𝑤𝑒𝑟𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒)/((𝑝𝑜𝑤𝑒𝑟𝑠𝑡𝑖𝑚𝑢𝑙𝑢𝑠 + 𝑝𝑜𝑤𝑒𝑟𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒)/2) 
b) A reference distribution based on the test statistics was estimated from the data by randomly 
permuting the samples between the experimental conditions (N=6000). 
c) The 95th percentile of the reference distribution then defined the two-tailed critical value. 
Sensors or grids points for the observed test statistic descriptive exceeding the critical values defined 
in b) were clustered by considering the spatial adjacency and summed. This thresholding provides the 
initial cluster candidates (the observed clusters). 
d) A second randomization approach was performed by randomly exchanging the experimental 
conditions. For each permutation, the cluster candidate with the highest sum of the test statistic-
descriptive was used to generate the permutation distribution.  
e) The statistical significance of the observed clusters (from c) was determined by comparing to 
the permutation distribution. Cluster (summed test statistics) being in the 95th percentile (summed test 
statistics) of the randomization statistics were considered significant (two-tailed). 
 
A repeated-measures ANOVA approach was used to asses drug main effects. P-values were calculated 
and Greenhouse-Geisser corrections were made to control of sphericity violation when appropriated. 
Subsequent post-hoc t-tests, in case of main effect and/or interaction, were always corrected by multiple 
comparisons using the False Discovery Rate approach (Benjamini & Hochberg, 1995). We did not 
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observe significant differences between hits and error responses in gamma (probe) and alpha (delay) 
bands, so we included all them in the analysis of the present manuscript. 
 
Sensors of interest. A subset of the posterior sensors was selected for the sensor level analysis. 
Clusters of sensors that were statistically significant and symmetric over the midline were selected. For 
the gamma band the sensor selection was constituted by the cluster representing a significant increase 
in the probe period (1.75 – 2.15s) compared to the baseline interval (-0.5 − -0.1s). For the alpha band 
the sensor selection was made during the cue period (-1 – -0.1s) by pooling all three MEG sessions 
together. 
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Abstract:  
Computational and rodent hippocampal models have revealed that GABAergic interneurons play an 
important role in the generation of gamma band oscillations. It has been shown that increasing inhibitory 
efficacy (pharmacologically and by computer simulations) results in decreases in the frequency, and 
increases in the amplitude of the gamma oscillations.  Using pharmacology combined with 
magnetoencephalographic (MEG) recordings we have recently demonstrated that the same 
neurophysiological mechanisms may apply to human visual cortex. Further, several magnetic 
resonance spectroscopy (MRS) studies have highlighted the importance of individual differences in 
endogenous GABA concentration to predict behavioral performance and brain activity, including 
gamma oscillations. In the present study we have related the modulations of gamma frequency and 
power with the endogenous GABA concentrations as measured with MRS. We considered the stimulus-
induced gamma power and frequency estimates in each pharmacological session separately but we 
were not able to predict the endogenous GABA levels in visual cortex. In addition, we did not find 
significant correlations between endogenous GABA concentration in visual cortex and the properties of 
the pharmacologically-related stimulus-induced gamma oscillations. As a control, we also quantified 
endogenous GABA concentrations in motor cortex but similar non-significant correlations were found. 
Our null-findings are consistent with a recent MRS-MEG study that also did not show a relationship 
between the endogenous GABA concentration and properties of the gamma oscillations in a larger 
sample (n = 50). In conclusion, we have not been able to establish a link between the endogenous 
GABA concentrations and the stimulus-induced gamma oscillations. It remains unclear whether this 
absence of correlation is physiological in nature or explained by limitations in the recording techniques.   
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Introduction. 
Gamma band (30 – 100Hz) oscillations are ubiquitous in the mammal brain (Buzsáki, Logothetis, & 
Singer, 2013; Fries, 2009). Its amplitude and frequency change as a function of stimulus features such 
as contrast (Ray & Maunsell, 2010), visual field eccentricity (van Pelt & Fries, 2013), and in response 
to natural images (Brunet et al., 2013; Hermes, Miller, Wandell, & Winawer, 2014). Moreover, 
compelling evidence from animal and human experiments suggest a fundamental role for gamma 
oscillations during cognitive processes such as attention (Bosman et al., 2012; Fries, 2009; Grothe et 
al., 2012; Koelewijn et al., 2013) and working memory (WM) (Jensen, Kaiser, & Lachaux, 2007; 
Rouhinen, Panula, Palva, & Palva, 2013). 
 
The neurophysiological mechanisms underlying the gamma rhythm have been extensively studied 
using computational and animal models (Bartos et al., 2007; McBain & Fisahn, 2001; Traub et al., 1999). 
Those studies highlight the key role of GABAergic inhibition for generating the gamma band activity. 
For example, pharmacological GABA enhancers such as barbiturates and benzodiazepines have been 
shown to modulate oscillations above ~20Hz. More specifically, in-vitro and in-vivo work using rat 
hippocampal slices demonstrated that the pharmacological increase of GABA conductance prolongs 
the decay constant of the inhibitory postsynaptic potentials (IPSP; i.e. barbiturates) or augments the 
size of the IPSP (i.e. benzodiazepines). Both effects lead to a decrease of gamma frequency due to the 
slower release from inhibition (Traub et al., 1996a; Whittington et al., 1995; Whittington et al., 2000). 
The increase in the interneuron IPSP amplitude by pharmacology (Traub et al., 1999) or by the stronger 
overall entrainment of local interneuron network (Vinck et al., 2013) may lead to the gamma power 
increase. 
 
Numerous investigations carried in humans have interrogated how GABAergic neurotransmission 
influences gamma-band rhythmicity (Muthukumaraswamy, 2014). Recent work aimed to quantify the 
concentration of endogenous GABA metabolites noninvasively by means of magnetic resonance 
spectroscopy (MRS). (Muthukumaraswamy et al., 2009) found that the participants with the highest 
stimulus-induced gamma peak frequency, as measured with magnetoencephalography (MEG), were 
the ones having the highest resting GABA concentrations in primary visual cortex. The authors 
interpreted that higher GABA concentrations would reduce the excitation-inhibition balance within 
pyramidal-interneuron network and the gamma peak frequency would increase (see (Brunel and Wang, 
2003) for model predictions). As such, this important finding implies that MRS can detect aggregates of 
GABA metabolites. However, a recent study has recently challenged these findings. Using a similar 
experimental design as in Muthukumaraswamy et. al., (2009) but measuring from a larger sample, 
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(Cousijn et al., 2014) were not able to find significant correlations between stimulus-induced gamma 
frequency nor of power with the endogenous GABA concentrations as measured with MRS.  
 
Complementarily, the role of GABAergic inhibition in gamma oscillations has been studied combining 
pharmacology with MEG. This approach relies on using different pharmacological agents, such as 
GABAergic enhancers, to determine the changes in amplitude and frequency of the gamma oscillations 
(Hall et al., 2010). These studies have provided mixed results: while some drugs modulated both 
amplitude and frequency (Campbell et al., 2014), others did not (Muthukumaraswamy et al., 2013a) or 
they only affected gamma power (Saxena et al., 2013), see (Muthukumaraswamy, 2014) for a review. 
Recently, we used lorazepam (LZP), a GABAA allosteric modulator also affecting the visual system 
(Giersch, Boucart, Elliott, & Vidailhet, 2010; Giersch & Herzog, 2004), and demonstrated modulations 
in the frequency and power of gamma oscillations as a function of drug dosage (Lozano-Soldevilla, ter 
Huurne, Cools, & Jensen, 2014). In a double-blind cross-over design, participants engaged in a visuo-
spatial WM task while they received either placebo, 0.5mg, or 1.5mg LZP. We found that stimulus-
induced visual gamma power increased with drug dosage while the gamma spectrum (50 – 100Hz) 
center of mass shifted towards lower frequencies. As part of the experiment we also collected MRS 
data for the participants, providing the unique opportunity to relate the pharmacologically-related 
stimulus-induced gamma oscillations with the endogenous GABA concentration. 
 
We hypothesized that gamma-band power and frequency would correlate with endogenous GABA 
concentrations in visual cortex as measured with MRS. In addition, we hypothesized that the induced 
gamma oscillations and the modulations in power and frequency correlate with resting GABA 
concentrations. The results of our analysis do not support any of the two hypotheses. The endogenous 
GABA concentrations in visual cortex did not predict gamma frequency, power or the drug effect on 
gamma frequency and power. The present results are in line with the findings of (Cousijn et al., 2014; 
Shaw et al., 2013).  
 
Material and methods. 
Experimental procedures. 
Details about participants, the experimental paradigm and the general procedure can be found in 
(Lozano-Soldevilla et al., 2014). One participant was excluded because MRS spectra contained large 
artifacts, leaving a total of 24 participants. In short, participants were engaged in a visuospatial delayed-
match-to-sample task (Vogel & Machizawa, 2004). Each trial started with a centrally presented visual 
cue for 1.5s. The task consisted to encode the configuration of sample array composed of colored 
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squares presented in the visual hemifield indicated by a spatial cue. After a 1.5s delay interval, a probe 
array was presented and participants had to indicate whether it matched the sample array or not. 
Participants had to keep their fixation to the center of the screen while covertly attending to the cued 
hemifield. 
 
MEG methods. 
Brain activity was recorded (sampled at 1200Hz) using a whole-head MEG system with 275 axial 
gradiometers (VSM/CTF systems, Port Coquitlam, Canada). Specific details about MEG data 
acquisition can be found in (Lozano-Soldevilla et al., 2014). Participants were instructed to rest their 
head in a comfortable position while seated in the MEG chair, releasing neck muscles from extra fatigue. 
Further we used an orthopedic neck-collar (Push braces, height 10, size 2, model 1.60.2.02; 
http://www.push.eu) during the MEG recordings to minimize participants head movement. We used the 
real-time head localizer tool (Stolk et al., 2013) to monitor participant’s head position and orientation 
relative to the MEG sensors during all MEG experiments. Before the second and the third MEG session 
(separated by minimum 4 days), each participant was requested to reposition his/her head in the same 
location and orientation as the position measured at the beginning of the first MEG session using the 
real-time head localizer tool. With this procedure we sought to minimize potential systematic differences 
in head position and orientation among the three MEG sessions. 
 
MEG data was down-sampled to 600Hz to be analyzed offline using Fieldtrip (Oostenveld et al., 2011) 
(http://fieldtrip.fcdonders.nl/); an open-source toolbox developed at the Donders Institute for Brain, 
Cognition, and Behaviour (Nijmegen, The Netherlands) and custom Matlab code (MathWorks, Natick, 
MA, USA).  
 
Sensor level analysis. The same preprocessing, artifact rejection and sensor spectral analysis 
procedures were applied as in (Lozano-Soldevilla et al., 2014). Trials 6.1s long (2 s before sample array 
stimulus to 4.1s post-stimuli) were extracted for each pharmacological session (Placebo, 0.5mg LZP 
and 1.5mg LZP). Synthetic planar gradients (Bastiaansen & Knösche, 2000) were computed by 
evaluating the magnetic field distribution of each sensor and its neighbors resulting in two gradient 
components in the tangential plane at each sensor location. Time-frequency representations (TFR) of 
power were calculated on both components and subsequently combined (summation). This combined 
planar gradient makes data interpretation easier since the strongest field is situated above the neural 
sources (Hämäläinen et al., 1993). Spectral oscillatory power was computed by applying a windowed 
Fast Fourier Transform (FFT) in steps of 5ms. We used a fixed window length of 0.5s multiplied by a 
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Hanning taper applied to the frequencies from 40Hz to 150Hz in 2Hz steps. TFRs were averaged across 
trials and the average spectral power was expressed as a relative increase compared to a baseline (-
0.5 – -0.1s; relative to memory array onset). Sensors of interest were defined based on the spatial 
attention modulations reported earlier (see (Lozano-Soldevilla et al., 2014); i.e. statistical significance 
over the normalized contrast attention left hemifield vs right hemifield). These sensors were 
subsequently used to assess the influence of LZP on gamma power and frequency and its relationship 
with the resting GABA concentrations as measured with MRS. 
 
To test the dependency between the gamma frequency and drug we computed ‘center of mass index’ 
(first spectral moment (Cohen, 1989)) defined as: 
𝑓𝑐 =
 ∑ 𝑓𝑖  · 𝑃(𝑓𝑖)
𝑁
𝑖=1
∑ 𝑃(𝑓𝑖)
𝑁
𝑖=1
 
where fi  is frequency and P(fi) stimulus-induced relative power centered at response peak (1.8 – 1.95s). 
The center-of-mass characterizes how the gamma power is weighted in a given a frequency interval 
(50 – 100Hz). It differs from the peak frequency in the sense that it takes the full frequency interval into 
account. This measure is useful when a frequency peak cannot be unambiguously identified in the 
power spectrum. 
 
Source level analysis. Sources of gamma band activity during the probe period were localized by an 
adaptive spatial filtering technique (Gross et al., 2001). More detailed procedures can be found in 
(Lozano-Soldevilla et al., 2014). Once the peak of the gamma sources were localized, a linearly 
constrained minimum variance beamformer technique (LCMV) (Van Veen, van Drongelen, Yuchtman, 
& Suzuki, 1997) was used to reconstruct the time course of the stimulus-induced gamma power and 
frequency center of mass from a specific region of interest. We constructed a sphere of 20mm radius 
around the peak of the stimulus-induced gamma power, located in the occipital lobe. This spherical 
region of interest was used as a spatial mask to extract gamma power and center of mass for each 
pharmacological session. The brain volume of each individual was divided into a grid with an 
approximate 1cm resolution based on a 1cm resolution template grid in normalized MNI space 
(International Consortium for Brain Mapping, Montreal Neurological Institute, Canada), using SPM8 
(http://www.fil.ion.ucl.ac.uk/spm). Lead-field matrices were computed for each grid location using a 
realistically shaped single-shell description of the brain for each participant based on individual 
anatomical MR images (Nolte, 2003). Spatial filters were constructed using the average of the single-
trial covariances between all sensor pairs. Before averaging and computing sensor covariance 
matrices, single-trials were band-passed filtered (40 – 120Hz). These spatial filters were used as virtual 
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channels of regions of interest (see below) to reconstruct the raw single trials. TFR of virtual sensors 
were computed using the same parameters and normalization as for the sensor analysis. 
 
MR methods. 
MRS acquisition. 
During the first intake session (see Supplemental Experimental Procedures in (Lozano-Soldevilla et al., 
2014)) the 3T Siemens Magnetom TimTrio MRI system (Siemens Healthcare, Erlangen, Germany) was 
used to acquire a high resolution T1-weighted image (TR/TE/TI=2300/3.03/1100ms, 8˚ flip angle, 1.0 x 
1.0 x 1.0mm3 resolution, 192 sagittal slices) and MRS GABA measurements. Two 20 x 20 x 20mm3 
voxels of interest were placed manually over the right primary visual cortex (V1) and, as a control region, 
over the right pre-central handknob (M1) using the participant-specific T1-weighted image. An example 
of single-participant voxel placement can be found in Figure S1AB. Voxel positions were identified using 
the Siemens AAScout (Autoalign) feature to facilitate the voxel placement across participants. Voxels 
were placed with care to exclude cerebral spinal fluid (CSF) from the ventricles or the cortical surface. 
The MEGA-PRESS sequence (Mescher, Merkle, Kirsch, Garwood, & Gruetter, 1998) was used to 
obtain the edited 1H J-difference spectra. Briefly, during each voxel (~12min acquisition) 512 transients 
were collected; TE = 68ms; TR = 1500ms. The GABA-H4 methylene protons at 3.01 parts per million 
(ppm), overlap completely with the combined resonance from creatine (Cr) and phosphocreatine. 
During the odd acquisitions (”on resonance”) a frequency selective, refocusing Gauss pulse (50Hz) at 
1.9ppm. This pulse refocuses the J evolution of the triplet peak at 3.0ppm. During the even acquisitions 
the same pulse is applied to the opposite side of the spectrum. During these acquisitions, while the 
3.0ppm remains unaffected, the outer signals from the triplet are inverted at TE = 1/(2J) = 68ms. A 
volume selective shim was performed prior to each GABA measurement. 
 
MRS preprocessing. 
V1 and M1 GABA quantification was performed using the Gannet 2.0 toolkit, a Matlab-based 
quantitative batch analysis tool for analyzing GABA MEGA-PRESS spectra (Edden, Puts, Harris, 
Barker, & Evans, 2014). Signal preprocessing consisted to apply a line broadening of 3Hz, zero-padding 
up to 64 zeros per data point (512 x 64 = 32768) and a frequency and phase correction of individual 
spectra using Spectral Registration (Near et al., 2014). Accuracy of quantitative measurements was 
improved by discarding the time-resolved spectra time points that exceeded more than three standard 
deviations from the mean in either phase, frequency, area or full-width at half maximum of Cr peak. 
Rejections were applied in a pair-wise manner (i.e. both off and on resonance acquisitions) 
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GABA MRS quantification. 
Nonlinear least-squares fitting of the spectra was used to quantify the edited GABA signal at 3ppm and 
the Cr signal at 3ppm. For the GABA signal a Gaussian model was used: 
𝐴𝑒𝑥𝑝(−𝐺(𝑓 − 𝑓0)2) + 𝐶 + 𝑀(𝑓 − 𝑓0) 
Where A, G and f0 represent the amplitude, width and center frequency of the Gaussian peak, f is the 
GABA peak (initially set as 3.0ppm) and C and M represent the baseline offset and slope (initially set 
as zero). The non-linear fitting was performed over a range of the spectrum between 2.79ppm and 
3.55ppm (Edden et al., 2014). 
 
Cr peak fitting was performed using a Lorentzian model: 
𝐴
2𝜋
〈
𝐿 cos(𝜑)
(𝑓 − 𝑓0)2 + 𝐿2
 +  
(𝑓 − 𝑓0) sin(𝜑)
(𝑓 − 𝑓0)2 + 𝐿2
〉  +  𝐶 + 𝑀(𝑓 − 𝑓0) 
Where A, L, f0 and 𝜑 represent the amplitude, width, center frequency, and phase of the Lorentzian 
peak. Fitting was performed between 2.72ppm and 3.12ppm frequency range. See (Edden et al., 2014) 
for more details. GABA concentration was defined as the integral ration between the edited GABA signal 
and the Cr signal in the time-averaged off spectrum.  
 
Results. 
For each participant and pharmacological session, we calculated the time and frequency gamma (60 – 
90Hz) responses from the occipital lobe during the probe period using a spatial filter (1.75 – 2.15s). 
Figure 1A shows the gamma sources (left) and its TFR of power (right) of a representative participant 
during the Placebo (top) and 1.5mg LZP sessions (bottom). LZP increased gamma power below 90Hz. 
This was also the case for the grand-average source reconstructed responses (Figure 1B). Figure 1C 
displays the GABA concentration as measured with MRS of the same representative participant as in 
Figure 1A with the Gaussian estimates in red. Figure S1 shows GABA concentration estimates for all 
participants in V1 (Figure S1C) and M1 (Figure S1D). 
 
First, as reported in (Muthukumaraswamy et al., 2009) we sought to correlate the stimulus-induced 
gamma power and frequency estimates in each pharmacological session separately with the 
endogenous GABA levels in the two scanned voxels. For that, we used beamforming spatial filters to 
locate the stimulus-induced gamma power peak in the visual cortex (DICS), and we drew a ROI of 
20mm around it to compute a TFR or the reconstructed time series (LCMV). Then, we computed the 
center of mass of the gamma frequency spectrum (50 – 100Hz) during the probe peak (1.8 – 1.95s) for 
each session separately. We did not find any significant correlation between endogenous GABA as 
measured with MRS and gamma frequency (Table 1) nor for power estimates (Table 2) in any of the 
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Figure 1. Stimulus-induced gamma oscillations and magnetic resonance spectroscopy (MRS) data from a 
representative participant. (A) Source reconstructed gamma band response in a representative participant. 
Upper left: Localization of stimulus-induced gamma power (60 – 90Hz; 1.75 – 2.15s) in occipital lobe of the 
participant during Placebo session using the dynamic imaging of coherent sources beamforming approach. 
Color code represents the relative gamma power in comparison with a baseline (-0.5 – -0.1s). Upper right: Time-
frequency source reconstruction of the 20mm region of interest defined by a sphere of 20mm radius around the 
peak of the stimulus-induced gamma power during the probe period from the occipital lobe using linearly 
constrained minimum variance beamformer technique (same color code conventions). Lower: same conventions 
and relative power scale as in upper row but for 1.5mg LZP. (B) Grand-mean source reconstructed gamma 
spectrum during the probe period on where the relative power reached its maxima (1.8 – 1.95s). Specifically 
with1.5mg LZP, gamma power below ~90Hz was higher in comparison with Placebo. Conversely, gamma power 
above ~90Hz in 1.5mg LZP session was lower than Placebo. Red triangles indicate significant differences in 
gamma center of mass between 1.5mg LZP versus Placebo (corrected by multiple comparisons). Error bars 
show the SEM. (C) Edited MRS spectra from the same participant as in (A). Upper: Visual cortex (V1) edited 
spectra with a clear GABA peak at 3 ppm (fitted Gaussian model indicated in red). Lower: Motor cortex (M1) 
edited spectra from the same participant with a clear GABA peak at 3 ppm (fitted Gaussian model indicated in 
red). 
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pharmacological sessions. 
 
Next, we asked whether individual differences in resting GABA concentrations as measured with MRS 
related with the reported LZP-induced gamma frequency and power modulations. The gamma power 
and frequency modulation with LZP at the sensor level were published elsewhere (Lozano-Soldevilla 
et al., 2014). First, we computed the center of mass of the gamma frequency spectrum (50 – 100Hz) 
during the probe peak (1.8 – 1.95s) in the session space for each MEG session separately. Second, 
we correlated (Pearson product-moment correlation coefficient) the drug-related changes in frequency 
with the GABA concentration acquired in V1 and M1 voxels. We did not find any significant correlation 
between the two factors with the exception of the V1 voxel GABA concentration with 1.5mg LZP minus 
 
 
Gamma frequency Placebo 0.5mg LZP 1.5mg LZP 
V1 voxel r=0.28; p=0.53 r=0.22; p=0.59 r=0.41; p=0.28 
M1 voxel r=0.13; p=0.68 r=0.12; p=0.68 r=0.09; p=0.68 
 
Table 1. Pearson correlations between stimulus-induced gamma frequency as detected by occipital virtual 
sensor applied to MEG data and endogenous GABA concentration in as measured by MRS for each drug 
session separately. Gamma frequency was estimated using the center of mass index (see “MEG methods” 
section). The correlation p-values are corrected by multiple comparisons using the False-Discovery Rate 
procedure. 
 
 
Gamma power Placebo 0.5mg LZP 1.5mg LZP 
V1 voxel r=-0.32; p=0.38 r=-0.27; p=0.41 r=-0.38; p=0.38 
M1 voxel r=-0.09; p=0.73 r=-0.15; p=0.73 r=-0.07; p=0.73 
 
Table 2. Pearson correlations between stimulus-induced gamma power as detected by occipital virtual sensor 
and endogenous GABA concentration as measured by MRS for each drug session separately. The correlation 
p-values are corrected by multiple comparisons using the False-Discovery Rate procedure. 
 
Placebo center of mass (rPearson = 0.41, p < 0.05; Figure 2A). It is well established that Pearson 
correlation is not a robust index when extreme (marginal) data points are included in the sample. In the 
latter case, a significant Pearson correlation would not mean that the two variables are linearly related 
and complementary estimators should be used (Rousselet & Pernet, 2012). To address this potential 
concern, we computed the Spearman-rank correlation because is less sensitive than the Pearson 
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correlation measure when considering extreme data points. However we obtained a non-significant 
correlation (rSpearman = 0.28, p = 0.20), suggesting that the two variables we tested are not monotonically 
related. To ensure that the drug-related gamma band frequency and the resting GABA concentration 
measured with MRS is not spurious and/or it depends on specific data points, we used the Shepherd 
pi correlation approach proposed by (Schwarzkopf, De Haas, & Rees, 2012). The procedure works by 
first computing the Mahalanobis distance (Ds) between all data points (i.e. participant’s dependent 
measures). As marginal data points could skew the Ds values, a bootstrap (n = 1000) procedure was 
carried out to improve distance accuracy. We used quantitative criteria to detect data points whose 
average Ds values were greater than or equal to six squared units. Those data points were rejected 
and not used in subsequent Spearman rank correlation (Shepherd pi correlation is a Spearman-rank 
without the extreme data points). Shepherd pi was very low and non-significant (Shepherd pi = 0.08, p 
=1; Figure 2A lower-left). Importantly, the reported correlation (r = 0.41, p < 0.05; Figure 2A) did not 
survive the multiple comparisons correction (r = 0.41, p = 0.2; four comparisons: drug(0.5mg, 1.5mg)-
related correlations over V1 and M1 MRS voxels) using False Discovery Rate approach (Benjamini & 
Hochberg, 1995). 
 
It could be argued that non-parametric tests (i.e. Spearman-rank) could be less sensitive that the 
parametric ones (i.e. Pearson). Complementarily, we computed the Bayes factor (BF) to find the 
probability of the observed data in favor of the null hypothesis (Wetzels & Wagenmakers, 2012). The 
BF = 1.08 suggests “no evidence” according to the category scheme proposed by (Jeffreys, 1961). 
Present lack of evidence could be because our experiment was not sufficiently sensitive or because an 
absence of a true effect. Although in Bayes theory there are no absolute thresholds, BF less than 1 can 
be interpreted as data supporting the null hypothesis and BF above 3 provides substantial evidence in 
favor of the alternative hypothesis. All BF we obtained were below 1.08, not providing strong evidence 
for the relationship between resting GABA concentration in V1 and drug-related changes in the center 
of mass frequency of the gamma response. 
 
We also set out to investigate the relationships between resting GABA concentration as measured by 
MRS with the LZP-related changes in gamma power in the sensor space. As for the center of mass 
index, we did not find any significant correlation accompanied with very low BF values (Figure 2B). 
 
The issue of the field-spread of MEG signals is well known. Spatial filters aim at disentangling the 
contribution from individual sources albeit their contributions are mixed in the sensors. We used spatial 
filters based on a beamforming approach to estimate, for each participant and MEG session, the   
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Figure 2. Pearson product-moment correlations between gamma LZP-related changes as measured by MEG 
occipital sensors and endogenous GABA concentration as measured by MRS (each dot represents a participant 
n = 24). (A) Pearson correlations between drug-related gamma center of mass changes as measured by MEG 
occipital sensors and resting GABA concentration. (A1) Scatter plot with x-axes representing the center of mass 
index difference between 0.5mg LZP minus Placebo during stimulus-induced gamma period (1.8 – 1.95s; 50 – 
100Hz) and y-axes representing the resting GABA concentration in V1 as measured with MRS. (A2) Same 
scatter plot as (A1) with x-axes representing the center of mass index difference between 1.5mg LZP minus 
Placebo (same time and frequency selections). White dots indicate outlier participants not included in the 
Shepherd pi correlation. The contour lines indicate the bootstrapped Mahalanobis distances from the bivariate 
mean in steps of six squared units (purple colors denote greater distances) See (Schwarzkopf et al., 2012) for 
details. (A3) Scatter plot with x-axes representing the 0.5mg LZP-related changes in center of mass and y-axes 
representing the endogenous GABA concentration in M1. (A4) Scatter plot displaying the 1.5mg LZP-related 
changes in visual gamma center of mass (x-axes) and the resting GABA concentration in M1. (B) Pearson 
correlations between drug-related gamma relative power changes and resting GABA concentration. Same 
conventions as in (A) with x-axes representing the 0.5mg LZP (B1 and B3) and 1.5mg LZP (B2 and B4) -related 
change in relative power. Acronyms: r, Pearson correlation coefficient; p, p-value; BF, Bayes Factor; conc., 
concentration; a.u., arbitrary units; Cr, creatine. 
 
stimulus-induced gamma (60 – 90Hz) power maxima during the probe period (1.75 – 2.15s) based in 
our previous findings (Lozano-Soldevilla et al., 2014). Once the maximum was found, a sphere of 20mm 
radius around the peak was defined as a region of interest to reconstruct the time and frequency 
characteristics of the induced gamma response using LCMV beamformer (Figure 1B). We correlated 
the drug-related source reconstructed gamma center of mass change with the resting GABA 
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concentration in V1 and M1. Once again, no significant correlations (p > 0.17) with very low BFs ([0.17 
0.39]) were found.  
 
We then explored other gamma frequency ranges in a data-driven way by identifying the strongest 
significant differences between Placebo and LZP center of mass. We computed the center of mass 
frequency between 40Hz to 130Hz using a sliding bandwidth of 50Hz in steps of 2Hz. Wilcoxon signed-
rank tests between Placebo v.s. treatments centers of mass were performed, obtaining the 56 – 130Hz 
range as the only significant one (Placebo v.s. 1.5mg LZP, z = -3.94, p < 10-4; see Figure 1B; corrected 
by multiple comparisons (Benjamini & Hochberg, 1995)). Despite of the clear frequency spectrum shift 
towards lower frequencies, we did not find a significant relationship with resting GABA concentration in 
any voxel (Figure 3A). Similar results were obtained correlating MRS data with the source reconstructed 
gamma power (Figure 3B). 
 
Discussion. 
In the present study, we sought to relate the frequency and power of stimulus-induced gamma 
oscillations, and their modulation by LZP, with the endogenous GABA metabolite concentration in visual 
and motor cortex as measured with MRS. Despite the clear gamma frequency and power modulations 
produced by LZP in the sensor and in the source space (Figure 1B), we did not find significant 
correlations between the gamma oscillations, or their modulation by LZP, and resting GABA 
concentrations. When considering each pharmacological session separately, neither stimulus-induced 
gamma frequency nor power predicted endogenous GABA concentrations. Our results are in line with 
(Cousijn et al., 2014; Shaw et al., 2013) who did not find GABA-MRS and gamma peak nor amplitude 
correlations. This is in clear contrast to other MRS studies that have found a relationship between 
gamma peak frequency and resting GABA concentration in V1 (Edden, Muthukumaraswamy, Freeman, 
& Singh, 2009; Muthukumaraswamy et al., 2009) and dorso-lateral prefrontal cortex (Chen et al., 2014). 
It is important to note that the latter three studies relied on smaller samples (n = 16, 13, 12, respectively) 
in comparison with (Cousijn et al., 2014) and the present data (n = 42, 24, respectively). 
 
(Cousijn et al., 2014) provided convincing evidence for a lack of a correlation between individual 
differences in visual gamma amplitude and peak frequency and endogenous GABA concentrations in 
occipital cortex. Although we used a different MRS acquisition protocol, we found similar magnitudes of 
correlations and BFs that estimate how likely the null hypothesis is given a body of data. Correlating 
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Figure 3. Pearson correlations between gamma LZP-related changes as measured by occipital virtual sensor 
and endogenous GABA concentration as measured by MRS (each dot represents a participant n = 24). (A) 
Pearson correlations between drug-related changes in gamma center of mass as measured by occipital virtual 
sensor and resting GABA concentration (same conventions as Figure2). (B) Pearson correlations between drug-
related gamma relative power changes as measured by occipital virtual sensor and resting GABA concentration 
(same conventions as Figure 2). 
 
the stimulus-induced gamma estimates for each session separately or taking the pharmacologically-
related gamma changes, did not allow us to predict endogenous GABA concentration in any of the 
voxels we scanned. Moreover, we have used a robust correlation index (Shepherd pi) to downgrade 
the influence of extreme data points (Schwarzkopf et al., 2012). It was clear that one of the correlation 
measures could be explained by two extreme data points (Figure 2A). After being discarded, the 
significant relationship disappeared. Without discarding those two data points, Spearman-rank 
correlations were not significant either and, additionally, the correlation did not survive the multiple 
comparison correction. Moreover, when we used state-of-the-art source-reconstruction techniques to 
estimate the gamma activity in primary visual cortex, the correlation remained non-significant. The 
computation of the BF of the Pearson correlations yielded very low values, adding convergent evidence 
in favor of the null hypothesis.   
 
In contrast to (Cousijn et al., 2014; Edden et al., 2009; Muthukumaraswamy et al., 2009), one of the 
limitations in our study is the lack of an unambiguous gamma peak frequency. This due the short 
duration of the stimulus presentation compared with their studies. For this reason, we used the center 
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of mass index to characterize how the gamma power was weighted as a function of frequency. On the 
other hand, when compared with the studies cited above, the present null findings should be interpreted 
carefully. The lack of effect could be explained by differences in task and/or frequency metrics. The 
visual stimulation was also different in our experiment. Other studies carried in humans and monkeys 
using similar geometrical shapes as in our study have shown robust stimulus-induced gamma 
oscillations (Morgan et al., 2011; Rols, Tallon-Baudry, Girard, Bertrand, & Bullier, 2001). Although 
gratings produce stronger band-limited gamma responses, it remains to be tested whether the shape 
of the stimuli we applied (and the task) could have played an important role with the lack of correlations 
between gamma frequency and GABA concentration as measured by MRS. 
 
It is still a matter of debate which kind of GABA signals MRS is measuring. Combined pharmaco-MRS 
has shown that the GABAergic modulations produced by some antiepileptic drugs can be detected by 
MRS. However it is also true that recent reports did not find MRS signal changes before and after an 
acute intake of GABAergic enhancers in healthy participants (Myers, Evans, Kalk, Edden, & Lingford-
Hughes, 2014; Preuss, van der Veen, Carlson, Shen, & Hasler, 2013). A recent thorough review 
concluded that the metabolite signals presumably measured by MRS are reflecting the overall GABA 
levels: “the end outcome of GABAergic activity is a sum of inhibitory and excitatory activity across all 
the cells affected by the GABAergic modulation. It is this summed activity which one would be 
measuring with 1H MRS”  (Rae, 2014)(page 14). Along those lines it has been argued that the GABA 
metabolites measured using MRS would be a mix of GABA signals that come from the intra- and extra- 
synaptic space (Stagg, Bachtiar, & Johansen-Berg, 2011).  If true, this lack of GABA-MRS specificity 
could explain why we were able to find neither gamma frequency nor power modulations with LZP that 
correlated with the GABA-MRS signal. How MRS-GABA measurements relate to the GABA synaptic 
concentration increase caused by pharmacological enhancers (allosteric modulators and agonists) is 
not straightforward. These and related issues deserve its own research line and are beyond the scope 
of the present manuscript.  
 
Finally, a recent study using Positron Emission Tomography (PET) combined with MEG found strong 
correlations between GABAA receptor density in visual cortex and gamma peak frequency (Jerbi, 2014). 
Then, refining the GABA receptor estimates could be the key factor that explains why using MRS or 
non-specific GABAA enhancers does not contribute to the gamma power and/or peak frequency 
modulations Recently, a research team reported a positive correlation between frontal gamma power 
and tiagabine-induced GABA-shift as measured by PET (Frankle et al., 2008) that was replicated 
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(Frankle et al., 2012). Although the samples were small, PET in combination with electrophysiology 
looks like a very promising research are for the near future. 
 
Conclusion. 
In the present study, despite the robust stimulus-induced gamma power and frequency modulations 
produced by LZP, we did not find significant correlations between the drug-related oscillatory changes 
with the tonic GABA concentrations as measured with MRS. The correlations between stimulus-induced 
gamma estimates for each pharmacological session separately and the MRS data were also not 
significant. Our results are in the line with recent MRS investigations that did not find significant 
correlation between GABA concentrations and gamma peak frequency (Cousijn et al., 2014; Shaw et 
al., 2013). Taken together, present inconclusive results could be explained by multiple reasons: a real 
lack of physiological evidence, limitations in the recording techniques. Future PET studies could help 
us to reconcile the mixed evidence between MRS in relation to the properties of the gamma oscillations. 
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Figure S1. Fitted GABA peaks for each individual participant in parts per million (ppm). Example of voxel placement 
in visual cortex (A) and motor cortex (B) in a single participant. (C) Visual cortex (V1) GABA-edited spectra are 
displayed in blue, the fitted Gaussian model is in red and the residual is represented in black. Fitting was performed 
over the range shown (2.79ppm and 3.55ppm). Y scaling is arbitrary. (D) Motor cortex (M1) GABA-edited spectra 
(same conventions as in (C)). 
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Abstract:  
 
Neuronal oscillations in different frequency bands might play a pivotal role on various cognitive 
processes. Instead of working in isolation, recent findings have demonstrated that neuronal oscillations 
interact by so-called cross-frequency coupling (CFC). Models based on rat hippocampus physiology 
have convincingly demonstrated that GABAergic neurotransmission is a key player for neuronal 
synchronization in the beta and the gamma frequency range (15 – 100Hz). However the modulation of 
CFC between different frequencies by GABA is far from understood. In this study we aim to investigate 
the role of GABA neurotransmission on CFC in healthy volunteers. We designed a double-blind 
pharmacological study in which participants received either placebo, 0.5mg and 1.5mg of lorazepam 
(LZP; GABAergic enhancer) in different experimental sessions. By acquiring oscillatory brain activity 
with magnetoencephalography (MEG) during rest and working memory (WM) maintenance, our findings 
demonstrate that posterior alpha (8 – 12Hz) phase was coupled to beta-low gamma band (20 – 45Hz) 
amplitude envelope. The CFC occurred with absent visible power in the 20 – 45Hz frequency range. 
LZP only decreased the coupling during eyes-closed conditions without changing neither alpha nor 
gamma bands. To fully characterize the CFC, we used measures as such as cross-frequency 
directionality (CFD), bicoherence and oscillatory peak-triggered averages. These measures did not 
allow us to dissociate whether the beta-low gamma amplitude we observed in our CFC were due to 
harmonics produced by the alpha waveform deviating from sinusoidally or due to a true interaction 
between two independent oscillatory phenomena. 
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Introduction. 
Traditionally brain rhythms have been divided in different frequency bands: delta (1 – 4Hz), theta (4 – 
8Hz), alpha (8 – 12Hz), beta (15 – 30Hz), and gamma (> 30Hz). These oscillations have been linked to 
normal and pathological behavioral phenotypes (Steriade, Gloor, Llinás, Lopes da Silva, & Mesulam, 
1990). Importantly, this classification seems to be well preserved amongst species despite the large 
differences in brain size (Buzsáki et al., 2013). Recent studies suggest that different brain rhythms can 
interact in various ways (i.e. phase-to-phase, phase-to-amplitude, amplitude-amplitude or phase-to-
frequency) forming the so called cross-frequency coupling (CFC) (Jensen & Colgin, 2007). The CFC 
between different frequencies depends on many factors. For example, some studies have found 
broadband gamma power (80 – 200Hz) locked to theta phase (4 – 8Hz) in humans (Canolty et al., 2006) 
while others have found beta-low gamma power (20 – 40Hz) modulated by theta phase (6 – 10Hz) in 
rat hippocampus (Igarashi, Lu, Colgin, Moser, & Moser, 2014). Despite insights obtained in recent 
years, more research is needed to establish a clear link between CFC and their functional role (see 
(Canolty & Knight, 2010; Lisman & Jensen, 2013) for recent reviews). Invasive recordings in animals 
and humans have implicated CFC dynamics to a large variety of functions such as neuronal 
communication between brain regions (Colgin et al., 2009; von Nicolai et al., 2014) and cortical layers 
(Spaak et al., 2012), regulation of the firing rate of a particular brain area (Canolty, Ganguly, & Carmena, 
2012), associative learning (Igarashi et al., 2014; Tort, Komorowski, Manns, Kopell, & Eichenbaum, 
2009), working memory (WM) information maintenance (Axmacher et al., 2010; Shirvalkar, Rapp, & 
Shapiro, 2010; Siegel, Warden, & Miller, 2009) and neuronal communication of dispersed functional 
cell assemblies (Canolty et al., 2012; Canolty et al., 2010). The overarching idea behind CFC is that 
independent brain rhythms interact hierarchically: while low frequency oscillations would synchronize 
large neuronal ensembles, local populations could be synchronized by faster rhythms modulated by the 
phase of slower oscillations (Buzsaki, 2006). The function of a particular brain rhythm should not only 
be classified based on its frequency but also by its interaction with other rhythms. Therefore, it is 
important to characterize the CFC to understand the dynamics and functions of brain rhythms. 
 
By means of magnetoencephalographic (MEG) measurements we are able to record synchronized 
neuronal activity produced by post-synaptic action potentials from pyramidal neurons non-invasively. 
This is for instance possible when a sufficient large pool of pyramidal neurons receive synchronized 
firing such that they produce macroscopic oscillatory activity in multiple frequency bands (Hämäläinen 
et al., 1993; Lopes da Silva, 2013). During the last 20 years, impressive in-vitro, in-vivo and 
computational work have provided mechanistic explanations about how synaptic time constants govern 
the amplitude and frequency features of fast neuronal oscillations (~15 – 200Hz) in health and disease 
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(Traub & Miles, 1991; Traub & Whittington, 2010; Traub et al., 1999). Focusing on rat hippocampal in 
vitro recordings, compiling evidence demonstrated that the pharmacological increase of inhibitory 
postsynaptic potential currents (IPSC) increased gamma amplitude while decreased its frequency 
(Bartos et al., 2007; Traub et al., 1996a; Whittington et al., 1995). In short, it is highly recognized that 
neuronal synchronization is tightly linked to GABAergic inhibition. 
 
As with any other approach, there are methodological concerns when analyzing and interpreting CFC 
results. The first caveat is related to sharp edge artifacts producing spurious CFC (Kramer, Tort, & 
Kopell, 2008). Using synthetic data, the authors convincingly demonstrated that periodic sharp 
transients in the low frequency signals can produce high frequency power modulations that become 
visible in the CFC frequency-by-frequency comodulogram plots. The reason that sharp edges produce 
broadband frequency power coupled to predictable specific phase bins of slow oscillations (Kramer et 
al., 2008). Therefore the gamma power modulations coupled to slow rhythms could be trivially explained 
by the non-sinusoidal properties of the sharp edges (i.e. the high frequencies explained by the spectral 
contribution from the sharp edges). Very recently, (Aru et al., 2015) discussed, in an exhaustive review, 
multiple simulated and empirical CFC patterns that could be explained by non-linear oscillators, non-
stationarity of the data or by improper filter settings.  
 
Previous research has shown CFC between gamma and alpha bands using MEG during resting state 
conditions (Hawellek et al., 2013; Osipova et al., 2008; Roux, Wibral, Singer, Aru, & Uhlhaas, 2013) 
and also WM task-related CFC between theta phase and gamma power in humans using intracranial 
recordings (Axmacher et al., 2010; Canolty et al., 2006). Moreover, computational and experimental 
findings have suggested that oscillatory phase-to-amplitude coupling might support information 
maintenance during WM information maintenance (Jensen & Lisman, 2005; Lisman & Jensen, 2013). 
Specifically, while the phase of slower oscillations (7 – 12Hz) would organize the communication 
between different brain regions, the information processing would be reflect by gamma band activity (~ 
40Hz) (Saalmann et al., 2012). Dual oscillations not only would represent multiple items as gamma 
bursts within a theta cycle (Lisman & Idiart, 1995; Lisman & Jensen, 2013) but they would also define 
the span of the perceptual snapshots by the gamma/alpha ratio (Miconi & VanRullen, 2010). Given the 
importance of CFC for information processing and the GABAergic influence on neuronal 
synchronization, in the present study we used a pharmaco-MEG approach to investigate its impact on 
CFC dynamics during resting state and WM. We performed a double-blind randomized cross-over 
design pharmacological challenge where healthy participants received either placebo or lorazepam 
(LZP; GABAA allosteric modulator) of different doses (0.5mg and 1.5mg) in separate sessions. 
76  
Pharmacological power modulations during WM using the same dataset have been published 
elsewhere (Lozano-Soldevilla, ter Huurne, Cools, & Jensen, 2014). 
 
Material and methods. 
Experimental procedures. 
Participants were engaged in a classic delayed-match to sample visuo-spatial WM task (Vogel & 
Machizawa, 2004) while brain oscillatory activity was acquired with whole-head MEG. Each trial started 
by presenting a centrally presented visual cue for 1.5s. The task required participants to encode a 
sample array composed of colored squares presented in the visual hemifield indicated by a spatial cue. 
After a 1.5s delay interval, a probe array was presented and participants had to indicate whether it 
matched the sample array or not. Participants had to keep their fixation to the center of the screen while 
covertly attend to the cued hemifield. Before the WM task, two minutes eyes-closed (EC) and two 
minutes eyes-opened (EO) resting state recordings were acquired (the order was counterbalanced 
across sessions).  
 
MEG methods. 
Specific information about MEG data acquisition can also be found in (Lozano-Soldevilla et al., 2014) 
and we describe here the fundamental information. Ongoing brain activity was recorded (sampled at 
1200Hz) using a whole-head MEG system with 275 axial gradiometers (VSM/CTF systems, Port 
Coquitlam, Canada). To minimize participants head movement while maximizing participant’s comfort, 
we used an orthopedic neck-collar (Push braces, height 10, size 2, model 1.60.2.02; 
http://www.push.eu) during the MEG recordings. We used the real-time head localizer tool (Stolk et al., 
2013) to monitor participant’s head position and orientation relative to the MEG sensors during the 
recordings. Before the second and the third MEG session (separated by minimum 4 days), each 
participant was requested to reposition his/her head in the same location and orientation as the position 
measured at the beginning of the first MEG session using the real-time head localizer tool (Stolk et al., 
2013). Using this procedure we sought to minimize potential systematic differences in head position 
and orientation among the three MEG sessions. To monitor blinks and eye movements horizontal and 
vertical electro-oculograms (EOGs) were recorded using bipolar Ag/AgCl electrodes (<10kΩ 
impedance) placed below and above the left eye and at the bilateral outer canthi. An EyeLink 1000 
eyetracker was used to monitor the movements of the participants’ right eye. The electrocardiogram 
(ECG) was also recorded with electrodes (impedance <50kΩ) attached above the right clavicle and 
under the last false rib on the left side. 
 
77 
MEG data was lowpass filtered at 200Hz and then down-sampled to 600Hz and analyzed offline using 
Fieldtrip (Oostenveld et al., 2011) (http://fieldtrip.fcdonders.nl/); an open-source toolbox developed at 
the Donders Institute for Brain, Cognition, and Behaviour (Nijmegen, The Netherlands) and custom 
Matlab code (MathWorks, Natick, MA, USA).  
 
Sensor analysis.  
Resting-state data. We eliminated line noise by fitting sine and cosine functions between 48 – 52Hz, 98 
– 102Hz, 148 – 152Hz and subsequently subtracting these estimated components EC and EO 
recordings were cut in epochs of 120s. Raw data was visually inspected and the pieces containing eye-
blink, muscle activity, or SQUID artifacts were rejected. Sensors with noisy periods were rejected and 
linearly interpolated (neighbor average). After partial artifact rejection, data segments shorter or equal 
to 2s were excluded leaving the rest of the data cleaned for the main analysis. Remaining eye 
movements and electrocardiogram (ECG) activity were isolated by independent component analysis 
(ICA) (Jung et al., 2000). The independent components (ICs) reflecting potential artifacts were semi-
automatically identified by correlating the time-course of the ICs and respectively the vertical EOG and 
ECG. Given the stable periodicity of the ECG signal and the QRS complex sharpness, spurious CFC 
could arise (Kramer et al., 2008). To reduce ECG residual activity after the removal of the identified ICs, 
we adapted a procedure described in (Tal & Abeles, 2013) to eliminate the QRS complex. Briefly, we 
bandpass filtered the ECG (bipolar derivation) with a zero-phase two-pass Butterworth filter of order 4 
(0.5 – 50Hz). Then we took the absolute value of the ECG signal and we found the QRS complex peaks 
that were separated between them a minimum of 0.66s. Once all the peaks were identified, we 
computed a peak-triggered average (-0.3 – 0.4s) using the time points defined in the ECG bipolar 
channel in the unfiltered MEG data. The obtained template locked to the heartbeat peaks was 
subtracted from the MEG recordings cycle-by-cycle. We observed ECG residuals in most of the 
participants after ICA. Given that is has been empirically demonstrated that the reliability of Infomax 
ICA decomposition is positively related to the amount of data samples and inversely related to the 
number of sensors2 (Groppe, Makeig, & Kutas, 2009) and we only obtained less than 4min recordings 
with 273 sensors, it is likely that the Infomax algorithm did not have enough data points per sensor to 
perform a more accurate decomposition. 
 
Spectral oscillatory power was performed by means of Fast Fourier Transform (FFT) using a fixed 
window length of 4s, 50% overlap, multiplied by a Hanning taper applied to frequencies from 4Hz to 
40Hz in 0.25Hz steps. Prior to spectral analysis, the mean of each epoch was subtracted. Spectra were 
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normalized based on the total power (4 – 40Hz average) in each sensor within each participant and 
MEG session before group averaging. 
 
To investigate cross-frequency interactions we use the coherence value index as defined in (Osipova 
et al., 2008) and (Jiang, Bahramisharif, van Gerven, & Jensen, 2015). In short, it measures the phase 
consistency between a low frequency signal from 0Hz to 30Hz and the time course of the amplitude 
envelope at higher frequencies from 5Hz to 90Hz in steps of 1Hz. Let the signal be represented by the 
time series x1, x2, …, xN where N is the number of time points acquired at specific sampling rate (Fs). 
First, the time-course of amplitude 𝒚ν = (𝑦1
ν, 𝑦2
ν, … , 𝑦𝑁
ν ) was estimated for frequency  by applying a 
sliding tapered time-window followed by a Fourier transformation: 
 𝑦𝑛
𝑣 =
1
𝐹𝑠
|∑ 𝒉𝑚𝒙𝑛+𝑚−𝑀/2
𝑀
𝑚=1
𝑒
−𝑖2𝜋𝑣𝑚
𝐹𝑠 | 
The function hm is a Hanning taper M data points-long equaling the length of the sliding time window. 
The length of the time-window decreased with frequency: 𝑀 = 𝑤 ∙ 𝐹𝑠 𝑣⁄ , where 𝑤 denoted the numbers 
of cycles per time window (5 cycles in the present study). Note that the time-series x can be zero-
padded to reduce boundary effects at the beginning and end of the segments. 
 
 Next we proceeded to estimate the Fourier spectra of x and y. Data was segmented into a set of S 
segments 0.6s long with 50% overlap. Using a standard Fast Fourier Transform (FFT) algorithm, the 
complex representations are calculated: 
𝑿𝑠 = FFT(𝒉𝑇𝒙𝑠, 𝑛𝐹𝐹𝑇) 
and 
 𝒀𝜐,𝑠 =  FFT(𝒉𝑇𝒚𝑣,𝑠, 𝑛𝐹𝐹𝑇) 
with 𝒙𝑠 representing the temporal evolution of raw signal of segments s, 𝒚𝑣,𝑠 represents the amplitude 
envelope at high frequency v and segment s, 𝑛𝐹𝐹𝑇  defines the frequency resolution of the x-axis ∆𝑓 =
𝐹𝑠 𝑛𝐹𝐹𝑇⁄  of the CFC comodulogram (𝑛𝐹𝐹𝑇 = 1024). The output vector 𝑿
𝑠 = (𝑋1
𝑠, 𝑋2
𝑠, … , 𝑋𝑛𝐹𝐹𝑇
𝑠 ) and 𝒀𝜐,𝑠 =
(𝑌1
𝜐,𝑠, 𝑌2
𝜐,𝑠, … , 𝑌𝑛𝐹𝐹𝑇
𝜐,𝑠 ) are Fourier transforms centered at the frequencies: 𝑓 ∈ {0,
𝐹𝑠
𝑛𝐹𝐹𝑇
, … ,
𝐹𝑠
2
(1 −
1
𝑛𝐹𝐹𝑇
)}. 
The cross-spectra 𝛏 or the individual segments is defined as 𝛏𝑣,𝑠 = 𝑿𝑠(𝒀𝜈,𝑠)∗ where ‘*’ denotes the 
complex conjugate.  
 
To quantify the CFC, we used the approach proposed in (Osipova et al., 2008) by estimating the 
magnitude squared cross-frequency coherence (η2):  
 𝜼𝟐(𝑣, 𝑓) =
|∑ 𝝃𝑣,𝑠𝑆𝑠=1 |
2
∑ |𝑿𝑠|2 ∙ ∑ |𝒀𝑣,𝑠|2𝑆𝑠=1
𝑆
𝑠=1
 
where frequencies: 𝑓 ∈ {0,
𝐹𝑠
𝑛𝐹𝐹𝑇
, … ,
𝐹𝑠
2
(1 −
1
𝑛𝐹𝐹𝑇
)}. 
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To assess the directionality of CFC, we use a new metric (Jiang et al., 2015) based on the phase-slope 
index (Nolte et al., 2008) defined as cross-frequency directionality (CFD). The metric rests on the 
assumption that when the transmission between two signals (sender and receiver) is associated with a 
fixed delay, the phase difference between the signals will change systematically with frequency as 
observed in the phase spectrum (Gotman, 1983; Mima, Steger, Schulman, Gerloff, & Hallett, 2000). 
The PSI estimates the slope of the phase difference as a function of frequency in a given frequency 
band and the direction of interaction is attached to its sign. We here applied the PSI to the signal x and 
the power envelope of the signal 𝒚𝑣 at frequency tile (𝑣, 𝑓𝑗):  
𝛹̃ (𝑣, 𝑓𝑗) = ℑ
(
 
 
∑ 𝑪∗(𝑣, 𝑓𝑗)
𝑓𝑗+
𝛽
2
𝑓𝑗−
𝛽
2
𝑪 (𝑣, (𝑓𝑗 + ∆𝑓))
)
 
 
 
where the complex coherency is defined as: 
𝑪(𝑣, 𝑓𝑗) =
∑ 𝑿𝑠(𝒀𝑣,𝑠)∗𝑆𝑠=1
√∑ |𝑿𝑠|2∑ |𝒀𝑣,𝑠|2𝑆𝑠=1
𝑆
𝑠=1
 
∆𝑓 is the frequency resolution and ℑ() denotes the imaginary part. We use 𝛽 to denote the bandwidth 
for which the phase slope is calculated (𝛽 = 4Hz). Ψ ̃corresponds to a weighted average of the slope 
and we normalized it by an estimate of its standard deviation through a jackknife method (i.e. Ψ = 
Ψ̃/std(Ψ̃)) (Nolte et al., 2008). The authors considered absolute values larger than 2 as significant. 
 
In order to assess cross-frequency phase-to-phase coupling we used the magnitude squared 
bicoherence index (Kim & Powers, 1979) which is defined as: 
𝑏2(𝑣, 𝑓) =  
|∑ 𝑋𝑠(𝑣)𝑋𝑠(𝑓)𝑋∗𝑠(𝑣 + 𝑓)𝑆𝑠=1 |
2
∑ |𝑋𝑠(𝑣)𝑋𝑠(𝑓)|2𝑆𝑠=1  ∑ |𝑋
𝑠(𝑣 + 𝑓)|2𝑆𝑠=1
 
The bicoherence is close to 0 when the phases of Fourier frequency triplets (𝑣, f and 𝑣+f) behave 
randomly across S segments and 1 indicating that the phase of the numerator (bispectrum) remains 
constant over segments. As for cross-frequency coherence, a fixed window length of 0.6s, 50% 
overlapping, multiplied by a Hanning taper was used. 
 
To further explore the phase relationship between beta-low gamma power and the alpha signal, we 
used two complementary approaches based on event-related averages. The first one used the same 
approach as in (Canolty et al., 2006; Osipova et al., 2008): time-frequency plot of mean power 
modulation time-locked to the alpha peak. The MEG axial gradiometers of each participant and 
pharmacological sessions were band-pass filtered in the alpha band (8 – 12Hz; zero-phase two-pass 
Butterworth filter of order 4) based on the spectral alpha frequency peak in the resting data. After that, 
alpha peaks were identified and the unfiltered raw data was cut in 0.6s epochs centered around the 
peak. Time-frequency representations (TFRs) of power were calculated for each single trial using same 
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parameters as for the cross-frequency coherence (i.e. |𝑦𝑣|2). Induced power estimates were averaged 
across trials and normalized relative to the mean power per frequency. Complementarily, we also 
performed event-related gamma peak-triggered averages as in (Bragin et al., 1995). In case of true 
frequency interaction between slow and fast oscillations (here phase-to-amplitude coupling), the three 
approaches (cross-frequency coherence comodulogram, event-related TFR locked to alpha peaks and 
beta-low gamma peak trigger averaging) should yield comparable results (see for example (Spaak et 
al., 2012) Figure 3A, Figure 2 and Figure 4 respectively). 
 
Resting state source analysis. To localize the LZP-related oscillatory power modulations during EC and 
EO conditions, we applied an adaptive spatial filtering technique. Alpha band source reconstruction was 
computed by applying a tapered FFT approach to the data of each resting state condition using a fixed 
window of 0.6s centered at 10Hz with one Slepian taper resulting in 2Hz smoothing. The source 
reconstruction of the beta band activity (14 – 30Hz) was centered at 22Hz and 9 orthogonal Slepian 
tapers resulted in 8Hz smoothing. The brain volume of each individual was divided into a grid with a 
1cm resolution and normalized toward the template MNI brain (International Consortium for Brain 
Mapping, Montreal Neurological Institute, Canada) using SPM8 (http://www.fil.ion.ucl.ac.uk/spm). Lead-
field matrices were computed for each grid location using a realistically shaped single-shell description 
of the brain for each participant, using the individual anatomical MR images (Nolte, 2003). A common 
spatial filter was constructed for all conditions for each grid point, for each participant and session. The 
spatial filters were constructed for each grid location based on leadfield and cross-spectral density 
(CSD) matrices. CSD matrices were computed between all MEG pairs for the time period and frequency 
of interest. Using this common spatial filter, the distribution of power was estimated for each 
experimental condition separately. We estimated the orientation in which the power of each dipole grid 
was maximal according by single value decomposition (Schoffelen et al., 2011). 
 
Working memory (WM) data. Preprocessing, artifact rejection and sensor spectral analysis procedures 
were done as in (Lozano-Soldevilla et al., 2014). Briefly, trials of 1s (0.5 – 1.5s after memory sample 
array) were extracted for each pharmacological session (Placebo, 0.5mg LZP and 1.5mg LZP). CFC, 
CFD and bicoherence sensor analysis were performed on MEG axial gradiometers with same 
parameters as those ones used for the resting state data.  
 
Statistical analysis. To statistically assess the drug main effect on oscillatory power, cross-frequency 
coherence, bicoherence or peak-triggered averages at the sensors space, a cluster-based 
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nonparametric permutation test was applied (Maris & Oostenveld, 2007). This approach provides an 
effective method for controlling for multiple comparisons. The procedure was performed as follows: 
a) For every participant, a given contrast was compared using a test statistics. When considering 
a specific signal estimate for each pharmacological session, the test statistics was constituted by means 
of permutation repeated-measures ANOVA.  
b) A reference distribution based on the test statistics was estimated from the data by randomly 
permuting the samples between the experimental conditions (N=1000). 
c) The 95th percentile of the reference distribution then defined the two-tailed critical value. 
Sensors or grids points for the observed test statistic descriptive exceeding the critical values defined 
in b) were clustered by considering the spatial adjacency and summed. This thresholding provides the 
initial cluster candidates (the observed clusters). 
d) A second randomization approach was performed by randomly exchanging the experimental 
conditions. For each permutation, the cluster candidate with the highest sum of the test statistic-
descriptive was used to generate the permutation distribution.  
e) The statistical significance of the observed clusters (from c) was determined by comparing to 
the permutation distribution. Cluster (summed test statistics) being in the 95th percentile (summed test 
statistics) of the randomization statistics were considered significant (one-tailed). 
 
A repeated-measures ANOVA approach was used to asses drug main effects on selected sensors of 
interest. P-values were calculated and Greenhouse-Geisser corrections were made to control of 
sphericity violation when appropriated. Subsequent post-hoc t-tests, in case of main effect and/or 
interaction, were always corrected by multiple comparisons using the False Discovery Rate approach 
(Benjamini & Hochberg, 1995). 
 
Results. 
LZP modulations in alpha (8 – 12Hz) and beta (15 – 30Hz) bands during resting state. 
Spectral analysis was applied to the MEG axial gradiometers to investigate the power modulations 
produced by LZP administration during the EO and EC conditions. We found significant differences 
between drug conditions both during EO (cluster-based nonparametric permutation test, p < 0.001; 
Figure 1A left) and during EC (cluster-based nonparametric permutation test, p < 0.001; Figure 1A 
right). Under resting state conditions, LZP reduced alpha power in many sensors, especially in occipital 
areas. As expected, alpha power ~10Hz appeared with maxima over occipital sensors in both 
conditions. Repeated-measures ANOVA revealed that LZP strongly reduced occipital alpha power 
during EO (F2, 48 = 14.48, p < 5 x 10-5; Placebo = 0.5mg LZP: t24 = 1.44; p = 0.16; Placebo > 1.5mg LZP: 
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t24 = 4.42, p < 0.001; 0.5mg LZP > 1.5mg LZP: t24 = 3.95, p < 0.001; Figure 1B top). During EC there 
was also a robust posterior power reduction by LZP (F2, 48 = 7.66, p < 0.005; Placebo = 0.5mg LZP: t24 
= 1.24; p = 0.23; Placebo > 1.5mg LZP: t24 = 4.24, p < 0.001; 0.5mg LZP > 1.5mg LZP: t24 = 2.45, p < 
0.05; Figure 1B bottom). To identify the brain sources associated the drug-related power modulations, 
we pooled the source data ( (EO+EC)/2 ) and then considered the relative change: (1.5mg LZP – 
Placebo)/Placebo. As expected, the maximum of the LZP alpha power decrease was located over the 
occipito-parietal cortex (Figure 1C). 
 
While LZP decreased occipital alpha power, fronto-central beta power increased as a function of dosage 
(Figure 1D) both during EO (F2, 48 = 12.91, p < 5 x 10-5; Placebo = 0.5mg LZP: t24 = -0.88; p = 0.38; 
Placebo > 1.5mg LZP: t24 = -4.12, p < 0.001; 0.5mg LZP > 1.5mg LZP: t24 = -4.23, p < 0.001; Figure 1E 
top) and during EC (F2, 48 = 38.87, p < 1 x 10-10; Placebo > 0.5mg LZP: t24 = -3.98; p < 0.001; Placebo 
> 1.5mg LZP: t24 = -7.06, p < 1 x 10-6; 0.5mg LZP > 1.5mg LZP: t24 = -5.81, p < 1 x 10-5; Figure 1E 
bottom). In line with previous evidence (Hall et al., 2010; Jensen et al., 2005), the strongest LZP power 
increase occurred in the sensorimotor cortices (Figure 1F). 
 
In conclusion, LZP produced robust power modulations during resting state conditions: while parieto-
occipital alpha power decreased, with LZP dosage, sensorimotor beta power increased. 
 
LZP decreases alpha-phase to beta-low gamma amplitude coupling during rest 
Given we found a clear alpha power peak in the resting state spectrum, we set out to investigate whether 
the ongoing alpha phase link with higher frequency amplitude modulations (Osipova et al., 2008). 
Moreover, we also seek whether LZP modulated its amplitude or frequency (Scheffzük et al., 2013). 
First, we calculated the cross-frequency coherence measure 𝜼𝟐
 
between low frequency phase (5 – 
25Hz) and high frequency amplitude (5 – 90Hz) for all participants and drug sessions during rest. We 
observed alpha phase (8 – 12Hz) to beta-low gamma (20 – 45Hz) amplitude coupling over posterior 
sensors (Figure 2A). Moreover, LZP significantly changed the alpha/beta-low gamma CFC during EC 
conditions (cluster-based nonparametric permutation test, p < 0.001; Figure 2A right, marked sensors) 
but not during EO. Repeated-measures ANOVA on sensors of interest revealed that GABAergic 
enhancement decreased alpha/beta-low gamma CFC under high LZP dosage relative to Placebo and 
low dosage, with no significant differences between Placebo and low dosage (F2, 48 = 8.29, p < 0.001; 
Placebo = 0.5mg LZP: t24 = 1.42; p = 0.17; Placebo > 1.5mg LZP: t24 = 2.81, p < 0.05; 0.5mg LZP > 
1.5mg LZP: t24 = 3.85, p < 0.005; Figure 2BC). It is interesting to observe that the beta-low gamma 
amplitude (Figure 2B) was not detected in the classical spectral analysis (Figure 1B). 
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Figure 1. LZP modulations in the alpha (8 – 12Hz) and beta (15 – 30Hz) bands during rest. (A) Grand mean 
topographic representation of alpha power during eyes opened (EO; left) and eyes closed (EC; right). Color 
code represents relative power changes with respect to the mean of the power spectrum (5 – 40Hz). The rows 
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reflect the drug levels: Placebo, 0.5mg and 1.5mg LZP. Sensors marked in bold display statistical significant 
drug main effect (repeated-measures ANOVA) using a cluster-based nonparametric permutation test. (B) Grand 
average of power spectra (sensors marked white Figure 1A) estimated for the EO (top) and EC (bottom) and all 
drug sessions. Inserts show a repeated-measures ANOVA confirming that the occipital alpha power decreased 
with LZP. Error bars show the SEM. (C) The sources in the occipito-parietal cortex reflected the alpha power 
decrease under 1.5mg LZP dosage relative to placebo (EO and EC averaged). (D) Gran mean topographic 
representation of beta power during EO (left) and EC (right) during rest (same conventions as in (A)). (E) Grand 
average of power spectra (sensors marked white Figure 1D) estimated for the EO (top) and EC (bottom) and all 
drug sessions. Inserts show a repeated-measures ANOVA confirming that the sensorimotor beta power 
increased with LZP dosage; same conventions as in Figure 1B). Error bars show the SEM. (F) The sources in 
the sensorimotor cortex reflected the beta power increase under 1.5mg LZP dosage relative to placebo (EO and 
EC averaged) (same conventions as in Figure 1C). The peak of the beta source lies out of the brain due to 
inaccuracies after the individual head model normalization to the MNI space. †p < 1 x 10-6; ***p < 1 x 10-5; **p < 
0.001; *p < 0.05. 
 
  
 
Figure 2. High LZP dosage decreases alpha phase (8 – 12Hz) to beta-low gamma (20 – 45Hz) amplitude 
coupling during eyes closed (EC). (A) Grand mean topographic representation of alpha phase to beta-low 
gamma amplitude coupling during eyes opened (EO; left) and EC (right) resting state. The color reflect the 
magnitude of coupling (magnitude squared coherence). The rows reflect the drug levels: Placebo, 0.5mg and 
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1.5mg LZP. The sensors marked in white displayed significant drug main effect (repeated-measures ANOVA; 
multiple comparisons controlled by a cluster-based nonparametric permutation test). (B) Grand mean frequency-
by-frequency coherence comodulogram of the occipital axial gradiometers that were significantly modulated by 
LZP (white marked sensors Figure 2A). Same color code and scale as in Figure 2A. Black rectangles indicate 
frequency ranges used for the statistical analysis and topographic representations (8 – 12Hz; 20 – 45Hz). (C) 
1.5mg LZP decreased alpha phase to beta-low gamma amplitude coupling as revealed by repeated-measures 
ANOVA. **p < 0.005; *p < 0.05. Error bars show the SEM. 
 
It could be that the CFC coherence we observe in Figure 2 is produced by harmonics of the alpha 
oscillations. Previous studies using synthetic (Kramer et al., 2008) and empirical EEG data in humans 
(Chella, Marzetti, Pizzella, Zappasodi, & Nolte, 2014) have demonstrated that bicoherence is sensitive 
to harmonics (i.e. phase-to-phase coupling). To test this possibility we computed the magnitude squared 
bicoherence index for the MEG axial gradiometers. We observed strong bicoherence values in the alpha 
range (8 – 12Hz) during EO peaking over left central and parieto-occipital sensors. The former were 
modulated by LZP (cluster-based nonparametric permutation test, p < 0.005; Figure 3ABC left, marked 
sensors) showing an inverted U-shape (F1.6, 38.9 = 17.14, p < 5 x 10-5; Placebo < 0.5mg LZP: t24 = -3.02; 
p < 0.01; Placebo > 1.5mg LZP: t24 = 3.73, p < 0.005; 0.5mg LZP > 1.5mg LZP: t24 = 4.88, p < 5 x 10-4; 
Figure 3D). Posterior sensors did not show statistical significant differences as a function of drug 
dosage. During EC conditions, non-significant differences were found (cluster-based nonparametric 
permutation test, p = 0.22; Figure 3EFGH) but strong bicoherence values were observed over posterior 
axial gradiometers around ~10Hz and ~20Hz. On that note, the CFC topographies (Figure 2A) in both 
resting state conditions remarkably overlapped to the ones obtained with bicoherence (Figure 3) and 
with the alpha power topographies (Figure 1A). It is worth to mention that the bicoherence values in the 
alpha range (8 – 12Hz x-axes; 8 – 12Hz y-axes; Figure 3, black rectangles) suggest that, over occipital 
sensors, there is not only consistent phase difference within the ~10Hz frequency but also between the 
~10Hz and the ~20Hz frequencies (i.e. |∑ 𝑋𝑠(𝑣)𝑋𝑠(𝑓)𝑋∗𝑠(𝑣 + 𝑓)𝑆𝑠=1 |
2).  
 
In summary, parieto-occipital sensors display the strongest higher harmonics of the 10Hz rhythm, 
although weaker, in the ~20Hz band which means that there were also at ~30Hz (Figure 3EFG right 
side). 
 
Next, we aimed to study the directionality of the coupling to see whether alpha phase or beta-low 
gamma amplitude envelope lead or lag each other. To achieve that, we used the new CFD metric (Jiang 
et al., 2015) on MEG axial gradiometers for all participants and sessions during EC. Figure 4A showed 
the topographic representation of the CFD index over the same frequency ranges as in Figure 2A. We 
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did not observe a clear directionality pattern over posterior sensors. Also, we did not observe significant 
drug modulations taken the pre-defined frequency selections (8 – 12Hz; 20 – 45Hz; cluster-based 
nonparametric permutation test, p = 1). The CFC observed in Figure 2B was not present in the CFD 
comodulogram in any of the MEG sessions, with very low sigma values ±0.3 (Figure 3B; Note that 
(Nolte et al., 2008) considered ±2 sigma as statistically significant PSI). CFD index did not show the 
CFC coupling pattern found in Figure 2. Instead higher variance values were observed over alpha to 
beta frequency range (Figure 3D). 
 
The cross frequency coherence observed in Figure 2 contains harmonics from the alpha band as 
revealed by bicoherence (Figure 3) and does not yield significant CFD patterns. These results raise the 
question whether complementary CFC metrics could further confirm the existence of the beta/low 
amplitude to alpha phase coupling. To assess the robustness of the beta-low gamma amplitude 
envelope to alpha phase coupling, we calculated the high frequency TFRs locked to the alpha peaks. 
If beta-low gamma power is phase locked to the alpha rhythm as the CFC index suggests, specific 
alpha phase segments (i.e. peaks or thoughts) should be associated with different power modulations 
(Canolty et al., 2006; Osipova et al., 2008; Roux et al., 2013). Furthermore, those modulations should  
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Figure 3. Bicoherence modulations by LZP during eyes opened (EO) and eyes closed (EC). (A) Grand mean 
topographic representation of alpha (8 – 12Hz) to alpha coupling under Placebo during EO (left) and 
comodulogram (right). Color code represents magnitude squared bicoherence. Black rectangles in the 
comodulogram indicate frequency ranges used for the statistical analysis and topographic representations (8 − 
12Hz; 8 − 12Hz). White marked sensors over the left sensorimotor cortex indicate a statistically significant drug 
main effect (cluster-based nonparametric permutation test, p < 0.005). (B) Topographics representation of 
bicoherence (left) and comodulogram (right) under 0.5mg LZP during EO (same conventions as (A)). (C) 
Topography representation of bicoherence (left) and comodulogram (right) under 1.5mg LZP during EO (same 
conventions as (A)). (D) LZP modulated sensorimotor (white bold marked sensors) alpha bicoherence in an 
inverted U-shape as revealed by repeated-measures ANOVA. Error bars show the SEM. (E) Grand mean 
topographic representation of alpha to alpha coupling under Placebo during EC (left) and comodulogram (right; 
same conventions as (A)). The comodulogram displays the average over the occipital white marked sensors 
from Figure1 (A)). (F) Topography and bicoherence comodulogram under 0.5mg LZP during EC (same 
conventions as (B)). (G) Topography and bicoherence comodulogram for 1.5mg LZP during EC (same 
conventions as (C)). (H) LZP did not modulated occipital alpha bicoherence coupling (white bold marked sensors 
topography in Figure 1A). ***p < 5 x 10-4; **p < 0.005; *p < 0.01. Error bars show the SEM. 
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Figure 4. LZP did not significantly change cross-frequency directionality (CFD) during eyes-closed (EC). (A) 
Grand mean topographic representation of the CFD (8 – 12Hz; 20 – 45Hz) for the separate drug conditions. 
White sensors were significantly modulated by LZP in Figure 2. The color code indicates the normalized Ψ̃ 
weighted average of the CFD slope (Ψ = Ψ̃/std(Ψ̃)). (B) Grand mean normalized CFD index averaged over the 
occipital sensors marked in topographies (A) for each drug session. Note the low sigma values we obtained 
(~±0.3; ±2 is considered significant). (C) CFD weighted average (Ψ̃) and (D) standard deviation of the slope 
(std(Ψ̃)) averaged over the occipital sensors marked in topographies for each drug session. 
 
 
 
Figure 5. Time-frequency representations (TFR) of induced power locked to the peaks of the alpha oscillation 
during rest. (A) Grand mean TFRs from left and right hemisphere MEG axial gradiometers (for white sensors in 
Figure 4E) time-locked to the alpha peaks (t = 0s) under placebo session during eyes opened (EO). TFRs were 
calculated for each single trial and then averaged. Color code represents the relative power normalized to the 
average power per frequency (y-axes). (B) TFRs of induced power locked to the peak of alpha oscillations for 
0.5mg LZP during EO. Same conventions as in (A). (C) TFRs of induced power locked to the peak of alpha 
oscillations during 1.5mg LZP during EO. Same conventions as in (A). (D) Grand mean of event-related fields 
locked to the alpha peaks. The peaks were found after bandpass filtering of the data (8 – 12Hz). MEG axial 
gradiometers from left and right hemispheres (marked white in topography) during EO for all drug levels. (E) 
Grand mean topographic representation of alpha peak-triggered average over the period (-0.015 – 0.015s) 
around the alpha peak (t = 0s). Marked sensors indicated statistical significant main effect (repeated-measures 
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ANOVA) between treatments using the cluster-based nonparametric permutation test. (F), (G), (H), (I) and (J) 
are the same as (A), (B), (C), (D) and (E) but for eyes closed respectively. 
 
 
 
Figure 6. Beta-low gamma peak-triggered average during rest. (A) Grand mean of event-related fields locked to 
the beta-low gamma (20 – 45Hz) peaks. MEG axial gradiometers from left and right hemispheres (marked white 
in (B)) during EO for all drug sessions. Vertical dashed lines at ±0.05s indicates the lower limit of the bandpass 
filter used for peak detection (1/0.05s = 20Hz). Beyond the ±0.05s limit, the underlying alpha oscillations were 
highly reduced. (B) Grand mean topographic representation of beta-low gamma peak-triggered average taken 
around the peak period (-0.015 – 0.015s). Marked bold sensors of interest based on Figure 1A. (C) and (D) are 
the same as (A) and (B) but for eyes closed respectively with same figure conventions. 
 
be differently affected by LZP as shown in Figure 2. Contrary to our hypothesis, we did not observe the 
beta-low gamma power modulations at any alpha cycle and it was not modulated by the drug levels 
(Figure 4). Despite the clear alpha waves whose central peak (time = 0s) was decreased with LZP 
(Figure 5 DEIJ), there were not clear oscillatory power modulations locked to neither alpha peaks nor 
troughs. Complementarily, we used the event-related peak triggered averages around the beta-low 
gamma frequency range to align signal traces nested to slow oscillations (Bragin et al., 1995). It is 
important to note that in case of robust CFC, the high frequency amplitude peak traces (time = 0s) 
should be on the top of the specific phase of the ongoing oscillation (Kramer et al., 2008). Despite the 
obvious beta-low gamma peaks (Figure 6AC) no clear underlying alpha oscillation appeared in the 
average. Given that we have bandpass filtered between the 20 – 45Hz range, the central averaged 
peak results from the signal peak alignment whose amplitude is accumulated. The lack of underlying 
alpha rhythm in the average is less obvious despite the clear spectral peak in the alpha range (Figure 
1A), the alpha phase to beta-low gamma CFC (Figure 2B) and the robust alpha peak-triggered average 
(Figure 5DI). Summarizing, event-related oscillatory averages did not allow us to show clear CFC 
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patterns putting into question that the coherence between the alpha band and the beta-low gamma 
amplitude envelope are two independent oscillations. 
 
Occipital alpha phase to beta-low gamma power coupling during working memory delay is not 
modulated by LZP. 
So far, we have focused the analysis on the resting state conditions but it remains to be tested whether 
similar CFC and drug modulations can be observed under complex cognitive operations. To explore 
whether the amplitude of high frequency oscillations is phase-lock to the phase of slow rhythms during 
the WM delay periods, we computed the same CFC measures when participants engaged in a visuo-
spatial WM task. Given previous evidence (Lozano-Soldevilla et al., 2014), the analysis was focused 
on the WM delay interval (0.5 – 1.5s) using the same parameters as done in the resting state analysis.  
 
 
 
Figure 7. LZP did not modulate alpha-phase to beta-low gamma amplitude coupling during working memory 
(WM) delay. (A) Grand mean topographic representation of alpha-phase to beta (16 – 22Hz; left) and to beta-
low gamma amplitude coupling (25 – 45Hz; right) during WM delay (0.5 – 1.5s). Color code represents 
magnitude squared coherence. Note that topographies have different scale. The strongest coherence values 
appeared over occipito-parietal sensors. Grand mean frequency-by-frequency coherence comodulogram 
(middle) of the occipital axial gradiometers of interest as in Figure 1A. Black rectangles indicate the x-y frequency 
selections used in the statistical analysis and topographic representations (8 – 12Hz; 16 – 22Hz; 25 – 45Hz). 
Comodulograms have the same coherence scale as alpha – beta topography (left). (B) and (C) are the same as 
(A) but for 0.5mg and 1.5mg LZP respectively. 
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We first computed CFC and the strongest coherence appeared in the occipital beta range (16 – 22Hz) 
with very weak modulation in the beta-low gamma band (25 – 45Hz; Figure 7). LZP did not modulate 
the coupling significantly in any frequency range (cluster-based nonparametric permutation test, p > 
0.16). Magnitude squared bicoherence showed the strongest coupling in the first two harmonics over 
occipital sensors (8 – 12Hz; 18 – 22Hz) but they were not significantly modulated by LZP (cluster-based 
nonparametric permutation test, p > 0.11) (Figure 8). The CFD did not show any significant directionality 
coupling (Figure 9) and LZP did not modulate it. 
 
In conclusion, we observed CFC between alpha phase and beta-low gamma amplitude during the WM 
delay maintenance period. We found occipital phase-to-phase coherence between alpha and its first 
two harmonics. CFD did not show convincing evidence of directionality within the frequency range under 
 
 
 
Figure 8. LZP did not modulate bicoherence values during working memory (WM) delay. (A) Grand mean 
topographic representation of alpha – alpha (8 – 12Hz; 8 – 12Hz; left) and alpha – beta coupling (8 – 12Hz; 18 
– 22Hz; right) during WM delay (0.5 – 1.5s). Color code represents magnitude-squared bicoherence. Note that 
the topographic plots have different scale. The strongest bicoherence values appeared over occipito-parietal 
sensors. Grand mean frequency-by-frequency bicoherence comodulogram (middle) of occipital axial 
gradiometers of interest chosen from Figure 1A. Black rectangles indicate the x-y frequency selections used in 
the statistical analysis and topographics representations (8 – 12Hz; 8 – 12Hz; 18 – 22Hz). Comodulograms have 
the same scale as alpha – alpha topography (left). (B) and (C) are the same as (A) but for 0.5mg and 1.5mg 
LZP respectively. 
 
92  
study. Lastly, the pharmacological GABAergic enhancement did not significantly change most of the 
CFC metrics used here. 
 
Discussion. 
Here we used a pharmaco-MEG approach (Hall et al., 2010) to investigate how CFC coupling dynamics 
were modulated by LZP during rest and WM maintenance. During rest, we demonstrated that while 
occipital alpha power decreased with LZP (Ahveninen et al., 2007; Link et al., 1991; Schreckenberger 
et al., 2004), sensorimotor beta power increased with drug dosage (Baker & Baker, 2003; Hall et al.,  
 
 
 
Figure 9. LZP did not change cross-frequency directionality (CFD) during working memory (WM) delay. (A) 
Grand mean topographic representation of alpha-beta CFD (16 – 22Hz) during WM delay for each drug 
separately. LZP did not modulate directionality. Color code indicates the normalized Ψ̃ weighted average of the 
CFD slope (Ψ = Ψ̃/std(Ψ̃); color scale same as in (B)). (B) Grand mean normalized CFD index taken over the 
occipital sensors of interest chosen from Figure 1A. Note the low sigma values we obtained (~±0.6; ±2 is 
considered significant). (C) CFD weighted average (Ψ̃) and (D) standard deviation of the slope (std(Ψ̃)) taken 
over the same occipital sensors for each drug session respectively. Drug sessions are displayed in different 
columns. 
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2010; Jensen et al., 2005). Interestingly, we found alpha phase to beta-low gamma amplitude coupling 
over occipital sensors that decreased with 1.5mg LZP during EC.  
 
However, CFD and peak-triggered averages did not provide additional phase-to-amplitude coupling 
evidence. In addition, we found phase-to-phase coupling between alpha and beta over occipital 
sensors. The strongest CFC pattern we observed during WM conditions was between alpha phase 
~10Hz and beta amplitude ~20Hz, with robust phase-to-phase alpha-beta coupling without significant 
drug modulations. This suggest that the cross-frequency coupling is explained by higher harmonics of 
the alpha oscillations. Based on invasive neurophysiological findings, several MEG studies have 
investigated on the role of phase-to-amplitude coupling in various experimental. In one of the first 
investigations, (Osipova et al., 2008) found that the ongoing gamma (30 – 70Hz) power was phase-
locked to the alpha band (8 – 12Hz) over posterior regions. This was mainly observed in subjects with 
strong alpha power. We however found a coupling in a lower gamma range over occipital sensors. A 
similar gamma (19 – 76Hz) range phase-locked to slower rhythms (5 – 13Hz) was reported by (Hawellek 
et al., 2013). A very recent study found that the phase of spontaneous alpha oscillations in thalamus 
coupled to ~40Hz gamma power in parieto-occipital cortex during EC conditions(Roux et al., 2013). 
ECoC recordings in humans reported the same phenomenon in lower (Fitzgerald, Valentin, Selway, & 
Richardson, 2013) and higher gamma band frequency during resting state (Bahramisharif et al., 2013). 
Moreover, the high frequency gamma activity were phase-locked to the alpha travelling waves 
(Bahramisharif et al., 2013). The absence alpha phase coupling to high frequency gamma power in our 
MEG data could be related to due to a lower signal-to-noise ratio for MEG as compared to ECoG data.  
 
Only a few set of studies have investigated the influence of pharmacological manipulations on CFC. 
(Caixeta, Cornelio, Scheffer-Teixeira, Ribeiro, & Tort, 2013) used ketamine, a glutamate N-methyl-D-
aspartate receptor (NMDAR) antagonist, to study the hippocampal theta (5 – 10Hz) phase to gamma 
(30 – 100Hz) amplitude coupling in awake rats. They found that while low dosages increased the theta-
gamma coupling, high dosages decreased it. However, the theta-high frequency oscillations (110 – 
160Hz) coupling increased with ketamine at all doses. In a similar study using diazepam, a GABAA 
allosteric modulator similar to LZP, (Scheffzük et al., 2013) found that theta-phase to gamma-amplitude 
coupling slowed in gamma frequency parametrically with dose. The CFC strength was slight but 
significantly reduced with diazepam dosage during wakefulness relative to placebo. In our study, we 
found alpha to beta-low gamma CFC reduction with GABAergic enhancement only during EC 
conditions. However, the beta-low gamma band coupled to the alpha phase did not slowed with LZP in 
any dosage. Using propofol, a powerful GABAA agonist used as a general anesthetic, (Ching, Cimenser, 
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Purdon, Brown, & Kopell, 2010) found a robust frontal alpha frequency decrease as a function of drug 
dosage. However, as far as we know, these alpha frequency changes do not occur in occipital cortex 
and are only found using high anesthetic dosages that induce loss of consciousness which was not the 
case for our study. 
 
On the other hand, it is well established that in rat hippocampus GABAergic inhibition increases gamma 
power and decreases its frequency (Traub et al., 1996a; Traub et al., 1999; Whittington et al., 1995). 
Under resting state conditions, as reported by others (Hawellek et al., 2013; Osipova et al., 2008; Roux 
et al., 2013), no clear gamma peak was observed in the power spectrum. Too low LZP dosage and/or 
low signal to noise ratio in the gamma band could explain the absence of gamma power increase with 
drug. In sum, we found beta-low gamma CFC decrease with LZP as in rat hippocampus (Scheffzük et 
al., 2013) but it did not slowed in frequency in the way the hippocampal theta-gamma coupling did with 
GABAergic enhancement (Scheffzük et al., 2013).  
 
The cross-frequency coherence coupling reported in Figure 2 may have another parsimonious 
explanation. It could be the case that the observed beta-low gamma amplitude modulations are 
harmonics produced by the non-sinusoidal properties of the alpha oscillations. Several features in our 
data support this. In first place, using bicoherence we found a strong phase to phase coupling between 
alpha – beta band over occipital sensors during rest (Figure 3) and WM delay maintenance (Figure 8). 
Bicoherence is a CFC index that detects consistent phase differences between frequency triplets. 
Therefore, this measure is sensitive to harmonic contributions that might not appear in the power 
spectrum. Recently, it has been proposed to use bicoherence in order to assess the contribution of 
potential non-linearities in the data that may lead to spurious CFC (Aru et al., 2015; Kramer et al., 2008). 
For instance, present cross-frequency coherence results found under rest (Figure 2) and during WM 
maintenance (Figure 7) contain non-linearities (as revealed by bicoherence, see Figures 3 & 8) that 
may come from the non-sinusoidal properties of the alpha band. The Fourier transform decomposes 
time domain signals of arbitrary waveform in a series of sine and cosine functions of harmonic frequency 
whose sum yield the original signal. If a time-domain signal is not sinusoidal but oscillates with a stable 
periodicity (i.e. oscillation at 10Hz with a sawtooth-like wave morphology), its power spectrum will show 
multiple harmonics. Importantly, these harmonics will be coherent with the fundamental frequency, 
yielding the spurious CFC.  
 
This could explain why the cross-frequency coherence topographic representation within the beta-low 
gamma to alpha range is so similar to the bicoherence topographic representation within the alpha 
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harmonics both during rest and WM maintenance. This is in line with previous research finding alpha 
to beta phase synchronization in humans (Carlqvist, Nikulin, Strömberg, & Brismar, 2005; Chella et al., 
2014; Gaarder & Speck, 1967; Jürgens, Rösler, Hennighausen, & Heil, 1995; Nikulin & Brismar, 2006; 
Nikulin, Nolte, & Curio, 2012; Palva, Palva, & Kaila, 2005). However, counter-arguments against the 
possibility that spectral features between 20 – 50Hz are alpha harmonics have also been described 
based on differences in source localization of the ~10Hz from the ~40Hz neural sources (Tesche & 
Hari, 1993), different power time courses (Muller, 2000) or phase-synchronization between fundamental 
and non-harmonic frequencies (Schanze & Eckhorn, 1997). Then our CFC results (Figure 2) cannot be 
easily dissociated from harmonic contributions whose beta-low gamma band could not be present in 
the time domain. In addition, the lack of coupling using CFD and peak-triggered averages make us to 
be very conservative when interpreting the present CFC. Although we do not claim that the CFC can 
be fully explained by harmonics from the alpha band, we cannot tell apart the power estimates of 
independent neuronal oscillation with frequency overlaps from harmonics of the alpha band. We want 
to stress that this is especially problematic if the CFC occurs over the first harmonics as in our case (20 
– 45Hz) but it is less likely to be problematic for CFC of higher gamma band. 
 
There are physiological reasons to believe that there are at least harmonic contributions in the CFC 
results presented here. It has been observed and empirically demonstrated that some brain rhythms 
oscillate with characteristic non-sinusoidal wave morphology. The spike-and-wave discharges are well 
known epileptic complexes between 2 – 4Hz with associated bursts at 10 – 15Hz (Jasper & Droogleever-
Fortuyn, 1947; Steriade & Contreras, 1998). (Belluscio, Mizuseki, Schmidt, Kempter, & Buzsáki, 2012) 
found that the CA1 hippocampal theta waves were asymmetric in amplitude respect to the time axis 
(ratio of the duration of the ascending and descending parts; sawtooth waveform-like). Another cases 
are the sensorimotor mu rhythm (Pfurtscheller & Lopes da Silva, 1999), thalamic spindles (see Figure 
3 in (Contreras, Destexhe, Sejnowski, & Steriade, 1997)) or occipital alpha oscillations (Nikulin et al., 
2007; Stam, Vliegen, & Nicolai, 1999). Specifically, the posterior alpha oscillations show a characteristic 
wave morphology where the amplitude of the peaks and troughs is not symmetric. The non-sinusoidal 
shape properties of the alpha band (i.e. magnitude of the peaks higher relative to the magnitude of the 
troughs) should not be confused with the alpha asymmetric amplitude fluctuation properties defined by 
(Mazaheri & Jensen, 2008). The asymmetric amplitude fluctuations were defined as the normalized 
ratio of the variance (not the amplitude) of the peaks of an oscillatory activity minus the variance of the 
troughs (Mazaheri & Jensen, 2008) and the model would not produce harmonics. This property of the 
alpha band is thought to arise from the asymmetry between the magnitude of forward and backwards 
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current flows due to the excitatory synaptic inputs and after-hyperpolarizations (Mazaheri & Jensen, 
2010).  
 
Summarizing, there are physiological reasons to believe that some neurophysiological signals have 
non-sinusoidal properties (i.e. waveforms deviating from sines and cosines). For instance, when 
assessing CFC between different frequencies, the potential harmonic contribution to the coupling 
should be taken into account using bicoherence or any other metric sensitive to harmonicity. 
 
Conclusion. 
In conclusion, our findings show that LZP decreased occipital alpha power while increased sensorimotor 
beta during resting state. We found that while 1.5mg of LZP reduced the CFC between spontaneous 
alpha and beta-low gamma over occipital sensors during rest, no CFC modulations during the WM were 
observed. The observed phase-to-amplitude coupling contained harmonic power contributions 
presumably from the non-sinusoidal properties of the alpha band. Although alpha harmonics may not 
fully explain the CFC pattern, this seems to be the most parsimonious interpretation of the results found. 
In a broader scope, the present results highlight that the signal waveform could play and important role 
when interpreting CFC results. 
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Abstract:  
Cross-frequency coupling (CFC) is a conceptual framework that describes how oscillations at different 
frequency bands interact. In the previous chapter, we reported CFC between the phase of alpha and 
the amplitude of beta to low gamma in MEG signals observed in resting state and working memory 
(WM) conditions. However, the CFC patterns we found may be influenced by features in the signal that 
do not relate to underlying physiological interactions. Hence, we were not able to provide conclusive 
evidence that the observed CFC patterns reflected a genuine interaction between physiological 
processes at independent frequency bands.  
We hypothesize that the CFC estimates may be sensitive to spectral correlations due to non-sinusoidal 
properties of the alpha band activity. In this study we used synthetic and real data to investigate how 
spurious CFC patterns may arise due to signal morphology, i.e. deviations from sinusoidal waveforms. 
We utilized cross-frequency coherence, cross-frequency directionality (CFD) and bicoherence to 
quantify CFC due to phase-locked harmonics in simulated and empirical data. We observed that non-
sinusoidal periodic signals without sharp edge artifacts, when estimating its analytic amplitude and 
phase following narrow band-pass filtering, produce higher harmonics that yield non-zero phase-to-
amplitude CFC. The CFC due to spectral harmonics of alpha band activity may not be related to coupled 
physiological processes, but might merely be a side-effect of describing non-sinusoidal periodic 
waveforms using Fourier techniques. The results demonstrate the possible role of the non-sinusoidal 
wave morphology on CFC metrics. 
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Introduction. 
Almost 100 years ago, Hans Berger was the first to report in humans an inherent waxing and waning 
electrical voltage around 10Hz in occipital lobe (Berger, 1929). This rhythmic oscillatory activity was 
also shown even in water-beetles, exhibiting dynamics remarkably similar as in humans (Adrian & 
Matthews, 1934). Modern views suggest that these neuronal oscillations do not reflect a functional role 
in isolation, but that function relates to the interaction between oscillations at different frequencies. This 
conceptual framework is called cross-frequency coupling (CFC) (Canolty & Knight, 2010; Jensen & 
Colgin, 2007). Specifically, while slower oscillations would establish neuronal synchronization between 
long distant neuronal ensembles, fast rhythms generated from local circuits would arise at a specific 
phase of the slower oscillations (Buzsaki, 2006). There is evidence suggesting that the strength of 
phase-to-amplitude coupling between different frequency bands is modulated as a function of task 
demands correlating with performance (Canolty & Knight, 2010; Lisman & Jensen, 2013). Importantly, 
fast and slow rhythms are conceived as two independent oscillatory phenomena that interact in a 
specific way: phase-to-amplitude, phase-to-phase or power-to-power coupling (Jensen & Colgin, 2007). 
 
Despite the popularity of the CFC framework in describing empirical data, recent studies demonstrate 
potential caveats and pitfalls in the interpretation of results of the different CFC algorithms. Kramer et 
al. (2008) demonstrated that sharp transient features in periodic signals produce spurious CFC, which 
resembles broadband gamma activity. The broadband activity arises because sharp-edged transients 
in the time domain signal correspond to high-frequency broadband components in the frequency 
domain. This phenomenon has subsequently also been reported in data recorded from rat hippocampus 
(Tort, Scheffer-Teixeira, Souza, Draguhn, & Brankačk, 2013) see Figure 8C). The term spurious CFC 
refers to the correlations between multiple frequency components (i.e. terms of the Fourier 
decomposition) caused when the input signal contain non-sinusoidal properties. These non-sinusoidal 
features can be transient or periodic and result in spectral correlations that will produce a non-zero 
CFC, even when a true physiological interaction is absent. More recently, (Aru et al., 2015) provide an 
exhaustive review with several caveats and confounds in the current CFC methodology, such as non-
stationarities that may lead to spurious CFCs due to spectral correlations. They mention the difficulty to 
generate surrogate data that effectively destroys the specific cyclo-stationarities associated to the CFC 
effect of interest, while retaining the original probability distributions of all unspecific effects (i.e. not 
associated to the hypothesized CFC). Although the authors do not provide a conclusive solution to deal 
with the caveats, they propose a number of sanity checks to be performed in order to support the 
mechanistic interpretation of CFC results. To list a few, the authors propose that spectral peaks should 
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be identified to justify subsequent CFC analysis, that filter bandwidth should be properly selected and 
that non-linearity in the data needs to be assessed using bicoherence. 
 
In Chapter 4, we found that beta-low gamma amplitude (20 – 45Hz) modulations are phase-locked to 
the alpha rhythm during resting state and WM conditions. Considering the caveats reviewed above (Aru 
et al., 2015; Kramer et al., 2008; Tort et al., 2013), the reported phase-to-amplitude coupling may 
overlap with the spectral harmonics of the fundamental alpha band frequency. Various studies have 
shown (Nikulin, Linkenkaer-Hansen, Nolte, & Curio, 2010; Nikulin et al., 2007; Stam et al., 1999) or 
observed (Contreras et al., 1997; Gastaut, 1952) that the alpha rhythm does not appear to be a pure 
sinusoidal wave, with a stronger amplitude of the peaks relative to the troughs. These non-sinusoidal 
features in the periodic signal will be expressed a harmonic signal, i.e. with power at the fundamental 
frequency, corresponding to the periodicity, and at integer multiples of the fundamental frequency. This 
raises the concern whether the CFC results reported in Chapter 4 are a genuine interaction reflecting a 
mechanistic physiological process, or whether it might be a more trivial consequence of spectral 
correlations due to the non-sinusoidal shape of the oscillations. 
 
To investigate the influence of the morphology of periodic signals on CFC metrics, we constructed 
synthetic data with systematically varying waveforms. We applied state of the art CFC-metrics such as 
cross-frequency coherence, cross-frequency directionality (CFD) and bicoherence to quantify the CFC 
in the simulated signals. We used data recorded in absence epilepsy with well-known periodic but non-
sinusoidal waveforms to demonstrate that cross-frequency coherence and CFD can produce non-zero 
coupling. 
 
Material and methods. 
We constructed synthetic data combining two features that are relevant for CFC. Starting with a 10Hz 
alpha band signal, we add high gamma signal amplitude (60 – 80Hz) or beta-low gamma (20 – 40Hz) 
with an amplitude envelope that is phase-locked to the slower frequency. Subsequently, we 
systematically changed the wave morphology of the alpha signal in different ways to study its 
contribution to the different CFC metrics (see below). All simulations were generated using a sampling 
rate of 1000Hz (dt = 0.001) and 180s duration, unless otherwise specified. 
 
1) Narrow gamma amplitude (60 – 80Hz) to alpha phase (~10Hz) CFC. 
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We created a signal with CFC between the gamma amplitude envelope to alpha phase by adapting the 
simulation described in example 3 from (Kramer et al., 2008). Briefly, we constructed a cosine wave of 
unit amplitude as: 
𝛼 = cos(2πft) 
where alpha the frequency f randomly varied cycle-by-cycle with the form f = 1/(0.1s ± 0.01s). This way, 
the alpha signal fluctuated in frequency, in other words, we introduced small temporal variations in the 
alpha frequency f. The variable t defined the time axis running from 0 to 1 s. To each cycle of the alpha 
oscillation we add a short 50ms burst of high frequency white noise that was tapered with a Hanning 
window. The Hanning window was scaled to a maximum amplitude of 5. The high frequency noise was 
generated by applying a 60 – 80Hz bandpass filter to uniformly distributed random noise. The onset of 
the gamma signal relative to the alpha cycle was varied uniformly between 0 and 20º. Finally, normally 
distributed random noise with zero mean and standard deviation 0.1 was added to the complete signal. 
 
2) Narrow gamma amplitude (60 – 80Hz) to alpha phase CFC with non-sinusoidal shape 
properties. 
We generated the same gamma-alpha CFC as in 1) but the alpha waveform was generated with a non-
sinusoidal morphology; concretely, the magnitude of the amplitude of the peaks was higher than the 
troughs: 
𝛼 = ( (cos(2πft) +  1)/2 )𝑎 
This results in signals with a more Gaussian-like morphology, where the exponent a controls the degree 
of asymmetry between the amplitude magnitude of the peaks relative to the troughs. The exponent a 
was chosen to be 3. The signal 𝛼 was demeaned and rescaled by a factor 2. Note that the properties 
of the non-sinusoidal shape defined above differ from (Mazaheri & Jensen, 2008), and do not refer to 
the normalized variance of the peaks and troughs (see discussion section) but to the higher magnitude 
of the peaks relative to the troughs. 
 
3) Beta-low gamma amplitude harmonics (20 – 40Hz) coupled to alpha phase. 
We simulated a ”sawtooth” signal of ~10Hz period with and without frequency fluctuations (i.e. the 
frequency of the simulated alpha oscillation remained constant across time) with the following equation 
(Maccarone, 2013): 
𝛼 =  ∑ 1
𝑗2
 ∙𝑐𝑜𝑠(𝑗2πft+(𝑗−1)∙ φ)
𝐽
𝑗=1
 
where j indexes the j-th harmonic of frequency f, and the phase term (𝑗 − 1) ∙  φ determines the phase 
of the j-th harmonic. We used the first two harmonics of the alpha band (20Hz and 30Hz, J = 3). The 
sum of the fundamental and the 1st and 2nd harmonics with the phase term φ =  π/2 generates a 
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sawtooth wave whose amplitude raises rapidly decreasing with time in a given cycle (“left-side peak”). 
This waveform will be referred as ‘‘negative sawtooth’’ signal. In contrast, we will refer to a “positive 
sawtooth” (“right-side peak”) a waveform with a constant raising period and a rapidly amplitude 
decrease (φ =  3π/2). We used different φ values [2π, π/4, π/2, 3π/4, π, 5π/4, 3π/2, 7π/4] to simulate a 
variety of waveforms. Frequency fluctuations were introduced as in simulation case 1. In comparison to 
(Kramer et al., 2008), who showed spurious CFC due to the sharp edges in a sawtooth signal, we used 
the 
1
𝑗2
 factor, which results in a more “blunt” or curved sawtooth signal (Maccarone, 2013) to avoid high 
broadband frequency activity in the power spectrum. 
 
4) Broadband gamma amplitude (20 – 120Hz) to alpha imperfect sinusoid CFC. 
Adapted from example 2 in (Kramer et al., 2008), we explore how sharp transitions introduced into each 
alpha cycle affect not only the cross-frequency coherence and bicoherence measures, but also CFD. 
We created a 10Hz sinusoid with a constant period. We add a sharp edge that linearly increases the 
amplitude of the 10Hz oscillation after 1–5ms (uniformly distributed over the cycles). The sharp edge 
begins at phase values uniformly distributed between 233 and 265° (cosine phase), and the increase 
tapers down from one to zero after 67ms. 
 
The same data analysis was performed on the signals for each simulation case described above. First, 
spectral power analysis was performed by means of Fast Fourier Transform (FFT) using the whole time 
series, multiplied by a Hanning taper applied as common in spectral analysis of EEG and MEG data. 
We investigated frequencies from 2 to 120Hz. Second, to investigate cross-frequency interactions 
consistent with Chapter 4 we use the cross-frequency coherence index as defined in (Osipova et al., 
2008). Magnitude squared coherence was calculated between the amplitude envelope (from 5 to 120Hz 
in steps of 1Hz, using a wavelet of 5 cycles) and the raw signal, by segmenting the signal in epochs of 
2s with 50% overlap (𝑛𝐹𝐹𝑇 = 0). CFD was computed according to (Jiang et al., 2015). Unless specified 
otherwise, all simulations used a bandwidth (𝛽 = 4Hz) to computed the weighted average of the slope 
for CFD. We normalized it by an estimate of its standard deviation through a jackknife procedure (i.e. 
Ψ = Ψ̃/std(Ψ̃)) considering ±2 standard deviations as significant (Nolte et al., 2008). Lastly, magnitude 
squared bicoherence (Kim & Powers, 1979) was computed by segmenting the signal in epochs of 2s 
with 50% overlap multiplied with a Hanning taper (from 1 to 120Hz in steps of 0.5Hz). See Chapter 4 
for further details about CFC data analysis. 
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Results. 
Modeling data. 
1. Signal morphology produces spurious cross-frequency coherence, bicoherence and cross-
frequency directionality. 
This section presents the results of the three metrics (CFC coherence, CFD, bicoherence) to the 
different simulated time series.  
 
Figure 1A shows CFC between narrow gamma band amplitude (60 – 80Hz) and alpha phase (8 – 12Hz) 
as simulated in case 1. This periodic sinusoidal signal has a single identifiable peak in the power 
spectrum at 10Hz, broadband power from 60 to 80Hz and a strong CFC coherence. In addition, we 
observed a phase-phase coupling using bicoherence, with no contributions in at the harmonics of the 
alpha wave (i.e. 20Hz, 30Hz). We observe a very robust CFD, consistent with the simulated signal 
where the gamma bursts were leading the alpha cycles (between 0 and 20º of the phase of the slow 
frequency). The observed broadband coherence and directionality extended well beyond the simulated 
parameters (60 – 80Hz), presumably due to spectral leakage. Figure 1B represents the simulated signal 
from case 2 with a non-sinusoidal morphology of the alpha signal: higher magnitude of the peaks 
compared to the troughs. As before, the slower and faster rhythms were phase-coupled in the simulated 
raw signal. The power spectrum revealed three prominent peaks around ~10Hz (fundamental 
frequency), ~20Hz and ~30Hz (harmonic frequencies). Note that the ~20Hz and ~30Hz oscillations 
cannot easily be discerned in the time domain representation of the signal, due to the phase locking of 
the harmonics with the slow alpha signal. As a consequence of the harmonics, CFC coherence and 
bicoherence not only showed the high gamma to alpha coupling but also CFC at the harmonic 
frequencies. As bicoherence captures consistent phase difference between two frequencies and the 
sum of them (~30Hz), the highest peak appeared at ~20Hz (along vertical axis) to ~10Hz (along the 
horizontal axis). Interestingly we found CFD not only to be robust between high gamma and the ~10Hz 
phase but also with the ~20Hz phase, similar as in the coherence. This can be explained as the 
harmonics at 20 and 30Hz are phase-coupled to the 10Hz fundamental frequency and therefore the 
high gamma is coupled to all three. Striking is that no CFD was found at the lower frequencies, whereas 
the lower frequencies do show strong CFC coherence. CFD might be insensitive to the phase 
consistency between the slow signal and its harmonics due to the narrow bandwidth of the coupling 
between the 10, 20 and 30Hz components. So far, slow waves containing non-sinusoidal properties 
may produce non-zero CFC but not necessarily spurious CFD. 
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Figure 1. (A) Simulated alpha sinusoid (~10Hz) and gamma band (60 – 80Hz) cross-frequency coupling (CFC). 
Top: in blue full cosine cycle on a ~10Hz signal coupled to a gamma 50ms burst (red). Middle left: time course 
of the alpha gamma coupled signal with random noise and the power spectrum in decibels (dB). Middle right: 
bicoherence of the simulated coupled signal. Color code represents the magnitude squared coherence between 
a pair of frequencies (x and y axes) and its sum. Bottom left: CFC coherence of the simulated signal. Color code 
represents magnitude squared coherence between y-axes amplitude envelope frequencies and the phase of 
the raw signal (x-axes). Bottom right: cross-frequency directionality (CFD) between high frequencies (y-axes) 
and low frequencies (x-axes). Color code indicates the normalized Ψ̃ weighted average of the CFD. (B) 
Simulated alpha signal with non-sinusoidal shape (~10Hz) coupled to the amplitude of the gamma band (60 – 
80Hz). Top: in blue one asymmetric cycle on a ~10Hz signal coupled to a gamma 50ms burst (red). Same figure 
conventions as in (A). Arbitrary units, a.u., Phase slope index, PSI. 
 
To further assess the sensitivity of CFC metrics to signal morphology, in simulation case 3 we 
constructed a signal with a fundamental and two harmonics, varying the signal morphology and keeping 
the frequency constant (i.e. no period fluctuations); Figure 2A shows a curved negative sawtooth with 
very clean spectral peaks at the alpha frequency and its first two harmonics. We found that cross- 
frequency coherence and bicoherence captured the spurious CFC, whereas CFD showed low values 
not exceeding the significance threshold. As CFD is derived from the phase slope index (PSI) and uses  
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Figure 2. (A) Simulated alpha sinusoid (F1 = 10Hz) and its first two harmonics (H1 = 20Hz; H2 = 30Hz) with no 
period fluctuations. Top: full cosine cycle of the 10Hz (blue), 20Hz (green) and 30Hz (red) and the resulted signal 
(black) taking the sum over all the signals (F1 + H1 + H2 = total). Harmonic phase φ was set to π/2 (see 
simulation case 3) equation for more details). Middle left: time course of the alpha plus harmonics with random 
noise and the power spectrum in decibels (dB). Middle right: bicoherence of the simulated sawtooth signal. Color 
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code represents the magnitude squared coherence between a pair of frequencies (x- and y-axes) and its sum. 
Bottom left: CFC coherence of the simulated signal. Color code represents magnitude squared coherence 
between y-axes amplitude envelope frequencies and the phase of the raw signal (x-axes). Bottom right: cross-
frequency directionality (CFD) between high frequencies (y-axes) and low frequencies (x-axes). Color code 
indicates the normalized Ψ̃ weighted average of the CFD slope. (B) Time course of the simulated alpha sinusoid 
(F1 = ~10Hz) and its first two harmonics (H1 = ~20Hz; H2 = ~30Hz) with period fluctuations and random noise. 
Same sawtooth wave as in Figure 2A top was used. Below, the power spectrum in decibels (dB). CFC 
coherence, CFD and bicoherence have the same figure conventions as in Figure 2A. (C) Simulated alpha 
sinusoid (F1 = ~10Hz) and its first two harmonics (H1 = ~20Hz; H2 = ~30Hz) with period fluctuations. Top: full 
cosine cycle of the ~10Hz (blue), ~20Hz (green) and ~30Hz (red) and the resulted signal (black) taking the sum 
over all the signals (F1 + H1 + H2 = total). Harmonic phase φ was set to 2π (see simulation case 3) equation 
for more details). Same figure conventions as in Figure 2A. (D) Simulated imperfect sinusoid (see simulation 
case 4). Top: full cosine cycle of 10Hz with sharp edges and no period fluctuations. Same figure conventions as 
in Figure 2A. Phase slope index, PSI. 
 
the fluctuations in the period of an oscillation to capture the directionality (Nolte et al., 2008), it is not 
surprising that no significant directionality is found when the frequency of the signal does not fluctuate. 
However, when we include cycle by cycle fluctuations of the alpha period, the CFD appeared within the 
harmonic frequency range (Figure 2B, 8 – 12Hz frequency phase, 20 – 30Hz frequency amplitude). This 
directionality is consistent with the signal, as the negative sawtooth was modelled using harmonics that 
were phase-lagged relative to the fundamental frequency. Again, using a simulated signal with a 
spectral structure that is not obvious in the time domain representation of the raw unfiltered signal, we 
obtained significant CFC and CFD between the fundamental frequency and its harmonics. In sum, 
specific signal waveform may produce non-zero CFC and CFD at the same time. 
 
Significant CFC can be observed in the absence of CFD if the amplitude envelope of the higher 
frequencies and the analytic phase of the slow frequencies covary in time without phase delays (Jiang 
et al., 2015). If the signal is of non-sinusoidal shape, we might be unable to detect CFD due to the 
consistent zero phase-lag CFC between the slow frequency and its harmonics. To test this possibility, 
we made a variant of case 3 in which the harmonics were aligned to the fundamental frequency, 
showing non-sinusoidal shape properties without phase lead, nor lag (Figure 2C). As predicted, we 
observed spurious CFC between alpha and its harmonics but no significant directionality within the 
harmonic frequency ranges. To explore whether CFD could be insensitive to spurious CFC due to the 
non-sinusoidal properties of an alpha band signal, we systematically modulated the φ value 
[2π, π/4, π/2, 3π/4, π, 5π/4, 3π/2, 7π/4] to simulate a variety of waveforms that are displayed in Figure 
3 (see simulation case 3) for details). We found two cases on where CFD between harmonics and the 
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fundamental frequency were not significant for 8 – 12Hz frequency phase and 20 – 30Hz frequency 
amplitude: for the phase φ being π or 2π. In both cases the signal had a non-sinusoidal morphology (π, 
troughs with more amplitude than peaks; 2π, peaks more amplitude than troughs) and zero phase-lag 
between the amplitude envelope of the harmonics and the phase of the fundamental frequency. At the 
other values for φ, the directionality as assessed by CFD changed as a function of the sawtooth peak: 
negative CFD was obtained with a negative sawtooth waveforms and positive CFD was obtained with 
a positive sawtooth waveform. Comparing the upper (at 12:00) and lower (at 6:00) panels in Figure 3 
one can observe the sign of the directionality being flipped. In conclusion, we identify the wave 
morphologies that produce spurious CFC and CFD between harmonics. 
 
2. Sharp edges in the signal produce spurious cross-frequency directionality. 
Although CFD should not appear when the frequency of a periodic signal does not fluctuate, sharp edge 
transients could still introduce directionality. To assess the influence of sharp edge artifacts on the CFD 
index, in simulation case 4 we replicated the cosine example described in (Kramer et al., 2008). As 
seen in Figure 2D, we observed not only strong CFC coherence between the fundamental frequency 
and multiple harmonics, but also robust CFD between multiple frequencies. Therefore, we find that 
spurious CFD can be found in signals with edge artifacts even when the simulated signal has no 
frequency fluctuations.  
 
Experimental data. 
1. Epileptic seizure activity produces spurious cross-frequency coherence, bicoherence and 
cross-frequency directionality between slow and high frequencies. 
Moving beyond synthetic data to assess the influence of signal morphology on a number of CFC 
metrics, we turned to a signal with good signal-to-noise and a signal morphology for which CFC so far 
has not been considered. During epileptic seizures there are stationary periods of hypersynchrony that 
exhibit non-sinusoidal waveforms in intracranial EEG (iEEG). We used an short recording during an 
epileptic seizure that was made (Andrzejak, 2011; Andrzejak et al., 2001)1. The data consists of a 23.6s 
segment of a human hippocampal recording that was acquired at a sampling rate of 173.61Hz. For 
further details about the data see (Andrzejak et al., 2001). We performed the same CFC analysis as in 
the simulation section. Before the main analysis, data was up-sampled up to 500Hz to increase the 
frequency resolution. 
  
109 
 
 
 
Figure 3. Cross-frequency directionality (CFD) index changes as a function of harmonic phase alignment. 
Simulated alpha sinusoid (F1 = ~10Hz) and its first two harmonics (H1 = ~20Hz; H2 = ~30Hz) with period 
fluctuations. Inner circle: full cosine cycles of the ~10Hz (blue), ~20Hz (green) and ~30Hz (red) and the resulted 
signal (black) taking the sum over all the signals (F1 + H1 + H2 = total). Harmonic phase φ was set to the 
different phases as indicated in the circle (see simulation case 3) equation for more details) organized in a clock-
wise manner. Each time-resolved single cycle was associated to cross-frequency coherence, CFD and 
bicoherence plots. Figure scales and conventions were the same as in Figure 1. Phase slope index, PSI. 
 
Figure 4A shows the iEEG signal during an epileptic seizure. The slow oscillation (~5Hz) waveform 
resembles a negative sawtooth with non-sinusoidal morphology, i.e. the peaks are sharper than the 
troughs. A CFC coherence analysis revealed a highly robust theta phase (4 – 6Hz) to beta-gamma 
amplitude (15 – 80Hz) coupling. Correspondingly, a significant negative CFD was observed in the same 
frequency range, indicating the theta phase to lagged the beta-gamma amplitude (Figure 4A).  
 
Bicoherence confirmed the coupling between multiple frequencies separated by ~5Hz, even though the 
harmonics were not clearly visible as peaks in the power spectrum. Additional low-pass (< 20Hz) filtering 
of the signal with a windowed sinc two-pass filter did not change the signal morphology upon visual 
inspection, and similar CFC coherence and CFD patters were obtained (Figure 4B). As in the original 
110  
data, both CFC and CFD yield strong coupling values beyond the upper cut-off frequency, which can 
be interpreted as false positives. Bicoherence, on the other hand, detected phase-to-phase coupling 
between theta (4 – 6Hz; x-axes) and the frequencies below 20Hz (y-axis).  
 
A close visual inspection of the original signal sheds some light on the possible cause of CFC coupling 
between gamma amplitude and theta phase. The signal shows a small transient following the main 
peak (see Figure 4A and B, red arrows). In an attempt to rule out the effect of this transient on the CFC 
metrics, we applied a boxcar moving average filter of 0.1s. In Figure 4C one can see that this filter 
decreases overall signal amplitude, while the non-sinusoidal morphology is preserved (see Figure 4C 
top-left insert). Although the small transient peaks following the main peaks were eliminated, CFC 
coherence and CFD plots still showed broadband beta-gamma amplitude coupled to the theta phase 
(4 – 6Hz). Furthermore, prominent bicoherence values were found between the theta phase (~5Hz; 
horizontal axis) and its harmonics (~10Hz, 20Hz, ~30Hz and ~40Hz; vertical axis), indicating that the 
waveforms, although more symmetrical after the 0.1s smoothing still reflect the non-sinusoidal 
properties that produced spurious CFC results. Summarizing, physiological signal with non-sinusoidal 
wave morphologies, like the epileptic recordings, may produce non-zero CFC and CFD difficult to 
disentangle from independent oscillations that overlap with the harmonic frequencies. 
 
Discussion. 
We used simulated and experimental data to demonstrate the role of the signal wave morphology on 
three CFC metrics (cross-frequency coherence, CFD and bicoherence). We systematically evaluated a 
number of features in the simulated signal to assess the effect on CFC metrics. Furthermore, we 
evaluated the influence of signal filtering on the three indexes. 
 
We find that the three CFC metrics give different but complementary information that can be related to 
the morphology of the signal waveforms. Cross-frequency coherence is sensitive to couplings between 
the fundamental frequency and its harmonics, a common feature in periodic signals with a non-
sinusoidal morphology (case 2 and 3), in signals that contain edge artifacts (case 4) and also in absence 
epilepsy recordings. Bicoherence yielded results equivalent to cross-frequency coherence and CFD 
resulted in significant directionality between the phase of the fundamental frequency and the amplitude 
envelope of the harmonics. CFD not only showed this with simulated sawtooth waves, but also with 
absence epilepsy waveforms. CFD did not show significant directionality in signals whose magnitude 
of its peaks had higher amplitude relative to its troughs (or vice versa, see Figure 3). Furthermore, CFD 
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did not show significant directionality in signals where the fundamental frequency did not show any 
fluctuation unless they contain edge artifacts.  
 
Spurious cross-frequency coupling can be narrowband. 
Previous reports have shown that sharp edge artifacts (Kramer et al., 2008) or non-linearities and non-
stationarities in the data (Aru et al., 2015) may lead to spurious CFC. Here we complement these 
findings with similar concerns for smooth and stationary signals showing periodic non-sinusoidal wave 
morphologies. We show that with a simple superposition of three sinusoidal basis functions, it is 
possible to generate signals with not only narrow band CFC but also significant CFD. In contrast to the 
reported broadband effects produced by sharp edge artifacts (Kramer et al., 2008; Tort et al., 2013), 
non-linear oscillators as in the Van der Pol system, point process or stimulus-related responses (Aru et 
al., 2015), the present simulations show that spurious coupling (CFC and CFD) between the 
fundamental frequency and its harmonics can also be narrowband (20 – 40Hz). Therefore, we 
recommend extra care when interpreting CFC results that overlap with the harmonics of the frequency 
for phase. 
 
Mismatch between filter kernel and signal morphology produces non-zero CFC patterns. 
The results presented were computed using only a limited number of CFC metrics that were based on 
Fourier methods. We expect other methods based on band-pass filtering and Hilbert transform to yield, 
in principle, similar results (Canolty et al., 2006; Cohen, 2008; Penny, Duzel, Miller, & Ojemann, 2008; 
Tort, Komorowski, Eichenbaum, & Kopell, 2010). Although algorithmical details differ between the 
various methods, there is a equivalence between Wavelet, Fourier and Hilbert methods on amplitude 
spectral estimation (Bruns, 2004). E.g. considering filtering followed by Hilbert decomposition, we can 
describe a FIR filter as a convolution with a filter kernel that mimics a wavelet of limited duration.  
Conversely, (Lepage, Kramer, & Eden, 2013) suggest that the phase variance and bias of the three 
estimators “are shown, in simulation and in theory, to depend on the extent to which signal present in 
the data is matched to the phase estimator” (page 915). While Wavelet phase estimator outperforms 
Fourier and Hilbert transforms when the signal to be analyzed is a broadband pulse-like waveform, the 
Fourier approach yields more accurate phase estimates in comparison with the other two methods 
when the signal to be analyzed shows a sinusoidal-like waveform (see (Lepage et al., 2013) for details).  
 
Following this rationale, if the filter kernel can be adapted to the signal under analysis, the spectral 
estimation will be more accurate. This is basically the strategy that (Mallat & Zhang, 1993) adopted in   
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Figure 4. Cross-frequency coupling (CFC) under epileptic seizure. (A) Left: time course of the epileptic seizure. 
Below, amplified time selection (10 – 15s) to show the sawtooth amplitude asymmetric wave morphology during 
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seizure hypersynchrony. Right: power spectrum in decibels (dB) with a peak ~5Hz. Bottom: CFC coherence, 
cross-frequency directionality (CFD) and bicoherence. Phase slope index, PSI. (B) Same recording and figure 
conventions as in Figure 4A using a low-pass filtered below ~20Hz. (C) Same recording and figure conventions 
as in Figure 4A using a boxcar moving average filter of 0.1s. 
 
the “Matching Pursuit” time-frequency approach, where signals are decomposed into linear expansion 
waveforms from redundant dictionary of functions and those ones that match the signal morphology are 
selected. Future CFC metrics could use filter kernels adapted to non-sinusoidal signals to avoid 
spurious sensitivity to harmonics. 
 
Cross-frequency directionality index can produce spurious lags or delays between the fundamental 
frequency and its harmonics. 
Present simulations and empirical results show that spurious CFD may be indeed found between the 
phase of the fundamental frequency of slow oscillations that show non-sinusoidal properties and the 
amplitude envelope of its harmonics. The CFD proposed by (Jiang et al., 2015) is the PSI applied to 
the cross-frequency domain. PSI has been shown to be resistant to false positives when directionality 
between two independent time series containing non-linear interactions is assessed (Nolte, Ziehe, 
Krämer, Popescu, & Müller K, 2010). The PSI computes directionality by comparing two independent 
time series, but the CFD is computed here in the same recording (one time series) between different 
frequency bands. As non-sinusoidal signal morphologies can yield spurious CFC, harmonics coupled 
to the fundamental frequency with non-zero phase lag may result in a spurious directionality (see Figure 
3). One way to reduce this is to compute the CFD between sets of independent recordings (Aru et al., 
2015; Maris, van Vugt, & Kahana, 2011; van der Meij, Kahana, & Maris, 2012). For example, Spaak et. 
al., found stronger CFC patterns between monkey V1 layers (alpha phase of infragranular layer coupled 
to gamma power of supragranular layer) in comparison with CFC within the same layer (Spaak et al., 
2012). Datasets including spikes and local-field potentials (LFP) could help to dissociate the gamma 
oscillations from the potential harmonics from non-sinusoidal properties of slower rhythms. In this 
direction, (Colgin et al., 2009) found that both fast and slow gamma oscillations in different circuitry of 
rat hippocampus locked to spikes at different phases. Specifically, this would mean that both slow and 
fast gamma are rhythms not only related to spiking activity between regions relate to spiking activity but 
also modulated by the phase of the ongoing theta activity. However, this approach is not exempt of 
problems. It is not easy to establish unambiguously which variables are synchronized using different 
coherence measures (see (Buzsaki & Schomburg, 2015) for an elaborated argumentation). Gamma 
power can be contaminated by the spike activity, making very challenging to disentangle independent 
oscillatory gamma estimates from the spike activity (Buzsaki & Schomburg, 2015; Ray & Maunsell, 
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2015). This is the same problem described in the present Chapter, but this time the harmonic 
frequencies are originated from the non-sinusoidal properties of the spike wave morphology. Indeed, 
an empirical study found that the contribution of these spike-related harmonics can go as low as 10Hz 
(Waldert, Lemon, & Kraskov, 2013). Although spiking activity can definitely help to understand LFP 
activity, its interpretation in relation to neuronal oscillations needs to be done with careful. 
 
Neurophysiological oscillations with non-sinusoidal wave morphologies and its consequences for CFC 
analysis. 
The results of the simulations presented here raise a challenge to CFC analyses of signals whose 
waveform is known to be non-sinusoidal, such as the occipital alpha (Nikulin et al., 2007; Stam et al., 
1999), hippocampal theta (Belluscio et al., 2012) and the sensorimotor mu-rhythm (Salmelin & Hari, 
1994). The latter is in fact quite revealing, given that it was originally called “rhythme en arceau” by 
(Gastaut, 1952) due to its arch-like shape. The low gamma power which has been associated by CFC 
to the 6 – 10Hz phase have been empirically shown to be problematic (Tort et al., 2013), in line with 
results presented in Chapter 4 (CFC during resting state and WM conditions) and the epileptic 
recordings used in this Chapter. For instance, with the CFC metrics used here, we cannot differentiate 
the CFC due to harmonics from genuine CFC caused by independent (i.e. non-harmonic) beta-low 
gamma oscillations phase-locked to slower rhythms.  
 
The non-sinusoidal shape properties of the alpha band (i.e. magnitude of the peaks higher relative to 
the magnitude of the troughs) should not be confused with the alpha asymmetric amplitude fluctuation 
properties defined by (Mazaheri & Jensen, 2008). The asymmetric amplitude fluctuations were defined 
as the normalized ratio of the variance (not the amplitude) of the peaks of an oscillatory activity minus 
the variance of the troughs (Mazaheri & Jensen, 2008). The authors used a synthetic signal with the 
form: 
𝑎 = 𝐴(𝑡) ∗ (1 + 𝑠𝑖𝑛(2πft)) 
where A(t) is a slow signal (i.e. 3Hz) that determines the amplitude modulation of the alpha frequency 
f. Note that, by construction, this synthetic signal will not produce harmonics because it consists of a 
DC offset term and a single sine wave. This type of model do not apply to the empirical data presented 
in Chapter 4 because we observed strong coupling between 10Hz and it harmonics (20Hz and 30Hz) 
using bicoherence (see Figures 6 and 9 Chapter 4). Given that the modelled signal (Mazaheri & Jensen, 
2008) does not yield harmonics, computing bicoherence would not give any phase-to-phase coupling 
in the alpha band.  
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Conclusion. 
Concluding, the waveform morphology of specific brain oscillations is a basic and very important feature 
to be considered in CFC analysis. Neurophysiological signals with a non-sinusoidal wave morphology 
can produce spurious CFC on cross-frequency coherence, bicoherence and CFD metrics. We concur 
with (Aru et al., 2015; Kramer et al., 2008) to use the bicoherence metric to estimate the contribution of 
non-sinusoidal properties in the data and we propose to use this metric also to contribute to 
disentangling the models underlying the alpha wave morphology (Mazaheri & Jensen, 2008; Nikulin et 
al., 2010; Stam et al., 1999).  
 
In the context of the simulations presented here, the empirical CFC results obtained in Chapter 4 do 
not allow us to dissociate whether the alpha phase to beta-low gamma CFC is due to harmonics, due 
to independent oscillations that interact with each other, or whether it is a combination of the two. Given 
the non-sinusoidal alpha band waveform morphology, we consider it plausible that spurious CFC due 
to harmonics contributed at least partially to the results in Chapter 4. We suggest a cautionary 
interpretation of CFC results based on current models that assume that communication between 
neuronal ensembles is implemented as cross-frequency interactions between gamma and alpha activity 
(Jensen & Mazaheri, 2010). 
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CHAPTER 6 
 
 
General discussion. 
 
In the present thesis I have gained important new insights regarding how GABAergic neurotransmission 
influences neuronal synchronization in the human brain. Pharmacologically-induced GABAergic 
enhancement yielded profound and robust modulations in occipital oscillatory activity under rest and 
working memory (WM) conditions. My novel insight is that gamma oscillations associated to the stimulus 
period seem to share common neurophysiological mechanisms as the ones described in rat 
hippocampus models. Conversely, alpha oscillations were implicated in functional inhibition during top-
down periods, being also modulated by lorazepam (LZP). However, I could not find relationship between 
the drug-related oscillatory activity changes with the endogenous GABA concentrations in occipital nor 
motor cortices as assessed with MRS. During resting state and during WM information maintenance 
periods, I found that the amplitude envelope of the beta-low gamma band (20 – 45Hz) is locked to the 
ongoing phase of the alpha oscillations (8 – 12Hz). Only the highest LZP dosage during resting state 
affected the alpha to beta-low gamma cross-frequency coupling (CFC). However, the CFC metrics 
employed here did not allow me to distinguish a true neuronal cross-frequency interaction from spurious 
CFC due to the non-sinusoidal properties in the alpha band. In the next section, I will summarize the 
main findings presented in this thesis and I will end by discussing questions for future research. 
 
Summary of the findings. 
In chapter 2, I acquired whole-head MEG measurements from healthy participants that performed a 
visuo-spatial WM task using a double-blind randomized crossover pharmacological challenge. I found 
that while occipital stimulus-induced gamma power increased with LZP dosage, its frequency 
decreased. The drug-related increase in occipital gamma power contralateral to the attended hemifield 
was predictive of increases in response times during the low dosage sessions. Conversely, posterior 
alpha oscillations lateralized strongly during cue and delay periods, reflecting a disengagement of the 
ipsilateral hemisphere respective to the attended visual hemifield (i.e. power increase) and/or an 
engagement of the contralateral hemisphere (i.e. power decrease). This lateralized activity was 
parametrically reduced with LZP dosage and behaviourally relevant: it predicted WM performance 
impairment. Gamma power was modulated as a function of allocation of spatial attention although LZP 
did not influence the magnitude of the lateralization. Interestingly, gamma and alpha attentional 
modulations were linked: participants with stronger alpha attentional modulations during WM delay 
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interval were those ones with the strongest gamma attentional modulations over the subsequent 
stimulus-induced periods. Importantly, despite the system-wide pharmacological intervention, I 
obtained two findings that speak in favour of the LZP modulations in the visual cortex. First, despite of 
the stimulus-related occipital gamma modulations with drug, sensorimotor gamma activity associated 
to the button press remained unaffected. Second, LZP dosage interacted with hemispheric alpha power 
during the WM delay interval (not during the cue), being the ipsilateral hemispheric alpha power more 
reduced with drug dosage in comparison with the contralateral. Overall, these results imply that the 
GABAergic interneuronal network influences the gamma and alpha power during human WM 
operations.  
 
A recent report showed a positive correlation between resting GABA concentration and gamma peak 
frequency in visual cortex (Muthukumaraswamy et al., 2009). To further study the relationships between 
the GABAergic system and its associated oscillatory activity, in chapter 3 we measured endogenous 
GABA concentration in occipital and motor cortices by means of MRS. Despite the stimulus-induced 
gamma power and frequency modulations produced by LZP in both sensor and source space, none of 
them significantly correlated with the resting GABA concentration.  
 
In chapter 4, I demonstrated that, during resting state conditions, while occipital alpha power decreased 
with GABAergic enhancement, the sensorimotor beta power increased as a function of LZP dosage. 
Moreover, we found that the phase of the occipital alpha rhythm (8 – 12Hz) was coupled to amplitude 
of the beta-low gamma band (20 – 45Hz). Additionally, over similar occipital sensors, we found 
consistent phase differences between alpha (~10Hz) and beta (~20Hz) band activity in occipital sensors 
as revealed by bicoherence. However, neither beta-low gamma peak-trigger averaging nor time-
frequency representations locked to the alpha peaks provided convincing CFC patterns as those seen 
in the frequency-by-frequency comodulograms. During eyes closed (EC), LZP decreased the occipital 
alpha/beta-low gamma CFC. During WM delay we observed similar occipital CFC patterns but no drug 
modulations were found. Overall, our results could be explained by zero phase-lag coupling between 
alpha and beta-low gamma or by spurious CFC due to harmonics coming from the alpha band. 
 
I tried to dissociate between these two possibilities in chapter 5 using synthetic data and epileptic 
seizure recordings. It was demonstrated that, combining the alpha band with its first two harmonics 
(~20Hz, ~30Hz) to produce a wave morphology on where the magnitude of the peaks is higher relative 
to the troughs, robust CFC coupling and bicoherence could be observed. Moreover, I demonstrate that 
signal with sawtooth wave morphology can produce spurious cross-frequency directionality (CFD) 
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between the phase of the fundamental frequency and the amplitude envelope of its harmonics. 
However, signals with a magnitude asymmetry between peaks and troughs did not produce false 
positives. In summary, I demonstrated that periodic signals whose wave morphology does not match 
filter kernels (i.e. wavelets, finite impulse response filters.) may produce non-zero CFC and may or may 
not produce spurious CFD. Unfortunately, I could not dissociate this spurious CFC from a potential 
genuine CFC formed by independent higher frequency oscillations (not produce by spectral correlations 
due to the nonsinusoidal properties) interacting with the phase of slower oscillations. 
 
Outlook. 
Despite the recent intensive research on the GABAergic modulations of stimulus associated gamma 
oscillations (Muthukumaraswamy, 2014) the physiological mechanism underlying neuronal oscillations 
are far from understood. Using tiagabine (Muthukumaraswamy et al., 2013a) did not find neither 
frequency nor gamma power changes induced by the drug, (Saxena et al., 2013) applied propofol 
reporting stimulus-induced gamma power increase without frequency changes and (Campbell et al., 
2014), using alcohol intoxication, found a gamma frequency decrease with power increase. The results 
in chapter 2 are in line with the later study but all drugs employed in the studies cited above were 
GABAergic enhancers. On the other hand, physical stimulation parameters seem to influence the 
stimulus-induced gamma oscillations more than previously thought. For example, colour and luminance 
do not always evoke robust gamma oscillations (Swettenham, Muthukumaraswamy, & Singh, 2013). 
Both gamma peak frequency and power diminish as a function of stimuli eccentricity (van Pelt & Fries, 
2013). Recently, a debate has raised regarding whether the stimuli spatial pattern influence stimulus-
induced gamma power modulations (Brunet et al., 2014; Hermes et al., 2015). While natural images 
evoked strong gamma oscillations (50 – 80Hz) in monkey V1 (Brunet et al., 2013), noise patterns and 
some natural images failed to produced stimulus-induced gamma oscillations in human V1/V2 using 
electrocorticography (ECoG) recordings (Hermes et al., 2014). Further research will be needed to 
address whether the discrepancies between studies are due to differences in visual-stimulation, 
pharmacokinetics or cognitive task-demands. For example, a pharmaco-MEG study exploring 
systematically different grating parameters in combination with a WM task using different drug types 
(tiagabine, propofol, LZP) would help to shed light in these issues. 
 
While the underlying physiological mechanisms of gamma oscillations seem to rely on GABAergic 
inhibition (stimulus-induce gamma power increased with LZP, see chapter 2), the case seems to be 
different for the alpha band. LZP consistently decreased alpha power and its attention modulations 
during WM (chapter 2) and resting state conditions (chapter 3). Given the proposed inhibitory role of 
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the alpha band activity (Jensen & Mazaheri, 2010; Klimesch, 2012), one might have expected the alpha 
power to increase as the GABAergic inhibition increases. Indeed, as far as I know, only two MEG studies 
that used diazepam (Hall et al., 2010) and gaboxadol increased power in the occipital alpha band (Nutt 
et al., 2015). Pharmacological research in humans using GABAergic enhancers shows that the 
mechanism underlying occipital alpha oscillations do not seem to depend on inhibitory synaptic time 
constants in the same degree as for hippocampal gamma oscillations (Ching & Brown, 2014; Klimesch 
et al., 2007). For example, neither benzodiazepines (Ahveninen et al., 2007; Golombok & Lader, 1984; 
Hall, Barnes, Furlong, Seri, & Hillebrand, 2010; Schreckenberger et al., 2004) nor barbiturates 
(Cimenser et al., 2011; Kishimoto, Kadoya, Sneyd, Samra, & Domino, 1995; Muthukumaraswamy et 
al., 2013a; Purdon et al., 2013; Supp, Siegel, Hipp, & Engel, 2011) alter posterior alpha frequency. 
Frontal alpha power and frequency do change mechanistically as a function of propofol dosage (Ching 
et al., 2010; Vijayan et al., 2013). Pharmacologically-induced alpha frequency changes are more likely 
to be explained due to a change in synaptic constants in comparison with power changes. The last ones 
are known to vary with attention (Jensen & Mazaheri, 2010; Klimesch, 2012), are influenced by other 
brain regions (Capotosto et al., 2009) and it is difficult to de-mix those effects out of the system-wise 
pharmacological intervention. Given the inhibitory interneurons have been linked to the alpha rhythm in 
cats (Lőrincz et al., 2009) and monkeys (Vinck et al., 2013), further animal studies in combination with 
pharmacology will be needed to look deeper into the role of GABAergic neurotransmission and the 
~10Hz oscillations. In parallel, further research with neuromodulators as will be highly valuable given 
that acetylcholine increased alpha power with attention modulations predicting performance 
enhancement (Bauer et al., 2012). 
 
The lack of relationship between endogenous GABA concentration in visual cortex as measured with 
MRS and the gamma drug-related changes as measured with MEG does not have a clear explanation 
(chapter 3). This is in clear contrast with the original finding (Muthukumaraswamy et al., 2009). This null 
results could be possible explained by differences in the task/stimulus employed. The center-of-mass 
index I used here captures changes within a broad range in the frequency spectrum, not differences in 
the peak frequency. On the other hand, more recent evidence suggests that the relationship between 
endogenous GABA levels as measured with MRS and the gamma peak frequency are far from well 
established. The same research group that first reported that GABA levels predicted positively gamma 
peak frequency was unable to replicate their own findings (Shaw et al., 2013). Our results are also in 
line with a recent study that combined MEG and MRS in a large sample (n=50) providing convincing 
evidence about the absence of relationship between individual differences in gamma frequency and 
power and endogenous GABA concentrations in human visual cortex (Cousijn et al., 2014). 
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Alternatively, the LZP gamma modulations produced in our sample could have been not large enough 
to be measurable with MRS. It could also be the case that MRS measures non-specific (synaptic and 
extra-synaptic) GABA levels (Rae, 2014) that are not sensitive enough to find significant correlates with 
our oscillatory modulations. For instance, GABA-MRS findings need to be interpreted with caution, 
especially when a small sample is used. Moreover, there is a recent null finding showing that the BOLD-
GABA relationship originally found was probably biased (Harris et al., 2015). Future studies are needed 
to address these open issues. Recent evidence combining Positron Emission Tomography (PET) and 
MEG finds that the GABAA receptor density in visual cortex predicts gamma peak frequency among 
participants (Jerbi, 2014). Future studies combining PET, MRS, MEG and pharmacology could help to 
shed light in this issue. . 
 
CFC would provide a powerful framework to understand how information processing is supported by 
neuronal oscillations linking not only multiple time scales (i.e. phase-to-amplitude coupling between 
slow and fast rhythms) but also different spatial scales (i.e. slower oscillations would support long-range 
communication while fast frequencies would perform local computations). I found that different CFC 
metrics can provide complementary information about frequency interactions. However, some caveats 
may appear making the interpretation of the results challenging. For example, spectral analysis of 
periodic signals that systematically mismatch with a given filter kernel will produce harmonics. In other 
words, different estimators (discrete Fourier transform, Wavelet transform) can be a maximum likelihood 
estimator based on a different signal model (i.e. wave morphology) (Lepage et al., 2013). The power of 
the harmonics will appear at specific phase bins of the fundamental frequency, producing non-zero 
phase-to-amplitude coupling. This type of spurious CFC is difficult to dissociate from a model consisting 
of independent brain rhythms that interact with each other. As other authors (Aru et al., 2015; Kramer 
et al., 2008; Tort et al., 2013), I recommend the use of peak-triggered averages to assess the presence 
of real oscillations in the time domain phase-locked to a slower rhythm and bicoherence to test the 
presence of harmonics that can contribute to the CFC. Moreover, I show that different physiologically-
inspired wave morphologies (sawtooth-like and mu-like rhythms) can produce narrowband CFC within 
the 20 – 45Hz frequency range with significant (and spurious) CFD in specific cases (sawtooth). Given 
that it is known that some slower rhythms display non-sinusoidal properties (see chapters 4 and 5), 
special caution should be taken on data analysis and interpretation of the CFC patterns associated to 
them. If signals whose wave morphology deviate from sinusoidal are analysed with standard Fourier, 
Wavelet or recurrent band-pass filters, the likelihood to find non-zero CFC and non-zero CFD increases. 
In the future, alternative signal processing approaches are needed to complement current CFC 
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methodologies. Spectral techniques based on filter kernel adaptation could alleviate some of the 
problems described here.  
 
Conclusion. 
Computational and experimental rat hippocampal models have convincingly demonstrated the critical 
role of GABAergic neurotransmission, especially in fast neuronal oscillations. My work contributed to 
generalize to human visual cortex these physiological mechanisms, showing its behavioural relevance 
during WM operations. Alpha oscillations have been associated to a strong phasic inhibition, but how 
can it be that GABA decreases alpha power and attentional modulations? Does GABAergic inhibition 
influence the top-down drive from prefrontal brain regions producing the posterior alpha power 
reduction? What is the neurophysiological mechanisms by which the alpha band exerts its functional 
inhibition? Future research combining intracranial recordings with pharmacology in humans and 
animals is required to answer these questions and improve the mechanistic understanding of neuronal 
oscillations and its consequences for behavioural performance.
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Nederlandse samenvatting. 
 
 
Gedurende de laatste 4 jaar heb ik opgedaan belangrijke nieuwe inzichten over hoe GABAergic 
neurotransmissie invloeden neuronale synchronisatie zoals gemeten met magnetoencephalographic 
(MEG) opnames bij gezonde mensen. Lorazepam (LZP), een GABAergische versterker, geproduceerd 
sterke modulaties in het achterhoofd oscillerende activiteit onder rust en werkgeheugen (WG) 
omstandigheden. Mijn roman inzicht is dat gamma oscillaties gekoppeld aan de stimulus periode lijken 
gemeenschappelijke neurofysiologische mechanismen die in hippocampus rat modellen beschreven 
delen. Met name de verhoging van GABA werkzaamheid van LZP stijging stimulus-geïnduceerde 
gamma oscillaties toegenomen vermogen, terwijl verminderde frequentie. Omgekeerd werden alpha 
oscillaties betrokken bij functionele remming tijdens top-down periodes, wordt ook gemoduleerd door 
lorazepam (LZP). Belangrijker nog, vond ik dat farmacologisch geïnduceerde alfa-power reducties 
voorspelde WG prestaties daling. Echter, ik kon niet tussen de drugsgerelateerde oscillerende activiteit 
verandert met de endogene GABA concentraties in het achterhoofd, noch motorische cortex vinden 
zoals beoordeeld met magnetische resonantie spectroscopie (MRS). Het blijft onduidelijk of deze 
afwezigheid van correlatie fysiologische aard of verklaard door beperkingen in de opnametechniek. 
Tijdens rusttoestand en tijdens WG periodes informatie onderhoud, vond ik dat de amplitude envelope 
van de beta-lage gamma band (20 - 45Hz) wordt vergrendeld aan de lopende fase van de alfa oscillaties 
(8 - 12 Hz). Alleen de hoogste dosering LZP tijdens rusttoestand van invloed op de alpha naar beta-
laag gamma cross-frequentie coupling (CFC). Echter, de CFK metrics hier werkzaam niet toe dat ik een 
echte neuronale cross-frequentie interactie van valse CFC onderscheiden als gevolg van de niet-
sinusvormige woningen in de alfa band. 
 
Samenvattend zijn computationele en experimentele rat hippocampale modellen overtuigend 
aangetoond dat de kritische rol van GABAerge neurotransmissie, in het bijzonder in snelle neuronale 
oscillaties. Mijn werk heeft bijgedragen aan generaliseren naar menselijke visuele cortex deze 
fysiologische mechanismen, toont zijn behavioral relevantie tijdens WM operaties. 
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Occasionally I believed I had thoughts of my own – who does 
not now and then become a victim of such delusions? – but I 
would have never dreamt of regarding these thoughts as an 
essential part of myself. I, so I said when considering this 
matter, am very different indeed from the most sublime 
invention I have produced and the most deeply felt 
conviction than pervades me, and I must never permit these 
inventions and convictions to get the upper hand and to turn 
me into their obedient servant.  
 
— Paul K. Feyerabend (1987)  
Farewell to Reason. 
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